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Low molecular-weight gelators (LMWGs) are a fascinating and interesting class of compounds 
that can self-assemble and form supramolecular structures in appropriate solvents. The gelators 
form fibrous networks which entrap the solvent and result in a supramolecular gel. Carbohydrate-
derived LMWGs are especially useful since they are more likely to be biocompatible and 
biodegradable. Dendritic gelators are branch-shaped molecules with precise molecular weight that 
are between small molecules and polymer gelators. Glycoclusters with sugar moieties at the 
periphery of the molecules are important classes of bioactive compounds due to the multivalency 
effect. Lower generation glycoclusters are relatively small branched systems that have defined 
molecular weight and shape. There should be multivalent interactions between the repeating 
monomeric building blocks. Macrocyclic compounds play an important role in many research 
fields including drug development, bioorganic chemistry, and materials sciences. Many 
glycosylated natural macrocyclic compounds have important therapeutic activities and are 
privileged scaffolds in drug discovery. Apart from their pharmaceutical properties, sugar 
containing macrocycles have also found applications as catalysts and ligands or sensors for cation 
or anion recognition, and in the preparation of functional supramolecular assemblies.  
 
In this research, through copper-catalyzed azide–alkyne cycloaddition (CuAAC) reaction, also 
known as “click” chemistry, we designed, synthesized, and characterized three main classes of 
sugar triazole derivatives. These include the glycolipids (I), glycoclusters (II) and 
 
 
glycomacrocycle (III). These were prepared using readily available sugars such as D-glucose and 
N-acetyl-D-glucosamine. The design, synthesis and self-assembling properties of 
glycolipids/clusters as effective low molecular weight gelators will be discussed in this thesis in 
Chapter 2 and 3. The applications of these novel molecular systems will be explored. In addition, 
the efficient synthetic route to build glycomacrocycle and structural analysis of these cyclic 
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INTRODUCTION FOR CHAPTERS 
 
Chapter 1 introduces the background and literature review of low molecular weight gelators 
(LMWGs), especially on sugar based low molecular weight gelators, which is the main focus 
during the course of my research. In addition, a general introduction of sugar based macrocyclic 
compounds is presented.  
 
Chapter 2 reports the synthesis and systematically gelation-related characterization of 4,6-O-
benzylidene acetal protected D-glucose and D-glucosamine based β-triazolyl glycosides. We found 
that the presence of the 4,6-O-benzylidene acetal functional group seems to weaken the gelation 
tendencies for some triazolyl glycosides in comparisons to the corresponding tetra-acetyl glycosyl 
triazoles. Additionally, variable temperature 1H NMR and FTIR spectroscopic studies reveal the 
importance of free 3-hydroxyl towards molecular self-assembly. 
 
Chapter 3 presents the synthesis of a series of triazole containing glycoclusters through covalently 
linking the monosaccharide azides to the branched alkynes. Multivalence effect of sugar based 
gelators is observed on the gelation properties, which is, increasing the number of sugar unit in the 
molecules leads to enhancement of gelation performance. 
 
Chapter 4 reports the development of a new efficient synthetic route to afford sugar based 
macrocycles starting from N-acetyl-D-glucosamine (NAG). These glycomacrocycles were 
prepared using copper (I) catalyzed azide alkyne cycloaddition reactions as the ring-closing step.  
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CHAPTER 1. BACKGROUND AND LITERATURE REVIEW 
 
1.1.1 GENERAL INTRODUCTION OF GEL 
Gels are present everywhere in our everyday lives from cosmetics (hair gel), food (jam and jelly) 
to medicines (Advil Liquid-Gels). Gel is a type of soft material that a large amount of solvent is 
trapped in a three dimensionally network of molecules.1-4 Those molecules are termed as gelators. 
Typically, gels are classified as two main types, which are polymer gels and supramolecular gels. 
Polymer gels also known as chemical gels are thermally irreversible because the internal cross-
linked network are formed by strong chemical bonds, for example, covalent bonds. The gelator is 
usually a polymer. However, supramolecular gels or physical gels are reversible due to the 
formation of cross-linked network through weak non-covalent bond. The gelators usually have 
relatively lower molecular weight, which are defined as low molecular weight gelators (LMWGs). 
LMWGs are a class of organic molecules that can self-assemble to form reversible gel in organic 
solvents or water. The molecular weight of LMWG is typically below 3000 Daltons. Because of 
the reversible nature inherited in supramolecular gel, this provides a clear distinct advantage of 
supramolecular gel over in polymer based gel in certain applications especially in biomedical field. 
5 Supramolecular gels possess better bioavailability, less toxicity, and are more easily metabolized 
in the human body than polymer gels, due to the fact that they are made up of small molecules 














Over the past few decades, research in the field of LMWGs has gained numerous attention due to 
their interesting applications including drug delivery,6 tissue engineering,7 enzyme made by 
LMWGs are categorized as organogels or hydrogels depending on the solvent that is trapped in 
the gel matrix. If an organic solvent or an aqueous organic mixture is entrapped in the gel matrix, 
then the gel is called an organogel, the corresponding gelator which forms the gel is termed as 
organogelator. Similarly, such gel is classified as a hydrogel if water is trapped in the gel network, 
the gelator termed as hydrogelator. An example of mannose-derived low molecular weight 
organogelator 1 and diesel and isopropanol supramolecular organogels made by compound 1 are 
shown in Figure 1. 
 
Figure 1. Low molecular weight organogelator 1 derived from mannose and photos showing the 
organogels made by 1 in (a) diesel and (b) isopropanol. 
 
To prepare a supramolecular gel from LMWG two general methods are summarized below. One 
way for preparing the gel is called physical gelation method. In general, a certain amount of gelator 
is placed in a vial with the testing solvent. Then the mixture is heated above the Tgel (solution-





cooled below the Tgel. Sometimes a gentle sonication will accelerate the gel formation. The “crude 
determination” of whether the gel is successfully formed or not is essentially through human eyes 
simply by turning the vial upside down as shown in Figure 2. If the gelled sample does not flow 
and is found to be self-supporting, it is considered to be a stable gel. 
 
 
Figure 2. An illustration of physical gelation preparation method (heating and cooling) and 
inversion test (far right picture) to qualitatively confirm the gel formation. 
 
The limitation of using heat, which is required by the physical gelation method, to prepare gel in 
biological application is obvious, so triggered gelation method are developed. The gelator can 
function as smart material that will trigger gelation when it is exposed different stimuli such as 
certain chemicals, light, pH, or in the presence of enzyme. 
 
One example of hydrolysis of an ester bond under either weak basic or enzymatic condition to 
trigger the hydrogel formation was reported by Bing Xu’s lab.10 Figure 3 shows the structure of 
compound 2 which fails to form hydrogel either by changing pH or temperature. However, a 
simple installation of ester bond to compound 2 gave the molecule 3 with excellent water solubility 
at physiological pH. Through the treatment of chemical (NaOH solution at pH 9) or biological 
catalyst (10 µL 1U/µL esterase at pH 7.5) in a aqueous solution made by compound 3 caused the 






Figure 3. Structure of hydrogelator 2 that can trigger hydrogelation from the precursor 3 under 
weak basic or enzymatic condition. 
 
1.1.2 MECHANISM OF GELATION PROCESS 
Supramolecular gels through self-assembly are the result of non-covalent interactions such as H-
bonding, π-π interaction, C-H-π interaction, van der Waals forces etc. An example of mannose 
derived gelator which can be principally held together by various non-covalent interactions is 
illustrated below in Figure 4.11 
 






The mechanism of gelation process is illustrated in the Figure 5, which can be broken down into 
three steps.12 Molecular interactions, typically, non-covalent interactions promotes the aggregation 
of molecules. With the growing of aggregates, in the secondary step, fibers are formed. The tertiary 
step involves the interaction of the fibers, thus causing the formation of entangled network. If the 
generated network is strong enough to hold the tested solvent, a supramolecular gel is successfully 
formed as seen to stay at the bottom of vial when the vial is inverted. 
 
Figure 5. Primary, secondary, and tertiary structure of the gelation process. 
 
1.1.3 CHARACTERIZATION OF GELATOR AND GEL 
In order to under the gelation process and gel behavior, a wide of techniques have to be used. 
These techniques include NMR spectroscopy, IR spectroscopy, X-ray diffraction, UV-vis 
absorption, Fluorescence, Circular Dichroism, (cryo) SEM, (cryo) TEM, OM, AFM, Rheology, 
and Calorimetry etc. 1H NMR spectroscopy is an effective approach to confirm the formation of 
H-bonding during the gelation process. FTIR spectroscopy studies can also prove useful 
information on H-bonding as well as some other information such as hydrophobic interaction (long 





conjugated system in gelator may induce the intermolecular π-π stacking, which can be 
distinguished by UV-vis spectroscopy for the formation of the gel networks. Circular Dichroism 
(CD) is a technique which can be used to study not only the molecular chirality but also the 
chirality of supramolecular architectures. XRD diffraction can shed light on the detailed packing 
mode of the gelator in gel form. The network is usually observed by microscopic techniques to 
obtain the information such as the morphology of the network, the width and length of the fibers. 
The mechanic properties of gel can be measured by rheology, which give the information of flow 
and deformation of tested material. The thermos-reversibility of gel from gel-sol to sol-gel can 
proved by differential scanning calorimetry. 
 
1.1.4 EXAMPLES OF LMWGS 
Many different structural classes of compounds have been found to be useful building blocks in 
effective LMWGs.13-15 Compounds of biological origin and natural products such as amino acids,16 
nucleic acids,17 cholesterol 18 and carbohydrates19 have been reported to be effective gelators. 
Some representatives are shown in Figure 6. An octapeptide 4 composed of phenylalanine (F), 
histidine (H), aspartic acid (D) functions as very effective hydrogelator. The hydrogel made by 
gelator 4 was tested as the drug delivery carrier, which exhibit increased loading capacity of 
hydrophobic drugs and the character of sustained release. Thymidine derived nucleoside-fatty acid 
hybrids 5 were characterized as pretty gelator. 3-O’ monofatty acid derivatives 5a can form water-
induced gel. However, 3,5-O’ difatty acid substituted thymidine 5b typically formed gels in pure 
organic solvents and some of these organogels are highly sensitive to the presence of Hg2+ ion. 
Those gels fell apart and transited from stable self-supporting gel to slow free-flowing unstable 





application in sensing due to the incorporation of terthiophene moiety. 3,4-di-O-benzyl substituted 
N-acetyl glucosamine (NAG) derived gelator 7 can gel oils such as diesel or petroleum, which 
shows its potential in oil spill cleaning-up. 
 
Figure 6. Different structural classes of LMGWs. 
 
1.1.5 FUNCTIONAL GROUPS IN LMWGs 
To understand the structural requirement for molecules to form gel has been a long-standing 
challenge in this field. Discovery of gelators has been a circumstance of luck in most cases. Studies 
have shown that hydrogen bonding plays an important role in gelation. Extensive research in the 
area of molecular gelators has shown that some general structural features can affect gelation. For 
example, compounds that contain the various functional groups including amides,20-21 ureas,22-23 





Several examples containing aforementioned functional groups as efficient LMWG are presented 
in Figure 7. 25, 28-29 
 
Figure 7. Examples of LMGWs with different functional groups incorporated. 
 
The copper-catalyzed azide–alkyne cycloaddition (CuAAC) reaction has been discovered by 
Sharpless and facilitated the rapid progress in several chemistry fields including organic 
synthesis,30-31 medicinal chemistry32-33 and material chemistry.34 1,2,3-triazole functionality 
through CuAAC reaction possesses valuable properties such as high chemical stability, strong 
dipole moment, heteroaromatic character and hydrogen bonding donating and accepting abilities. 





excellently in certain cation binding, which leads to a thriving field of the sensing or the detection 
of ions in supramolecular chemistry.35  
 
Recently, cholesterol appended 1,4-substituted triazole incorporated compounds 14-15 have been 
synthesized and characterized by Ghosh et al vas shown in Figure 8.36 Hydrophobic interaction 
from the cholesterol unit and hydrogen bonding provided by triazole moiety allow the gelator 14-
15 to form gels in CHCl3/CH3OH (2/1, v/v). The gel formed by compound 14 transforms from gel 
to sol with the addition of Cu2+ to the gel phase. However, gel compound 15 exhibits the gel to sol 
transformation in the presence of two more cations, Ag+ and Hg2+, other than Cu2+. The reference 
compounds 16-17 without triazole functional groups failed to induce gelation in CHCl3/CH3OH 
(2/1, v/v) which suggests that 1,2,3-triazole motif plays a critical role in gelator design.  
 
Figure 8. Chemical structures of cholesterol coupled triazole containing compounds 14-15 and 





The 1,2,3-triazole moiety, an isostere of the trans secondary amide functional group, with a 
stronger dipole moment (5 D v.s. 4 D) may provide enhanced hydrogen bonding abilities. The use 
of triazole motif to replace amide functional group in gelator design has been studied to be more 
effective in gelling polar solvents by Diaz group in 2015.37 Amide gelator 18 and isosteric gelator 
19 were prepared using L-glutamic acid as the starting material as shown in Figure 9. In polar 
aprotic solvents (H2O, CH3OH, glycerol, CH3CN), the gelation properties of 19 shows 25–55% 
lower critical minimum gelation convention values compared to 18. However, an opposite trend 
was observed in non-polar solvents (Et2O, CH2Cl2, n-hexane, and toluene) where the gelation 
behavior of 19 exhibits 10–75% higher values than 18. The above results indicate that the amide–




Figure 9. Isosteric replacement of amide to triazole in LMWG design. 
 
1.1.6 CARBOHYDRATE BASED GELATORS 
Carbohydrates are abundant, renewable resources, which can be used for preparing chiral 






based gelators have gained splendid interest due to its diversity, availability and its biodegradable 
properties. The structural diversity of carbohydrate makes them an ideal building block for 
discovering gelators ranging from monosaccharides to polysaccharides. Free hydroxyl or amino 
groups can be functionalized to introduce certain functional groups rendering them suitable for a 
variety of special applications. The conversion of carbohydrates into functional materials by 
simple modification to their original structures is an effective strategy for the development of 
biocompatible materials. In the last few decades, we have seen various studies on the design, 
synthesis and analysis of monosaccharides (glucose, glucosamine, galactose, galactosamine etc.) 
or disaccharides (maltose, lactose, cellobiose etc.) based self-assembling systems. These 
derivatives have been found to be excellent low molecular weight hydro/organogelators. 
Polysaccharide, naturally occurring carbohydrate polymers, which certainly fall out of the LMWG 
category, have also been explored widely to function as polymer-based gelators with interesting 
applications discovered.38 39 Cellulose 20 is a glucose polymer linked by beta-linkage. Cellulose 
based gelators have found their applications in oil cleaning up.40 Chitosan 21, most abundant 
natural amino polysaccharide, can function as hydrogel after structural modification and find its 
use in controlled drug delivery. 
 







Monosaccharide based gelators  
Anomeric position functionalization on glucose, glucosamine, galactose and galactosamine 
Anomeric position is defined as the carbon derived from the carbonyl carbon of the open-chain 
form of the sugar molecules. Two anomers are designated as alpha (α) or beta (β) according to the 
configuration of reference atoms (O, N, S, P etc.). If the reference atom is at the axil position at 
the anomeric position when the sugar is drawn is drawn as chair conformation, the anomer is called 
alpha anomer. Similarly, if the reference atom is at equatorial position, the anomer is termed as 
beta anomer.  
 
Methyl α-D-glucopyranoside                             Methyl β-D-glucopyranoside 
Figure 11. Chemical structures of alpha (α) and beta (β) anomers of methyl-D-glucopyranoside. 
 
Recently, Wang group reported the synthesis and self-assembling properties of peracetylated 
glucosyl beta triazole derivatives 22 from glucose by Cu(I) catalyzed azide/alkyne cycloaddition 
reaction.41 They found that triazole analogs bearing long alkyl hydroxyl group 22a is very an 
efficient low molecular weight organogelators in gelling DMSO/H2O (v/v 1:1) with MGC obtained 
at 2.0 mg/mL. The peracetylated D-glucosamine triazole derivatives 23 via the click reaction was 
also studied by Wang group.42 Self-assembling properties of sixteen triazole analogues containing 
long alkyl chain, alkyl terminal substituted amine, hydroxyl, carbocyclic acid was tested in several 
organic solvents, aqueous solutions, and water. Among them, many were found to be 





at concentrations lower than 1.0 wt %. Hexyl derivative 23a and terminal phenyl propyl derivative 
23b forms hydrogel at 0.2 wt% and 0.22 wt% respectively. These results indicate that 
glucosamine-based hydrogels may find potential applications in biomaterials. 
 
Figure 12. Glucose and glucosamine based triazole derivatives as LMWGs. 
 
Most recently, the synthesis and characterization of a library of triazole based gelators from beta-
azido-4,6-O-benzylidene–galactopyranoside were reported.43 Through click reaction, various 11 
alkynes gave different gelators having different gelation properties. Gelation results showed that 
gelators having alkyl-chain substituents formed gel alkanes and various oils. However, the gelators 
bearing aromatic substituents can gel aromatic solvents. The styrene gel of gelator 24a was firstly 
polymerized and then washing away the gelator can give porous polystyrene. The 
tetraethylorthosilicate (TOES) gel of gelator 24b was polymerized to silica followed by removing 
the gelator via calcination to afford microstructured silica rods. Gelator 24c bearing an anthracene 






Figure 13. Galactose based triazole derivatives as LMWGs with various functions. 
 
Zhou and co-workers developed pH-responsive supramolecular hydrogelator based on N-Acetyl-
galactosamine as shown in Figure 14.44 Compound 25 displayed shrinkage or swelling behavior 
with pH variation when mixed with an appropriate amount of amphiphilic carboxylic acid 
derivatives 26. Changing pH has no effect on single-component hydrogel 25, that is, 25 forms a 
stable hydrogel without pH sensitivity. However, when a gel was prepared from an equimolar 
mixture of 25 and 26, the volume of the gel shrinks upon pH variation. These results suggest that 
the two-component combination strategy could be useful for the construction of novel, stimuli-







Figure 14. Chemical structures of galactosamine based gelator 25 and pH responsive partner 26.  
 
The influence of the anomeric position of the sugar headgroup towards functional material was 
studied by Wang group in 2010.45 As shown in Figure 15, both of long chain diacetylene containing 
diester 1-deoxyl derivative 27 and methoxyl derivative 28 at anomeric position are effective 
gelators in ethanol. A Gel formed by compound 27 in ethanol can be polymerized using a TLC 
lamp (6 W) to give blue colored gel. However, ethanol gel formed by compound 28 cannot be 
polymerized as easily compared to ethanol gel in 27 with the 6 W UV lamp. The anomeric effect 
was observed indicating that two diacetylene chains are not aligned perfectly for polymerization 
due to the presence of methoxyl group at anomeric position. In order to trigger ethanol gel formed 






Figure 15. Chemical structures of ester diacetylene derivatives without methoxyl 27 and with 
alpha-methoxyl 28 at anomeric position.  
 
2,3 position functionalization on O-methyl 4,6-O-benzylidene D-glucose and D-glucosamine  
Wang group has also studied the gelation abilities of diverse methyl 4,6-O-benzylidene-α-glucose 
and glucosamine derived LMWGs by functionalizing 2 and 3 position to form different 
derivatives46-50 including esters 29-31, carbamates 32-33, amides 34, ureas 35 and where R group 
range from aromatic group, long chain aliphatic group, short chain aliphatic group, cyclo-alkane 
group, terminal alkyne, halo-alkane group and alkene group. The influence of the different 
functional groups as well as the different R groups on the self-assembly properties were studied. 







Figure 16. Molecular structure of esters 29-31, carbamate 32-33, amide 34, urea 35. 
 
Several sugar based low molecular weight hydrogelators were designed, synthesized and studied 
with general structure shown in Figure 17.51 These new compounds combine two known structural 
features (amide and triazole functional groups) which are prepared by introducing a triazole 
functional group to the acetyl position of protected 2-glucosamine through Cu (I) catalyzed 
azide/alkyne cycloaddition reaction (CuAAC). Eleven compounds of all eighteen synthesized 
compounds are hydrogelators with minimum gelation concentrations of 0.15-1.0 wt%. The 
hydrogel made by gelator 36a are suitable carriers for sustained release of chloramphenicol. Dye 
diffusion with toluidine blue was also studied using UV-vis spectroscopy with the hydrogel 
prepared by compound 36b. These results show that the D-glucosamine amide triazole analogs are 








Figure 17. General structure of D-glucosamine based amide linked triazoles 36. 
 
4,6 position functionalization on D-glucosamine 
Wang group reported a series of interesting pH responsive carbohydrate based organogelator by 
introducing p-methoxylbenzylidene acetal protecting group at the 4,6 position.52 The gelation 
properties of these compounds were analyzed in various solvents. The synthesized amide (37) and 
urea (38) derivatives formed stable gel in at least three of the solvents tested. These pH responsive 
gelators can result in gel-sol transition over a period of time upon pH change. The stability of the 
gels in acidic condition (pH 1) was also tested by adding diluted sulfuric acid to the gels formed. 
All the tested gels formed by the compounds dissolved at various rate. The dissolution of the gels 
is because that the p-methoxylbenzylidene acetal moiety is an acid labile group. Furthermore, 
Naproxen sodium release studies in the gels made by urea derivatives 38 (R = n-heptyl) were 
carried out on neutral (pH 7) and acidic condition (pH 1.9). Under neutral condition, naproxen was 
released slower from the gel phase than that under acidic conditions. These pH responsive gelators 






Figure 18. Chemical structures of pH responsive gelators amides 37 and ureas 38. 
 
In order to probe the structure influence of the 4,6-benzylidene acetal functional group towards 
molecular self-assembly, a new series of amide 39 and urea 40 derivatives were studied by Wang 
group with a methylene spacer inserted between phenyl and acetal at 4,6 position.53 Nine 
representative amides and nine urea analogs were synthesized and their gelation properties 
analyzed in a series of organic solvents and aqueous solutions. Switching aromatic aldehyde to an 
alkyl aldehyde did not affect the gelation properties, most analogs are able to form stable gels in 
at least one tested solvents. Interestingly, the amide analogs bearing long alkyl group are effective 
gelators for pump oil and engine oils, while the urea analogs can form supramolecular gel in polar 
organic solvents such as ethanol, isopropanol and ethylene glycol. Variable temperature study 
using 1H NMR spectroscopy shows the importance of hydrogen bonding for both amide and urea 
analogs. 
 





Disaccharide based gelators 
Two series of peracetylated disaccharide beta-1,2,3-triazole derivatives using lactose and maltose 
as the starting materials via click chemistry were synthesized and studied by Wang group.54 The 
variable proton NMR temperature studies indicated that the triazole moiety played an important 
role in the formation of the supramolecular assembly, but the configuration of the sugar moiety 
has more impact on gelation. Majority of the maltosyl triazoles 41 and only one of the lactosyl 
derivatives 42 were found to be effective molecular gelators. A pH responsive gelator bearing a 
terminal carboxylic acid group showed faster release of chloramphenicol from the gel matrix at 
mild basic condition than neutral condition.  
 
Figure 20. Peracetylated maltosyl 41 and lactosyl 42 triazole derivatives.  
 
The Oriol group explored the gelation properties of maltose-based amphiphiles.55 In this work, the 
influence of triazole to gelation was studied by comparing the gelation abilities of compounds 43 
and 44 as shown in Figure 21. The gelation properties of the amphiphiles 43 and 44 were tested in 
different solvents including polar and non-polar organic solvents and water. From the studies, it 
was observed that the compounds did not form gels in any tested solvents except water. Compound 
44 formed a hydrogel at a minimum concentration of 1 wt % while compound 43 failed to. The 





proved that triazole functional group and hydrogen bonding were a critical factor to promote the 
gelation in water as the proton signal of the triazole ring experienced an upfield shift when water 
is added to a DMSO solution.  
 
Figure 21. Chemical structure of maltose-based amphiphiles 43 and 44.  
 
In another report, Oriol group also reported on the synthesis and characterization of 
supramolecular hydrogelators derived from lactose and cellobiose.56 In this report, the studies 
focused on the effect of varying disaccharide polar head group on gelation. The polar carbohydrate 
head group is connected to the non-polar alkyl chain via triazole as shown in Figure 22. Both 
derivatives did not form gel in the various organic solvents tested except water. The lactose 
derivative 45 formed a stable hydrogel at a concentration of 1.0 wt % while the cellobiose 
derivative 46 formed at a concentration of 0.5 wt %. NMR studies proved that amide group as well 





formation of supramolecular ribbons of hydrogels with different helical arrangement is dependent 
on disaccharide polar heads which was confirmed by circular dichroism. 
 
Figure 22. Chemical structure of lactose and cellobiose based amphiphiles 45-46. 
 
1.1.7 DENDRITIC GELATORS 
Dendrimer/Dendron based gels have received considerable amount of attention for the last a few 
decades. Dendritic gelators are defined as branch-shaped molecules with a well-defined molecular 
weight by iterative synthesis.57 These dendritic compounds have interesting symmetrical and 
spherical shape with diverse functional groups dispersed on the molecular surface, which usually 
dominate the properties of these dendrons.  
 
In a literature reported by Ji group, they have synthesized a series of amino-acid based dendrons 
from the first generation (G1) to third generation (G3) and systematically studied their self-





molecules were synthesized through a convergent manner using D-alanine and L-Aspartic acid 
(ala-asp) as the building blocks. G1 dendron 47 cannot form gel in any tested solvent. Both of G2 
dendron 48 and G3 dendron 49 showed self-assembly ability with higher generation exhibiting 
lower critical gelation concentration. This dendritic effect was further proved by the thermal 
stability of the gel, which is reflected from the gel-sol transition temperature (Tgel) of the gel.  
Different concentration (0.5 to 3.5 wt%) of DCM organogel made by 48 and 49 were prepared and 
Tgel was measured by ball dropping method. Tgel value increased with the concentration increasing, 
then remained constant after reaching its maximum. However, the Tgel values of 49 are always 
higher than those of 48 at the same concentration indicating that supramolecular organogel 
prepared from 49 are more thermally stable due to the dendritic effect.  
 
Figure 23. Chemical structure of different generations of Boc protected dendrons 47-49 using D-





Prasad group reported the synthesis of novel aryl ether dendritic gelators 50-51 containing glucose 
with general structure shown in Figure 24.59 The gelation behavior of these two dendrons was 
evaluated and found to be able to form gel in various solvent systems. Compound 50 can form a 
stable organogel in DMSO:H2O (v1:9) at a minimum gelation concentration as low as 0.1% (w/v), 
while compound 51 tends to self-assemble in alcoholic solvents. The gelation ability of these two 
compounds is dependent on the π-π interaction (size of aryl ether dendron). In addition, gel stability 
at different pH was also studied. Conversion of the DMSO-H2O gel made by compound 50 to 
solution was observed by adding KOH solution (pH = 10) to the gel. This gel-sol transition is the 
result of the deprotonation of sugar under the basic condition thus disrupting hydrogen bonding 
from the glucose moiety in the original gel stage.  
 
 





Glycocluster is one of the most important types of dendrimer which has sugar moiety on the 
spherical surface because carbohydrates play important roles in biological processes such as 
cellular recognition, adhesion, and differentiation.60-62 Interactions of carbohydrates and their 
respective binding receptors are usually weak due to the low binding affinity from monovalent 
interactions. Many efforts have been devoted to understanding the carbohydrate-protein 
interactions under the influence of the dendritic environment from multivalent glycoarchitectures, 
which provide increased interaction sites than a single carbohydrate can.63-68 These glycoclusters 
comprising versatile peripheral sugars, such as galactose, mannose, lactose, fucose, xylose, and 
glucose have been developed and exert important effects in the field of materials chemistry, and 
medicinal chemistry, etc. Since the supramolecular gel networks are held together solely by weak 
intermolecular forces, they typically are not as stable as polymer gels. Covalently attaching 
amphiphilic glycolipids to form branched derivatives enhance the stability of these assemblies, 
thus exhibiting interesting binding events between the branched molecules and receptors (lectins, 
ions etc.) with the help of inherent self-assembly capability.  
 
In 2011, Yamamichi group reported a supramolecular hydrogel made from amphiphilic compound 
56 with unprotected glucose on the periphery can response to two types of chemical stimuli, lectin 
and anion, through gel-sol phase transition.69 The hydrogelator 52 can from a pale-yellow 
transparent gel at 2.0 wt% at room temperature. Mixing compound 52 (2 mg) with concanavalin 
A (ConA) (< 0.35 mg) in 0.1 mL of water could still lead to the hydrogel formation at ambient 
temperature. However, when the amount of ConA is more than 0.35 mg in the gel formation 
experiment mentioned above, only cloudy solution was observed. The suitable amount of conA 





with ConA (0.10 – 0.20 mg) in water (0.1 mL). These results suggest that the amount of ConA is 
critical to forming the hydrogel from compound 52. An appropriate amount of ConA would help 
reinforce the formation of self-assemblies moderately, while an excess of ConA could lead to the 
destruction of cross-linking of fibrous aggregates.  
 
Figure 25. Chemical structure of chemical-responsive amphiphilic branched hydrogelator 52. 
 
The hydrogel formed by compound 52 can respond to anions because of the presence of urea 
moiety in the molecule. Detection of hardness of mineral waters of different brands using 
compound 52 was carried out. Crystal Geyser (soft water), Paradiso (moderately hard water), 





and Ca2+ in the given order of the brands. Interestingly, the hardness of water can be distinguished 
from the physical states of the results. Hydrogel formed by compound 52 with soft water sample 
and moderately hard water sample gave different gel appearances. Soft water test gave a 
transparent gel, while the moderately hard water sample resulted in an opaque gel. Cloudy solution 
was obtained from the hard water experiments. These results indicate that supramolecular hydrogel 
made by compound 52 can potentially function as chemical sensors, which can respond to lectin 
and anion. 
 
1.1.8 APPLICATIONS OF LMWGS  
Low molecular weight gelators have gained a wide range of applications including in cosmetics, 
pharmaceuticals, food industry, waste treatment, greases/lubricant and drug delivery. Applications 




As shown in Figure 26, the gel made by gelator 53 in CCl4 has self-healing properties, two blocks 
of this CCl4 gel (one doped with dye, another not) were cut into pieces. Then the dye-doped gel 
pieces and undoped gel pieces were placed in an alternate fashion. After pressing the gel pieces 
and as the dye diffused throughout the gel discs, a self-supported bar was obtained. The 







Figure 26. Self-healing property of carbon tetrachloride gel made by gelator 53. 
 
A pinch of gelator 53 was added to the mixture of petrol and water. After shaking the mixture and 
allowing it to settle for a while, gelator 53 can selectively formed gel with petrol and the gel is 
strong enough to prevent the water from falling when the vial is inverted. 
 





A piece of xerogel of gelator 53 in toluene was dipped in water contaminated with methylene blue, 
after 24 hours of soaking, the xerogel absorbed the dye completely, which shows it can potentially 
serve as water-purifying reagent. 
 
Figure 28. Absorption of organic dye by the xerogel of gelator 53 in toluene. 
 
Biological applications: 
In 2016, Feng group designed a multi-functional gelator precursor 54 composed of three parts 
which includes free galactose sugar polar head, the carbamate linkage and the fluorescent 
hydrogelator.73 The galactose moiety can selectively target liver cancer cells through specific 
interaction with the receptors overexpressed by liver cancer cells. Then the precursor 54 can 
undergo UV-light (320 nm) treated cleavage to release hydrogelator 55 inside cells, resulting in 
intracellular self-assembly and subsequently causing the death of the cancer cell. This study 
demonstrates a strategy of releasing the assembled gelators under external stimuli as selective and 










Macrocycles are a special class of molecules that exhibit unique properties which make them more 
advantageous over the linear molecules, such as more defined conformation and enhanced stability 
in biological system.74-76 Macrocyclic compounds play an important role in many research fields 
including drug discovery and development, bioorganic chemistry, and materials sciences.77-82 
Because of their unique structures and functions, many synthetic strategies have been developed 








1.2.2 SUGAR BASED MACROCYCLES  
Carbohydrate-derived macrocycles have attracted great interest because of the synthetic challenges 
associated with structural complexity and their applications in biological sciences, materials 
sciences and supramolecular chemistry.75-76, 81, 88-90 Carbohydrates are naturally abundant and 
renewable resources with rich chirality and structure diversity that are desirable for the design and 
synthesis of different macrocycles. The multiple chiral centers in carbohydrate make it possible to 
expand the structural diversity through functionalization at different positions on the sugar ring. 
Further, the chiral and conformationally restricted nature of sugar ring allows the formation of 
chiral cavities, which can be useful in the field of metal complexation, guest encapsulation, chiral 
recognition, biopharmaceuticals etc.91-95 Many glycosylated natural macrocycles have important 
therapeutic activities with their structures shown in Figure 30. For instance, Erythromycin 56 and 
their derivatives are macrolide antibacterial agents. Macrocyclic compounds containing a pyranoid 
ring structure are also important drug classes. For example, Tacrolimus 57 is immunosuppressant 
drugs used for prevent treatment during organ transplant. Bryostatin families contain two 20-
memebered macrolactone ring with three embedded pyran rings linked by a methylene group. 
Bryostatin 1 (58) functions as a potent protein kinase C inhibitor.  
 





CHAPTER 2. SYNTHESIS AND SELF-ASSEMBLING PROPERTIES OF 4,6-
BENZYLIDIENE ACETAL PROTECTED D-GLUCOSE AND D-GLUCOSAMINE 
BETA-1,2,3-TRIAZOLE DERIVATIVES 
This chapter is adapted from the paper published in “Chen, A.; Okafor, I.; Garcia, C.; Wang, G. 
Synthesis and self-assembling properties of 4,6-benzylidiene acetal protected D-glucose and D-
glucosamine β-1,2,3-triazole derivatives. Carbohydr. Res. 2018, 461, 60-75.” 
 
2.1 ABSTRACT 
Low molecular weight gelators (LMWGs) are interesting small molecules with practical 
applications as advanced materials. Carbohydrate derived small molecular gelators functioning as 
biomaterials has received increasing attention over recent years since they are more likely to be 
biocompatible and biodegradable. The structure and gelation relationship has been carried out for 
several monosaccharide derivatives. Selective functionalization of common monosaccharide has 
resulted in several novel classes of LWMGs. In this chapter, a series of 4,6-O-benzylidene acetal 
protected β-triazolyl glycoside of D-glucose and D-glucosamine were designed and synthesized. 
Evaluation of their self-assembling properties in a few solvents was performed. Several 
organogelators were obtained when 4-triazolyl substituent are alkyl chains. The resulting 
organogels were characterized using optical microscopy and rheology. Molecular assemblies were 
analyzed using 1H NMR spectroscopy and FTIR in order to probe the influences of the hydroxyl, 
amide, and triazole functional groups towards gelation. Naproxen was selected as a model drug 
for controlled release study with the aid of UV-Vis spectrometer.     
 







LMWGs are small molecules that can typically self-assemble and form reversible gels when the 
organic solvents or water are immobilized in the three-dimensional fibrous network.5, 13, 19, 96-97 
The formation of supramolecular gel network is the result of noncovalent interactions such as 
hydrogen bonding, hydrophobic interactions, -  stacking, CH- interactions, and van der Walls 
forces, etc. Sugar based gelators are likely to be biocompatible, and they have found many 
applications as advanced materials.98-100 Low molecular weight organogelators (LMOGs) have 
been found to be useful for environmental applications such as oil spill cleaning up,9, 21, 26, 72, 101-
110 removal of heavy metal ion,111 detection of dynamite trace71 etc. Organogels have been studied 
for biomedical applications including drug delivery, tissue engineering.112-113 Supramolecular gels 
have also been utilized in synthesis as organocatalysts with enhanced catalytic activities in the gel 
state.114-118 Carbohydrates are naturally abundant, renewable recourses and they contain multiple 
chiral centers that can easily been modified. Selective functionalization of common 
monosaccharides can afford supramolecular gels with desired properties.119-128 For instance, 
several monosaccharide derivatives 1-4 originated from D-glucose and D-glucosamine have been 
studied by our group and the general structures are shown in Figure 31. 41-42, 46, 48 We found that 
derivatives of 4,6-O-benzylidene acetal protected D-glucose and D-glucosamine derivatives 1 and 
2 are found to be effective low molecular weight gelators (LMWGs). Recently the peracetylated 
D-glucosyl triazoles and D-glucosamine triazole derivatives 3 and 4 were studied and their gelation 
properties screened in several organic solvents and aqueous mixtures. The peracetylated triazoles 
are also effective organogelators and are able to from gel in alcohols, DMSO and water mixtures, 
ethanol and water mixtures compared to 4,6-O-benzylidene derivatives. Excitingly, a few 





groups from the N-acetyl glucosamine derivatives 4. In order to understand how the modification 
of simple sugars could affect molecular self-assembly and gelation, a series of monosaccharide 
derivatives containing 4,6-O-benzylidene acetal and anomeric triazoles functional groups were 
deigned and synthesized. As shown in Figure 31, introducing triazole to the anomeric position of 
the 4,6-O-benzylidene acetal protected glucose or glucosamine will give compounds I and II. The 
study of these new compounds will allow us to find out whether the popular benzylidene acetal 
protective group is important for effective gelation when combined with triazole functional groups. 
 
Figure 31. Structures of various protected D-glucose and D-glucosamine derivatives 1-4 and the 
hybrid compounds I and II.   
 
2.3. RESULTS AND DISCUSSIONS 
As shown in Schemes 1, a series of triazole derivatives with the general structures of I were 
prepared from the D-glucose derived azido compound 5. Substituent R groups were chosen based 
on our previous findings of effective gelators. The headgroup compound 7 was made by treatment 





acetal protective group. Copper sulfate and sodium L-ascorbate as the catalytic combination were 
applied to click reactions with terminal alkynes with different functional groups. A series of new 
triazole derivatives 8-19 with the general structure I were obtained in good yields.  
Scheme 1. Synthesis of benzylidene acetal protected β-triazolyl glucosides 8-19.  
 
With compounds 8-19 synthesized in hand, their gel test in several solvents were performed and 
the results are shown in Table 1. In general, for the D-glucose triazole derivatives, the 4-triazolyl 
alkyl derivatives are generally more effective gelators than the derivatives with polar substituents. 
The butyl derivative 8 was able to form stable gels in isopropanol, pump oil and unstable gels in 
toluene and engine oil. The chlorobutyl derivative 9 formed gels in ethanol/water mixture and 
DMSO/water mixture. The compounds are more effective for oils with increased alkyl chain 





engine oil at 6.7 mg/mL. The octyl derivative 11 is the most versatile gelator, which can form gels 
in six of the tested solvents, including isopropanol, ethanol/water, and DMSO/water mixtures. 
When the alkyl spacers are longer than 8 carbons, the compounds cannot function as effective 
gelators for the tested solvents. D-glucosyl triazole 15 bearing a phenyl group with an alkyl spacer 
can form gels in DMSO/water mixtures. However, the terminal hydroxyl triazole analogues 17-19 
failed to form gels in any tested solvents possibly because the gelation systems are too polar in the 
presence of the hydroxyl group. 
 
 



















8  G20 UG UG  G 20 S S P P P 
9  S S P P P S G10   G10   I 
10  G10 G 6.7 P P S S P G 6.7   I 
11 
 
G20 G 20 P G 20   S UG  G10   G 20   I 
12 
 
G20 I P S S S P I I 
13 
 
G10 UG P P P P P I I 
14 
 
I I I P S S P S I 
15 
 
UG P P P P S P G 6.7   I 
16 
 
I S UG    S S S S S P 
17  I I I P S S S S S 
18  P I I S S S P P I 
19 
 





All compounds were tested starting from 20 mg/mL. G, stable gel at room temperature, the number 
is minimum gelation concentration (MGC) in mg/mL; UG, partial gel or unstable gel, the 
concentration is 20 mg/mL unless otherwise specified. P, precipitation; S, soluble; I, insoluble. All 
compounds were insoluble in hexane, all were soluble in THF except 16, which was insoluble. All 
gels were opaque except toluene gels, which were translucent. Pump oil, VWR® vacuum pump oil 
#19 composed of 100% solvent refined neutral paraffinic oil; Engine oil, Marvel® mystery oil 
composed of petroleum distillates (hydrotreated heavy naphthenic, stoddard solvent) and trace 
amount of  tricresyl phosphate, o-dichlorobenzene and p-dichlorobenzene. 
 
Similar to the synthesis of glycosyl triazoles I, N-acetyl D-glucosamine triazole derivatives II were 
prepared using azido compound 20 as the starting material. As shown in Scheme 2, same alkyne 
compounds from ester series I were utilized in the preparation of triazole derivatives II.  
 






For the D-glucosamine based triazoles 23-32, their gelation properties in several solvents were 
screened, the results are shown in Table 2. It is observed that none of these glucosamine triazole 
compounds are effective for gelling oils possibly due to extra NH moiety causing the increased 
polarity of the compound. When the triazolyl-4-substituents are aliphatic or phenyl in this series 
can form gel in toluene. The shorter alkyl chain derivatives (compound 25 and 26) are effective 
gelators towards aqueous mixtures of DMSO and ethanol. The hexyl derivative 25 and octyl 
derivative 26 can form DMSO/water (v/v 1:2) gel at 4.0 mg/mL and 3.3 mg/mL respectively. 
Several gel pictures of from these two series are shown in Figure 32.   
 
Table 2. Gelation properties of N-acetyl D-glucosamine triazole derivatives II. 













23  I I I S S UG20 O G12 O I 
24  I I I S S S S I 
25  I I G 20 C S S G 5.0 O G 4.0 O I 
26 
 
I I G 10 C S S G 6.7 O G 3.3 O I 
27 
 
I I G 20 C S S P P I 
28 
 
I I S S S P P I 
29 
 
I I G 20 T I P I I I 
30 
 
I I I S S S S S 
31  I I I S S S S S 
32 
 





All compounds were tested starting from 20 mg/mL. G, stable gel at room temperature, the 
numbers are MGCs in mg/mL; UG, partial gel or unstable gel; P, precipitation; S, soluble; I, 
insoluble. The subscribed letters denote the gel appearances: C, clear or transparent; T, translucent; 
O, opaque. All compounds were insoluble in hexane, and soluble in THF and ethylene glycol. 
Pump oil, VWR® vacuum pump oil #19 composed of 100% solvent refined neutral paraffinic oil; 
Engine oil, Marvel® mystery oil composed of petroleum distillates (hydrotreated heavy 




Figure 32. Gel photos for compounds 9, 25, and 26. a) Compound 9 in EtOH:H2O (v/v 1:2) at 10 
mg/mL; b) compound 25 in DMSO:H2O (v/v 1:2) at 4 mg/mL; c) compound 26 in EtOH:H2O (v/v 
1:2) at 6.7 mg/mL. 
 





Thermoreversibility experiments were carried out and the result was determined by “naked eye” 
measurement to confirm the reformation of gel after heating and cooling. The experiment setup is 
shown in Figure 33.  
 
Figure 33. Thermoreversibility experiment setup with water bath on a hot plate and thermometer. 
 
A gel was placed in a water bath and the equipped with a thermometer, the melting temperature 
was recorded. After the gel melted, it was removed from the water bath and left at room 
temperature for 30 minutes to observe the re-formation of the gel. This cycle was then repeated at 
least five times, the gels reformed at cycle 5. A few selected gels were tested including compounds 
9 in EtOH:H2O (v/v 1:2) at 10.0 mg/mL; compounds 25 in DMSO:H2O (v/v 1:2) at 4.0 mg/mL; 
compounds 9 in EtOH:H2O (v/v 1:2), 10.0 mg/mL. Figure 34 shows the liquid and the gel at cycle 








Figure 34. a) Gel formed by compound 9 in EtOH:H2O (1:2) melted at 75 °C in 10 seconds. b) Gel 
formed by compound 25 in DMSO:H2O (v/v 1:2) didn’t melt at 95 °C, therefore the gel was heated 
till melt using a heat gun. After 30 minutes standing at room temperature the gel reformed. c) Gel 
formed by compound 26 in toluene melt at 85 °C in 1 minute. Gel reformed at room temperature 






The gels formed by compounds 9, 25, and 26 were characterized under an optical microscope to 
see the entangled networks of aggregates. A few optical micrographic images are shown in Figure 
35-40. In EtOH:H2O (v/v 1:2) solvent, compound 9 showed the morphology of long thin fibers 
together with semi crystalline in certain areas (Figure 35). The gel formed by compound 9 in 
DMSO:H2O (v/v 1:2) exhibited uniform fibrous network (Figure 36). From the gel made by 
derivative 25 in EtOH:H2O (v/v 1:2), long fibers in uniform diameter (~1 µm) and up to 200 µm 
in length were observed (Figure 37). However, in DMSO:H2O (v/v 1:2) mixture, the same 
compound formed longer and narrower fibrous structures (Figure 38) with the diameter measured 
as 0.5 µm and the length measured up to 200 µm. The EtOH:H2O (v/v 1:2) gel of compound 11 
showed uniform birefringent fibrous morphology (Figure 39). Similarly to the morphological 
appearance of compound 9, the compound 26 formed aggregates, which appeared to be liquid 
crystalline and birefringent sheets or ribbons (Figure 40).  
 






Figure 36. Optical micrographic image of compound 9 in DMSO:H2O (v/v 1:2) at 10.0 mg/mL. 
 






Figure 38. Optical micrographic image of compound 25 in DMSO:H2O (v/v 1:2) at 4.0 mg/mL. 
 






Figure 40. Optical micrographic image of compound 26 in EtOH:H2O (v/v 1:2) at 6.7 mg/mL. 
 
To analyze the gels’ stability, the gels formed by several compounds in DMSO:H2O (v1:2) were 
studied using a rheometer. The storage modulus G and loss modulus G″ at different angular 
frequencies of the gels formed by compounds 9, 15, 25, and 26 are shown in Figure 41. The storage 
moduli for all four compounds are always greater than their loss moduli in all frequency ranges, 
which indicates that the gels are stable and have elastic properties. The gel formed by compound 






Figure 41. The rheological measurement of the gels in DMSO:H2O (v/v 1:2) formed by 9 at 10 
mg/mL, 15 at 6.7 mg/mL, 25 at 4.0 mg/mL, and 26 at 3.3 mg/mL concentrations, the applied strain 
was 5% for all samples.  
  
In order to find out how protective groups could have influence on the self-assembling properties, 
several effective gelators from these two series were selected to further prepare the peracetate. As 
shown in Scheme 3, full acetylation of the corresponding glucose derivatives 8 and 10 gave 
compounds 33-34 and compounds 36-38 are the acetates of the glucosamine based gelators 23, 25, 
and 26, which were prepared by acetylation of the azide headgroup 22 first and followed by the 
click reaction. The gelation properties of five fully protected compounds (33-34, 36-38) were 






Scheme 3. Synthesis of the acetylated β-triazolyl glycosides 36-38.   
 
Table 3. Gelation properties of the acetylated β-triazolyl glycosides 33-34 and 36-38. 












33 8 I S S I I I I S 
34 10 G 20 UG 20 S P P I I S 
36 23 I I P I P I I I 
37 25 I P P P P I I I 
38 26 S P P P I I I P 
All compounds were tested starting from 20 mg/mL. G, stable gel at room temperature, the 
numbers are MGC in mg/mL; UG, partial gel or unstable gel; P, precipitation; S, soluble; I, 






From the results obtained in Table 3, we found that after blocking the 3-OH positon, the gelation 
tendency diminished or disappeared. This indicated that 3-hydroxy group on the sugar ring plays 
an important role in forming gels, the hydrogen bonding donor is vital for effective gelation for 
this series of compounds. We rationalized the observation using 1H NMR spectroscopy studies at 
different temperatures for compound 25 and its acetate 37. The stacked 1H NMR spectra at 
different temperatures from 30 °C to 60 °C for compound 25 are shown in Figure 42. As 
temperature increases, chemical shift of the triazole aromatic C-H has shifted upfield significantly 
from 7.91 to 7.86 ppm ( 0.05 ppm). The amide signal moved upfield from 7.93 to 7.81 ppm ( 
0.12 ppm). Noticeably the proton of the 3-OH signal changed from 5.58 to 5.43 ppm ( 0.15 ppm). 
This was the largest chemical shift which suggests that hydrogen bonding from free 3-hydroxyl 
group is very critical for this system towards gelation. The acetate compound 37 derived from 
compound 25, which hydrogen bonding donor at 3-position had been blocked, was also studied 
using 1H NMR spectroscopy at variable temperatures as shown in Figure 43. The triazole aromatic 
C-H signal in compound 37 changed from 8.00 to 7.93 ( 0.07 ppm). Similarly, the NH signal 
shifted from 8.06 to 7.92 ppm ( 0.14 ppm) upon increasing temperature. After acetylation, the 
amide and triazole functional groups didn’t lose their intermolecular interactions. However, the 3-




















Computational modeling can shed some light on how molecules pack and provide evidence for 
inter and intramolecular forces. The energy minimized stable two-molecule stacking 
conformations of 3-hydroxyl 25 (a) and 3-acetate 37 (b) are shown in Figure 44. It was found that 
intermolecular hydrogen bonding exists between 3-hydroxyl and oxygen next to anomeric position 
in (a). The length of hydrogen bond is 2.0 Å between two 3-hydroxyl 25. While in energy 
minimized stacking of two 3-acetate 37, no intermolecular hydrogen bonding was observed. This 
indicates that 3-hydroxy group on the sugar ring as the hydrogen bonding donor is critical for 
effective gelation for this series of compounds. 
  
 
Figure 44. The energy minimized stable two-molecule stacking conformations of 3-hydroxyl 25 








FTIR analysis can interpret hydrogen bonding and other intermolecular forces in the gelation 
process. Therefore, FTIR spectra for triazole derivative 25 in its solid form and the gel in ethanol 
water mixture were acquired as shown in Figure 45-46. In Figure 45, a new peak at 3375 cm-1 was 
detected in the gel phase, which is due to the enhanced intermolecular hydrogen bonding from the 
free 3-OH and NH stretching vibration with other gelators and solvents. A noticeable stronger 
signal at 3062 cm-1 in the gel phase than the solid suggests that stronger - interactions from the 
aryl and triazole C-H stretch vibration occur at the gel phase. The C-H stretch signals at 2924, 
2869, and 2854 cm-1 in solid form are shifted towards 2828, 2877 and 2857 cm-1 in gel phase, 
which implies that the C-H stretching are weaker in the gel phase, possibly due to the formation 
of stronger hydrophobic interactions in the gel.  
 
Figure 45. FTIR spectra for compound 25 in 2700-3500 cm-1. The green curve corresponds to the 
solid form, the red curve corresponds to the gel form of 25 in EtOH:H2O (v/v 1:2) at 5 mg/mL, 





As shown in Figure 46, the amide-I (C=O stretching) and amide-II (N-H bend) bands of amide 
generally show shifts upon the formation of hydrogen bonds. In the solid form, the amide I band 
in the solid form was absorbed at 1661 cm-1, and the frequency of the amide II band was observed 
at 1536 cm-1. However, in the gel state, the amide I band shifts to 1668 cm-1 and the amide II to 
1530 cm-1 with enhanced intensities due to the intermolecular hydrogen bonding in the gel phase. 
The absorption of the triazole C=C stretch signal in the gel phase appears at 1643 cm-1, which is 
also stronger than the signal in the pure solid, this indicates aggregated packing of triazole in the 




Figure 46. FTIR spectra for compound 25 in 1400-1700 cm-1. The green curve corresponds to the 
solid form, the red curve corresponds to the gel form of 25 in EtOH:H2O (v/v 1:2) at 5 mg/mL, 






As shown in Figure 47, time dependent 1H NMR study for compound 25 was carried out to find out 
more evidence of intermolecular hydrogen bonding towards the gelation formation. D2O was added to 
the sample dissolved in pure d6-DMSO and spectra at different time points were acquired right away. 
We found that the proton signal of 3-OH disappeared right away after adding D2O, however the amide 
signal gradually exchanged with deuterium within one hour. Addition of D2O also resulted in chemical 
shift changes for several other signals including the NH signal and anomeric proton. The most 
significant shift observed is water signal, which changed from 3.30 to 3.90 ppm till equilibrium as 













Figure 47. Time dependent 1H NMR spectra of compound 25 (1.6 mg in 0.40 mL d6-DMSO) after 


















Figure 48. Stacked proton NMR spectra from 0 to 10 ppm of before (top) and after adding D2O at 
different time point. The numbers labelled in the spectra are the chemical shift of water peak in d6-
DMSO. 
 
Integration for exchanging proton (NH signal) at different time pints is shown in Table 4. Curve 
was plotted using data that was ≤ 95% exchanged as shown in Figure 49 and the fitting of the curve 
confirmed that the exchange rate follows first order kinetics. The rate constant was obtained as 
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Table 4. Integration of NH signal and H/D exchange percentage at different time points. 
Time 
Integration of NH 
signal 




0 minute 1.00 0 100 
5 minutes 0.70 30 70 
10 minutes 0.51 49 51 
15 minutes 0.33 67 33 
20 minutes 0.19 81 19 
25 minutes 0.09 91 9 
30 minutes 0.05 95 5 




Figure 49. Percentage H decrease versus time from 0 to 30 minutes. 
 
For potential biological applications, it is always more desirable if the concentration of DMSO can 
be reduced in DMSO/water gel. The gelation tendencies of compounds 10 and 25 was tested. The 



























performed by dissolving 2 mg of the gelator in 0.1 mL of DMSO first, then adding 0.1 mL water 
sequentially to observe whether a stale gel was formed, if a stable gel formed, and 0.1 mL water 
was added subsequently until a stable gel can no longer form. The glucosamine derivative 25 was 




Table 5. Gelation test in DMSO water mixture (water tolerance study) for compounds 10 and 25.  
Compound 
  
DMSO:H2O mixture  
1:0 1:1 1:2 1:3 1:4  1:5 1:6 
10 S 20.0 G 10.0 G 6.7 P 5.0    
25 S 20.0 G 10.0 G 6.7 G 5.0 G 4.0 G 3.3 I 2.9 
 
G, spontaneous gel; G, gel formed after heating and sonication; S, soluble; P, precipitation; I, 
insoluble. The numbers following the letters are the concentrations in mg/mL of the particular 
solvent. Both gels are opaque. 
 
Compound 25 was selected to form a co-gel with naproxen in DMSO:H2O (v/v 1:5) at 6.7 mg/mL 
and the sustained release of naproxen from the gel matrix to water phase was analyzed using UV-
Vis spectrometer. As shown in Figure 50, the gel was formed by 2 mg of compound 25 in 0.3 mL 





Naproxen control was prepared by dissolving 1 mg naproxen in 3 mL of water (pH 7) in order to 
monitor the sustain release. At different time points, the UV-Vis spectrum of aqueous phase was 
measured and plotted in Figure 51. As shown in Figure 52, 50 % of naproxen was released to the 
aqueous phase in 2 hours and full release was achieved within a day. 
 
0 h         0.5 h         1 h          1.5 h            4.5 h       6 h       7.5 h      24 h 
Figure 50. Photos at different time periods of naproxen release study. 
 
 
































Figure 52. Percentage release profile of naproxen from gel matrix to aqueous phase. Absorbance 
at 330 nm at different times versus the standard was used to determine the percentage release.  
 
For all these compounds, the purity was confirmed by 1D (1H, 13C), 2D (HSQC, COSY) NMR 
spectroscopic method and LC-MS. Spectra of a few reprehensive compounds are shown in Figure 










































Figure 54. HSQC and COSY spectra for compound 9 in d6-DMSO. 
In this HSQC spectrum, 
 Red cross peak 
stands for proton 
correlating with 
carbon attached 
to CH or CH3. 



















Figure 56. HSQC and COSY spectra for compound 25 in d6-DMSO. 
In this HSQC spectrum, 
 Red cross peak 
stands for proton 
correlating with 
carbon attached 
to CH or CH3. 











 LC-MS calcd for C21H22N3O5 [M + H]














LC-MS calcd for C23H32N4O5Na [M + Na]

















A series of β-triazolyl glycoside of 4,6-O-benzylidene acetal protected D-glucose and D-
glucosamine were synthesized and studied systematically. We found that the presence of the 4,6-
O-benzylidene acetal functional group seems to diminish the gelation tendencies for some triazolyl 
glycosides in comparisons to the corresponding tetra-acetyl glycosyl triazoles possibly due to the 
structural rigidity of the bicyclic ring system. However, a few low molecular weight 
organogelators were still obtained from this series. The gelation results showed that the D-glucose 
derivatives are more effective gelators for organic solvents especially for pump oil and engine oil, 
whereas the D-glucosamine derivatives are less effective for oils but more effective towards polar 
solvents and their aqueous mixtures. Several selected gels were characterized using optical 
microscopy to observe the fibrous network after the gels were dried. Rheological studies were 
performed to reveal the successful preparation of the gels as the semisolids. We also found that 
further fully acetylated compounds of a few effective organogelators lost their gelation abilities. 
We concluded that the hydrogen bonding of the free 3-OH group plays a critical role in this 
observed gelation trend. Variable temperature 1H NMR studies and computational modeling for 
compound 25 and its acetate 37 proved the importance of the free 3-hydroxyl group towards 
molecular self-assembly in the gelation process. To further study the driving force of the self-
assembling of compound 25, FTIR spectroscopic and time dependent 1H NMR 
deuterium/hydrogen exchange experiments were carried out. Compound 25 was also used to 
prepare naproxen co-gel and the controlled release of naproxen from the gel matrix was observed 
with the monitoring of UV-vis spectroscopy. Future study will be focused on application of 
triggered gelation in biomaterial filed due to the easy deacetylation by a base or enzyme to restore 





2.5. EXPERIMENTAL SECTION 
General method and materials: Reagents and solvents were used as they were received from the 
suppliers.  All purification was conducted by flash chromatography using 230-400 mesh silica gel 
with a gradient of solvent systems. 1H NMR and proton-decoupled 13C NMR spectra were obtained 
with Bruker 400 MHz spectrometers in DMSO-d6 or CDCl3. The chemical shifts were reported 
using CDCl3/DMSO-d6 as internal standard at 7.26/2.50 ppm and at 77.00/39.50 ppm, 
respectively. 2D NMR experiments (HSQC, COSY) were also conducted using a 400 MHz Bruker 
NMR spectrometer to assist the proto and carbon signal assignment. Carbon signals on phenyl ring 
(125 to 140 ppm) and aliphatic chain as well as cyclohexyl ring (below 30 ppm) were not assigned 
accurately due to clusters of proton signals present in the aromatic and aliphatic regions. Melting 
point measurements were carried out using a Fisher Jones melting point apparatus. Rheology 
experiment was done using a HR-2 Discovery Hybrid Rheometer from TA instrument and a 25 
mm Peltier Plate. FTIR experiments were conducted using liquid or solid samples directly. The 
molecular mass was measured using LC-MS on an Agilent 6120B Single Quad Mass Spectrometer 
and LC1260 system. 
 
Optical Microscopy: A small amount of the gels was placed on a clean glass slide and this was 
observed under an Olympus BX60M optical microscope and the Olympus DP73-1-51 high 
performance 17MP digital camera with pixel shifting and Peltier cooled. The imaging software for 
image capturing was CellSens 1.11. For aqueous DMSO mixtures, the gel was left air dried for a 






Gel Testing: About 2 mg of dried compound was placed in a 1 dram glass vial and the 
corresponding solvent was added to obtain a concentration of 20 mg/mL. The mixture was then 
heated until the solid was fully dissolved, sometimes sonication was needed to dissolve the sample, 
and then the solution was allowed to cool to room temperature and left standing for 30 minutes.  If 
a stable gel formed (observed by inverting the vial), it was then serially diluted till the minimum 
gelation concentration (MGC), which is the concentration prior to unstable gelation, was obtained.    
 
Rheological Analyses: The rheological behavior of the gel was investigated with an HR-2 
Discovery hybrid rheometer from TA Instruments with TRIOS software. A sample (approximately 
1mL of the gel) was placed on the steel plate of the rheometer. The cone geometry is a 25 mm 
Peltier plate with a gap of 100 μm. The experimental temperature was 25 °C, and the sample was 
subjected to amplitude sweep for oscillation strain from 0.125 to 10%. A frequency sweep was 
then performed for the sample in the range of 0.1 to 500 rad/s for the angular frequency. The results 
were expressed as the storage modulus (G’) and loss modulus (G’’) as a function of angular 
frequency. 
 
FTIR Spectroscopy: FTIR measurements were performed on a Bruker ALPHA Platinum ATR 
FTIR Spectrometer, the operating software is OPUS. The absorption spectra of all samples were 
obtained at room temperature in the range of 400-4000 cm-1.  
 
Time dependent Deuterium-Hydrogen exchange study: An initial NMR spectrum was acquired 
with 1.6 mg of compound 25 dissolved in 0.4 mL of d6-DMSO to mark the time as 0 minute. To 





substrate concentration as 3.2 mg/mL. For this experiment, spectra were acquired every 5 minutes 
through 60 minutes until the disappearance of the exchangeable proton signal into the baseline. 
Integration for exchanging proton (NH signal) are user-defined and self-consistent within each 
acquisition. A distinct non-exchanging signal (acetal signal, δ 5.64) was used as an internal 
integration reference. Rather than estimate the values at extended time, curve fits were performed 
using data that was ≤ 95% exchanged. The fitting of the time dependent variation in the integral 
areas of peaks to A(t) = A(o) × exp (−k × t) confirmed that the exchange rate follows first order 
kinetics. The rate constant was obtained from the processing software “Kinetic Studio”. The 
corresponding half-life was determined from the equation t ½ = ln 2 / k. 
 
Liquid chromatography-mass spectrometer (LC-MS) conditions:  The molecular mass 
acquisition was performed on a liquid chromatography-mass spectrometer system which consists 
of an Agilent 1260 Infinity LC system coupled to a G6120B single quadrupole mass spectrometer 
with an atmospheric pressure ionization electrospray (API-ES). The analytical column is an 
Agilent poroshell 120 EC-C18 4.6 mm × 50 mm column with 2.7 μm particle size. The mobile 
phase is 0.1% formic acid in acetonitrile/water (70/30, v/v). Ejection volume is 5 µL. Total runtime 
is 8 min. The flow rate is 0.40 mL/min and the column temperature is set at 25 °C. Wavelength of 
diode-array detector (DAD) is 254 nm. Data was collected and processed using Agilent OpenLAB 
CDS ChemStation (Version C.01.05). The ESI spray voltage was set at 4000 V. The source 
temperature is 350 °C. The nebulizer gas setting is 35. Range of mass spectrometer detector is set 






Naproxen trapping and release: A gel was prepared in a 1 dram via using 2 mg of compound 25 
and 1 mg of naproxen sodium and 0.3 mL DMSO:H2O (v1:5), after a stable gel was formed and 
the gel was left undisturbed for 2 hours, 3 mL of water at pH 7 was added to the top of the gel 
carefully. Naproxen release from the gel was monitored by UV absorption at certain time by 
transferring the supernatant with a pipet to a cuvette, after each measurement the aqueous phase 
was carefully transferred back to the vial and placed on top of the gel again till the next 
measurement. The UV spectra of the pure naproxen and pure gelator in the test solvent system 
were also recorded. 
 
Synthesis of sugar headgroup azide 7:  
Compound 5 (3.80 g, 10.15 mmol, 1 equiv) was dissolved in MeOH (15 mL) and NaOMe (273 
mg, 5.08 mmol, 0.5 equiv) were added to 50 mL round bottom flask. The reaction mixture was 
stirred for 12 hours at rt, neutralized with Amberlite IR 120 hydrogen form, filtered, concentrated 
and vacuum drying overnight to give 2.08 g (10.15 mmol, quantitative) brown semi-solid as the 
desired product. Compound 6 was co-distilled with toluene (3 x 10 mL) and directly used for the 
next step without further purification. Toluene treated compound 6 (2.08 g, 10.15 mmol, 1 equiv), 
dimethyl benzaldehyde acetal (1.83 mL, 12.18 mmol, 1.2 equiv), PTSA monohydrate (196 mg, 
1.02 mmol, 0.1 equiv) were added in the given order and followed by adding 10 mL of DMF 
(anhydrous) as the solvent. The resulting mixture was stirred for 8 hours at 60 °C. After 
neutralizing the reaction mixture by adding NaHCO3 (170 mg, 2.04 mmol, 0.2 equiv), DMF was 
removed by the rotavap and workup was performed using DCM (3x40 mL) /water (20 mL) to give 
the crude product, which was purified by column chromatography using eluent from 1% 





the desired product (Rf = 0.3 in 3% MeOH/DCM). mp 136-138 °C; 
1H NMR (400 MHz, CDCl3) 
δ 7.52-7.46 (m, 2H), 7.41-7.35 (m, 3H), 5.54 (s, 1H), 4.67 (d, J = 8.6 Hz, 1H), 4.38 (dd, J = 10.4 
Hz, 4.3 Hz, 1H), 3.85-3.75 (m, 2H), 3.59-3.51 (m, 2H), 3.44 (t, J = 8.6 Hz, 1H), 3.00-2.45 (br s, 
2H); 13C NMR (400 MHz, CDCl3) δ 136.7, 129.4, 128.4, 126.3, 102.0, 90.6, 80.1, 74.1, 73.5, 
68.41, 68.36.  
General procedure for the synthesis of triazoles 8-19: 
To a scintillation vial, azide 7 (100 mg, 0.340 mmol, 1 equiv) and alkyne (0.400 mmol, 1.2 equiv) 
were dissolved in the 6 mL of solvent mixture of THF: H2O: t-BuOH (v/v 1:1:1). CuSO4 (11.1 mg, 
0.068 mmol, 0.2 equiv) and L-ascorbic acid sodium salt (27.2 mg, 0.136 mmol, 0.4 equiv) were 
added to the reaction mixture. Reaction was stirred for 24 hours at rt. Solvent was removed under 
reduced pressure to give the crude product, which was purified by column chromatography to 
afford the desired triazole product 8-19.  
 
Synthesis of compound 8: 
1-Hexyne (0.047 mL, 0.410 mmol, 1.2 equiv) was used as the starting material. The crude product 
was purified by column chromatography to afford white solid (103 mg, 81%) as the desired product 
(Rf = 0.33 in 5% MeOH/DCM); mp 214-216 °C; 
1H NMR (400 MHz, CDCl3+ one drop d6-DMSO) 
δ 7.36 (s, 1H), 7.32-7.26 (m, 2H, Ar-H), 7.20-7.10 (m, 3H, Ar-H), 5.41 (d, J = 8.9 Hz, 1H, H-1), 
5.34 (s, 1H, Ph-CH-), 4.12-4.09 (m, 1H, H-6a), 3.86 (t, J = 8.9 Hz, 1H, H-2), 3.66 (t, J = 8.8 Hz, 
1H, H-3), 3.59-3.42 (m, 3H, H-6b, H-4, H-5), 2.49 (t, J = 7.7 Hz, 2H, -HC=C-CH2-), 1.47-1.39 (m, 
2H, -HC=C-CH2-CH2-CH2-CH3), 1.20-1.16 (m, 2H, -HC=C-CH2-CH2-CH2-CH3), 0.71 (t, J = 7.3 
Hz, 3H, -HC=C-CH2-CH2-CH2-CH3); 





(-HC=C-), 138.5, 128.6, 127.6, 125.9, 119.6 (-HC=C-), 101.3 (Ph-CH-), 87.5 (C-1), 79.7 (C-4), 
73.3 (C-3), 72.8 (C-2), 68.7 (C-5), 67.7 (C-6), 30.8, 24.7, 21.7, 13.3; LC-MS (ESI+) calcd for 
C19H26N3O5 [M + H]
+ 376.2 found 376.2. 
 
Synthesis of compound 9: 
6-Chloro-1-hexyne (0.050 mL, 0.410 mmol, 1.2 equiv) was used as the starting material. The crude 
product was purified by column chromatography to afford white solid (119 mg, 85%) as the desired 
product (Rf = 0.35 in 5% MeOH/DCM); mp 163-165 °C; 
1H NMR (400 MHz, d6-DMSO) δ 8.09 
(s, 1H, -HC=C-), 7.50-7.45 (m, 2H, Ar-H), 7.42-7.36 (m, 3H, Ar-H), 5.70 (d, J = 9.2 Hz, 1H, H-
1), 5.64-5.58 (m, 3H, Ph-CH-, 2-OH, 3-OH), 4.24-4.18 (m, 1H, H-6a), 3.95-3.88 (m, 1H, H-2), 
3.78-3.64 (m, 5H, H-5, H-6b, H-3, -CH2-Cl), 3.57 (t, J = 9.1 Hz, H-4), 2.67 (t, J = 7.1 Hz, 2H, -
HC=C-CH2-), 1.83-1.68 (m, 4H, -HC=C-CH2-CH2-CH2-Cl); 
13C NMR (100 MHz, d6-DMSO) δ 
147.2 (-HC=C-), 136.8, 129.1, 128.1, 126.3, 120.2 (-HC=C-), 101.8 (Ph-CH-), 87.9 (C-1), 80.0 
(C-4), 73.9 (C-3), 73.4 (C-2), 69.2 (C-5), 68.2 (C-6), 44.5 (-CH2-Cl), 31.7, 26.3, 24.6; LC-MS 
(ESI+) calcd for C19H25N3O5Cl [M + H]
+ 410.1 found 410.1. 
 
Synthesis of compound 10: 
1-Octyne (0.060 mL, 0.410 mmol, 1.2 equiv) was used as the starting material. The crude product 
was purified by column chromatography to afford white solid (118 mg, 86%) as the desired product 
(Rf = 0.3 in 5% MeOH/DCM); mp 200-201 °C; 
1H NMR (400 MHz, CDCl3 + one drop d6-DMSO) 
δ 7.49 (s, 1H, -HC=C-), 7.48-7.44 (m, 2H, Ar-H), 7.33-7.28 (m, 3H, Ar-H), 5.56 (d, J = 9.1 Hz, 
1H, H-1), 5.52 (s, 1H, Ph-CH-), 4.31-4.25 (m, 1H, H-6a), 4.09 (t, J = 8.9 Hz, 1H, H-2), 3.90 (t, J 





1.63-1.56 (m, 2H, -HC=C-CH2-CH2-), 1.37-1.19 (m, 6H, -HC=C-CH2-CH2-(CH2)3-CH3), 0.83 (t, 
J = 6.9 Hz, 3H, -HC=C-CH2-CH2-(CH2)3-CH3); 
13C NMR (100 MHz, CDCl3 + one drop d6-
DMSO) δ 148.1 (-HC=C-), 136.8, 129.1, 128.1, 126.3, 120.1 (-HC=C-), 101.8 (Ph-CH-), 87.8 (C-
1), 79.9 (C-4), 73.8 (C-3), 73.3 (C-2), 69.2 (C-5), 68.1 (C-6), 31.4, 29.0, 28.8, 25.4, 22.4, 13.9. 
LC-MS (ESI+) calcd for C21H30N3O5 404.2 [M + H]
+ found 404.2. 
 
Synthesis of compound 11: 
1-Decyne (0.072 mL, 0.410 mmol, 1.2 equiv) was used as the starting material. The crude product 
was purified by column chromatography to afford white solid (132 mg, 90%) as the desired product 
(Rf = 0.34 in 5% MeOH/DCM); mp 206-207 °C; 
1H NMR (400 MHz, d6-DMSO) δ 8.05 (s, 1H, -
HC=C-), 7.50-7.46 (m, 2H, Ar-H), 7.43-7.36 (m, 3H, Ar-H), 5.69 (d, J = 9.3 Hz, 1H, H-1), 5.63 
(s, 1H, Ph-CH-), 5.61-5.58 (m, 2H, 2-OH, 3-OH), 4.23-4.18 (m, 1H, H-6a), 3.96-3.88 (m, 1H, H-
2), 3.78-3.64 (m, 3H, H-5, H-6b, H-3), 3.57 (t, J = 9.1 Hz, 1H, H-4), 2.61 (t, J = 7.6 Hz, 2H, -
HC=C-CH2-), 1.63-1.54 (m, 2H, -HC=C-CH2-CH2-), 1.38-1.19 (m, 10H, -HC=C-CH2-CH2-
(CH2)5-CH3), 0.86 (t, J = 6.8 Hz, 3H, -HC=C-CH2-CH2-(CH2)5-CH3); 
13C NMR (100 MHz, d6-
DMSO) δ 147.0 (-HC=C-), 137.6, 128.8, 128.0, 126.3, 120.9 (-HC=C-), 100.7 (Ph-CH-), 87.4 (C-
1), 80.1 (C-4), 73.2 (C-3), 72.7 (C-2), 68.4 (C-5), 67.5 (C-6), 31.2, 28.8, 28.7, 28.59, 28.56, 25.0, 
22.0, 13.9. LC-MS (ESI+) calcd for C23H34N3O5 [M + H]
+ 432.2 found 432.2. 
 
Synthesis of compound 12:  
1-Dodecyne (0.088 mL, 0.410 mmol, 1.2 equiv) was used as the starting material. The crude 
product was purified by column chromatography to afford white solid (136 mg, 86%) as the desired 
product (Rf = 0.3 in 5% MeOH/DCM); mp 212-214 °C; 





(m, 2H, Ar-H), 7.47 (s ,1H, -HC=C-), 7.42-7.33 (m, 3H, Ar-H), 5.57 (s, 1H, Ph-CH-), 5.52 (d, J = 
8.9 Hz, 1H, H-1), 4.40-4.29 (m, 2H, H-6a, H-2), 4.07-4.00 (t, J = 8.9 Hz, 1H, H-3), 3.83-3.67 (m, 
3H, H-6b, H-4, H-5), 2.67 (t, J = 7.7 Hz, 2H, -HC=C-CH2-), 1.72-1.57 (m, 2H, -HC=C-CH2-CH2-), 
1.41-1.18 (m, 14H, -HC=C-CH2-CH2-(CH2)7-CH3), 0.88 (t, J = 6.8 Hz, 3H, -HC=C-CH2-CH2-
(CH2)7-CH3); 
13C NMR (100 MHz, CDCl3) δ 148.6 (-HC=C-), 136.7, 129.4, 128.4, 126.3, 120.6 
(-HC=C-), 102.0 (Ph-CH-), 87.8 (C-1), 79.9 (C-4), 73.7 (C-3), 73.2 (C-2), 69.3 (C-5), 68.3 (C-6), 
31.9, 29.6, 29.5, 29.4, 29.31, 29.27, 29.2, 25.5, 22.7, 14.1; LC-MS (ESI+) calcd for C25H38N3O5 
[M + H]+ 460.3 found 460.3. 
 
Synthesis of compound 13:  
1-Hexadecyne (0.100 mL, 0.410 mmol, 1.2 equiv) was used as the starting material. The crude 
product was purified by column chromatography to afford white solid (108 mg, 88%) as the desired 
product (Rf = 0.2 in 5% MeOH/DCM); mp 203-205 °C; 
1H NMR (400 MHz, CDCl3, spectrum was 
taken at 55 C) δ 7.54-7.50 (m, 2H, Ar-H), 7.47 (s, 1H, -HC=C-), 7.41-7.35 (m, 3H, Ar-H), 5.59 
(s, 1H, Ph-CH-), 5.52 (d, J = 8.9 Hz, 1H, H-1), 4.41-4.30 (m, 2H, H-6a, H-2), 4.06-3.99 (m, 1H, 
H-3), 3.84-3.69 (m, 3H, H-6b, H-4, H-5), 2.73 (t, J = 7.7 Hz, 2H, -HC=C-CH2-), 1.75-1.64 (m, 2H, 
-HC=C-CH2-CH2-), 1.43-1.19 (m, 22H, -HC=C-CH2-CH2-(CH2)11-CH3), 0.89 (t, J = 7.8 Hz, 3H, 
-HC=C-CH2-CH2-(CH2)11-CH3); 
13C NMR (100 MHz, CDCl3) δ 136.9, 129.4, 128.4, 126.3, 120.5 
(-HC=C-), 102.2 (Ph-CH-), 87.9 (C-1), 80.1 (C-4), 73.8 (C-3), 73.4 (C-2), 69.4 (C-5), 68.4 (C-6), 
31.9, 29.69, 29.67, 29.65, 29.6, 29.4, 29.34, 29.30, 29.2, 25.6, 22.7, 14.0; LC-MS (ESI+) calcd for 
C29H46N3O5 [M + H]







Synthesis of compound 14: 
Phenylacetylene (0.044 mL, 0.410 mmol, 1.2 equiv) was used as the starting material. The crude 
product was purified by column chromatography to afford white solid (103 mg, 76%) as the desired 
product (Rf = 0.24 in 5% MeOH/DCM); mp 242-244 °C; 
1H NMR (400 MHz, d6-DMSO) δ 8.86 
(s, 1H, -HC=C-), 7.93-7.86 (m, 2H, Ar-H), 7.52-7.33 (m, 8H, Ar-H), 5.81 (d, J = 9.2 Hz, 1H, H-
1), 5.72 (d, J = 6.1 Hz, 1H, 2-OH), 5.68-5.64 (m, 2H, Ph-CH-, 3-OH), 4.28-4.22 (m, 1H, H-6a), 
4.03-3.95 (m, 1H, H-2), 3.87-3.79 (m, 1H, H-5), 3.78-3.69 (m, 2H, H-6b, H-3), 3.61 (t, J = 9.3 Hz, 
1H, H-4); 13C NMR (100 MHz, d6-DMSO) δ 146.4 (-HC=C-), 137.6, 130.5, 128.9, 128.0, 126.3, 
125.2, 120.5 (-HC=C-), 100.7 (Ph-CH-), 87.7 (C-1), 80.2 (C-4), 73.1 (C-3), 72.8 (C-2), 68.5 (C-
5), 67.5 (C-6). LC-MS (ESI+) calcd for C21H22N3O5 [M + H]
+ 396.1 found 396.1. 
 
Synthesis of compound 15: 
5-Phenyl-1-pentyne (0.062 mL, 0.410 mmol, 1.2 equiv) was used as the starting material. The 
crude product was purified by column chromatography to afford white solid (113 mg, 76%) as the 
desired product (Rf = 0.36 in 5% MeOH/DCM); mp 230-232 °C; 
1H NMR (400 MHz, d6-DMSO) 
δ 8.11 (s, 1H, -HC=C-), 7.51-7.44 (m, 2H, Ar-H), 7.43-7.36 (m, 3H, Ar-H), 7.33-7.26 (m, 2H, Ar-
H), 7.26-7.16 (m, 3H, Ar-H), 5.70 (d, J = 9.2 Hz, 1H, H-1), 5.65-5.58 (m, 3H, Ph-CH-, 2-OH, 3-
OH), 4.24-4.18 (m, 1H, H-6a), 3.97-3.88 (m, 1H, H-2), 3.80-3.65 (m, 3H, H-5, H-6b, H-3), 3.58 (t, 
J = 9.2 Hz, 1H, H-4), 2.64 (t, J = 7.6 Hz, 4H, -HC=C-CH2-CH2-CH2-Ph), 1.96-1.86 (m, 2H, -
HC=C-CH2-CH2-CH2-Ph); 
13C NMR (100 MHz, d6-DMSO) δ 146.6 (-HC=C-), 141.7, 137.6, 
128.8, 128.3, 128.2, 128.0, 126.3, 125.7, 121.0 (-HC=C-), 100.7 (Ph-CH-), 87.4 (C-1), 80.1 (C-4), 
73.2 (C-3), 72.7 (C-2), 68.4 (C-5), 67.5 (C-6), 34.5, 30.5, 24.5; LC-MS (ESI+) calcd for 
C24H28N3O5 [M + H]





Synthesis of compound 16: 
3-Dimethylamino-1-propyne (0.044 mL, 0.410 mmol, 1.2 equiv) was used as the starting material. 
The crude product was purified by column chromatography to afford off-white solid (110 mg, 
86%) as the desired product (Rf = 0.3 in 20% MeOH/DCM); mp 204-206 °C; 
1H NMR (400 MHz, 
d6-DMSO) δ 8.19 (s, 1H, -HC=C-), 7.55-7.33 (m, 5H, Ar-H), 5.73 (d, J = 9.0 Hz, 1H, H-1), 5.68-
5.57 (m, 3H, Ph-CH-, 2-OH, 3-OH), 4.28-4.16 (m, 1H, H-6a), 4.00-3.89 (m, 1H, H-2), 3.77-3.62 
(m, 3H, H-5, H-6b, H-3), 3.63-3.48 (m, 3H, H-4, -CH2-N), 2.17 (s, 6H, -N(CH3)2); 
13C NMR (100 
MHz, d6-DMSO) δ 143.6 (-HC=C-), 137.6, 128.8, 128.0, 126.3, 122.9 (-HC=C-), 100.7 (Ph-CH-), 
87.5 (C-1), 80.1 (C-4), 73.2 (C-3), 72.7 (C-2), 68.5 (C-5), 67.5 (C-6), 53.4 (-CH2-N), 44.5 (-
N(CH3)2); LC-MS (ESI+) calcd for C18H25N4O5 [M + H]
+ 377.2 found 377.2. 
 
Synthesis of compound 17:  
Propargyl alcohol (0.024 mL, 0.410 mmol, 1.2 equiv) was used as the starting material. The crude 
product was purified by column chromatography to afford white solid (110 mg, 86%) as the desired 
product (Rf = 0.25 in 5% MeOH/DCM); mp 219-221 °C; 
1H NMR (400 MHz, d6-DMSO) δ 8.19 
(s, 1H, -HC=C-), 7.50-7.45 (m, 2H, Ar-H), 7.42-7.37 (m, 3H, Ar-H), 5.73 (d, J = 9.3 Hz, 1H, H-
1), 5.66-5.63 (m, 2H, Ph-CH-, 2-OH), 5.60 (d, J = 5.1 Hz, 1H, 3-OH), 5.20 (t, J = 5.7 Hz, 1H, -
CH2-OH), 4.53 (d, J = 5.7 Hz, 2H, -CH2-OH), 4.23-4.18 (m, 1H, H-6a), 3.98-3.91 (m, 1H, H-2), 
3.79-3.65 (m, 3H, H-5, H-6b, H-3), 3.59 (t, J = 9.1 Hz, H-4); 
13C NMR (100 MHz, d6-DMSO) δ 
147.9 (-HC=C-), 137.6, 128.8, 128.0, 126.3, 121.9 (-HC=C-), 100.7 (Ph-CH-), 87.4 (C-1), 80.1 
(C-4), 73.2 (C-3), 72.7 (C-2), 68.4 (C-5), 67.5 (C-6), 54.9 (-CH2-OH); LC-MS (ESI+) calcd for 
C16H20N3O6 350.1 [M + H]






Synthesis of compound 18: 
4-Pentyn-1-ol (0.038 mL, 0.410 mmol, 1.2 equiv) was used as the starting material. The crude 
product was purified by column chromatography to afford off-white solid (103 mg, 80%) as the 
desired product (Rf = 0.4 in 8% MeOH/DCM); mp 164-166 °C; 
1H NMR (400 MHz, d6-DMSO) δ 
8.06 (s, 1H, -HC=C-), 7.50-7.45 (m, 2H, Ar-H), 7.42-7.36 (m, 3H, Ar-H), 5.69 (d, J = 9.2 Hz, 1H, 
H-1), 5.66-5.57 (m, 3H, Ph-CH-, 2-OH, 3-OH), 4.47 (s, 1H, -CH2-OH), 4.24-4.18 (m, 1H, H-6a), 
4.00-3.87 (m, 1H, H-2), 3.80-3.64 (m, 3H, H-5, H-6b, H-3), 3.58 (t, J = 9.1 Hz, 1H, H-4), 3.45 (m, 
2H, -CH2-OH), 2.66 (t, J = 7.6 Hz, 2H, -HC=C-CH2-CH2-CH2-OH), 1.80-1.71 (m, 2H, -HC=C-
CH2-CH2-CH2-OH); 
13C NMR (100 MHz, d6-DMSO) δ 146.8 (-HC=C-), 137.6, 128.8, 128.0, 
126.3, 120.9 (-HC=C-), 100.7 (Ph-CH-), 87.4 (C-1), 80.1 (C-4), 73.2 (C-3), 72.7 (C-2), 68.4 (C-




Synthesis of compound 19: 
1-Ethynylcyclohexanol (0.053 mL, 0.410 mmol, 1.2 equiv) was used as the starting material. The 
crude product was purified by column chromatography to afford white solid (112 mg, 79%) as the 
desired product (Rf = 0.25 in 5% MeOH/DCM); compound decomposed at 245 °C; 
1H NMR (400 
MHz, d6-DMSO) δ 8.05 (s, 1H, -HC=C-), 7.52-7.44 (m, 2H, Ar-H), 7.42-7.36 (m, 3H, Ar-H), 5.72 
(d, J = 9.2 Hz, 1H, H-1), 5.65-5.61 (m, 2H, Ph-CH-, 2-OH), 5.58 (d, J = 5.1 Hz, 1H, 3-OH), 4.85 
(s, 1H, -C-OH), 4.23-4.18 (m, 1H, H-6a), 4.00-3.92 (m, 1H, H-2), 3.78-3.65 (m, 3H, H-5, H-6b, H-
3), 3.59 (t, J = 9.0 Hz, 1H, H-4), 1.93-1.81 (m, 2H), 1.78-1.61 (m, 4H), 1.58-1.49 (m, 1H), 1.48-
1.38 (m, 2H), 1.35-1.21 (m, 1H); 13C NMR (100 MHz, d6-DMSO) δ 155.7 (-HC=C-), 137.6, 128.8, 





(C-5), 67.9 (-C-OH), 67.5 (C-6), 37.7, 37.6, 25.2, 21.6. LC-MS (ESI+) calcd for C21H28N3O6 [M 
+ H]+ 418.2 found 418.2. 
 
Synthesis of sugar headgroup azide 22:  
Compound 20 (1.20 g, 3.22 mmol, 1 equiv) was dissolved in MeOH (8 mL) and NaOMe (173 mg, 
3.22 mmol, 1 equiv) was added to 50 mL round bottom flask. The reaction mixture was stirred for 
12 hours at rt, neutralized with Amberlite IR 120 hydrogen form (soaked with the resin for 2 hours 
after adjusting pH to 7), filtered, concentrated and vacuum drying overnight to give brown slurry 
as the product. The crude product was co-distilled with toluene (3 x 10 mL) and directly used for 
the next step without further purification. Toluene treated compound 21 (714 mg, 2.90 mmol, 1 
equiv) was dissolved in DMF (6 mL, anhydrous) followed by adding benzaldehyde dimethyl acetal 
(0.83 mL, 5.51 mmol, 1.9 equiv) and PTSA monohydrate (55 mg, 0.290 mmol, 0.1 equiv) under 
N2 atmosphere. Then the reaction mixture was stirred under the vacuum in a rotavap at 50 °C for 
2 hrs. Then the mixture was removed from the rotavap and then heated in an oil bath at 50 °C 
overnight under N2 atmosphere. NaHCO3 (36 mg, 0.435 mmol, 0.15 equiv) was added and stirring 
was continued for 30 minutes to neutralize PTSA followed by applying gravitational filtration to 
remove generated salt. Then DMF in the reaction mixture was removed under reduced pressure to 
give the crude product, which was purified by column chromatography using 2% MeOH/DCM to 
10% MeOH/DCM as the eluent to afford white solid (773 mg, 72% over two steps) as the product 
(Rf = 0.3 in 5% MeOH/DCM). mp 213-215 °C. 
1H NMR (400 MHz, d4-MeOH) δ 7.53-7.46 (m, 
2H), 7.38-7.31 (m, 3H), 5.62 (s, 1H), 4.65 (d, J = 9.1 Hz, 1H), 4.37-4.29 (m, 1H), 3.89-3.74 (m, 
3H), 3.63-3.52 (m, 2H), 2.00 (s, 3H); 13C NMR (400 MHz, d4-MeOH) δ 173.9, 139.0, 130.0, 129.1, 





General procedure for the synthesis of synthesis of compounds 23-32: 
To a scintillation vial, azide 22 (75 mg, 0.225 mmol, 1 equiv) and alkyne (0.269 mmol, 1.2 equiv) 
were dissolved in the 3 mL of solvent mixture of THF: H2O: t-BuOH (1:1:1). CuSO4 (7.2 mg, 
0.045 mmol, 0.2 equiv) and L-ascorbic acid sodium salt (18 mg, 0.090 mmol, 0.4 equiv) were 
added to the reaction mixture. Reaction was stirred for 24 hours at rt. Solvent was removed under 
reduced pressure to give the crude product, which was purified by column chromatography using 
from pure DCM to 5% MeOH/DCM to afford the desired triazole product 23-32.  
 
Synthesis of compound 23: 
1-Hexyne (0.032 mL, 0.269 mmol, 1.2 equiv) was used as the starting material. The crude product 
was purified by column chromatography to afford white solid (76 mg, 82%) as the desired product 
(Rf = 0.2 in 5% MeOH/DCM); mp 267-269 °C; 
1H NMR (400 MHz, d6-DMSO) δ 7.96-7.90 (m, 
2H, -NH-, -HC=C-), 7.51-7.45 (m, 2H, Ar-H), 7.43-7.36 (m, 3H, Ar-H), 5.85 (d, J = 10.0 Hz, 1H, 
H-1), 5.65 (s, 1H, Ph-CH-), 5.58 (s, 1H, 3-OH), 4.27-4.17 (m, 2H, H-6a, H-2), 3.86 (t, J = 9.2 Hz, 
1H, H-3), 3.77-3.62 (m, 3H, H-6b, H-5, H-4), 2.59 (t, J = 7.5 Hz, 2H, -HC=C-CH2-), 1.63 (s, 3H, 
CH3 in NHAc), 1.60-1.50 (m, 2H, -HC=C-CH2-CH2-CH2-CH3), 1.34-1.22 (m, 2H, -HC=C-CH2-
CH2-CH2-CH3), 0.88 (t, J = 7.4 Hz, 3H, -HC=C-CH2-CH2-CH2-CH3); 
13C NMR (100 MHz, d6-
DMSO) δ 169.2 (C=O in NHAc), 146.7 (-HC=C-), 137.6, 128.9, 128.0, 126.4, 120.4 (-HC=C-), 
100.8 (Ph-CH-), 86.0 (C-1), 80.7 (C-4), 70.4 (C-3), 68.7 (C-5), 67.4 (C-6), 55.0 (C-2), 30.9, 24.5, 
22.6 (CH3 in NHAc), 21.4, 13.6; LC-MS (ESI+) calcd for C21H28N4O5Na [M+Na]








Synthesis of compound 24: 
6-Chloro-1-hexyne (0.033 mL, 0.269 mmol, 1.2 equiv) was used as the starting material. The crude 
product was purified by column chromatography to afford white solid (86 mg, 85%) as the desired 
product (Rf = 0.4 in 5% MeOH/DCM); mp 185-187 °C; 
1H NMR (400 MHz, d6-DMSO) δ 7.97-
7.90 (m, 2H, -NH-, -HC=C-), 7.50-7.45 (m, 2H, Ar-H), 7.41-7.36 (m, 3H, Ar-H), 5.85 (d, J = 10.0 
Hz, 1H, H-1), 5.65 (s, 1H, Ph-CH-), 5.58 (d, J = 5.4 Hz, 1H, 3-OH), 4.28-4.17 (m, 2H, H-6a, H-
2), 3.86 (m, 1H, H-3), 3.77-3.61 (m, 5H, H-6b, H-5, H-4, -CH2-Cl), 2.50 (t, J = 7.4 Hz, 2H, -HC=C-
CH2-), 1.78-1.66 (m, 4H, -HC=C-CH2-(CH2)2-CH2-Cl), 1.63 (s, 3H, CH3 in NHAc); 
13C NMR 
(100 MHz, d6-DMSO) δ 170.8 (C=O in NHAc), 147.3 (-HC=C-), 137.9, 129.7, 128.8, 127.0, 121.4 
(-HC=C-), 101.5 (Ph-CH-), 86.7 (C-1), 80.9 (C-4), 71.1 (C-3), 69.3 (C-5), 67.9 (C-6), 55.7 (C-2), 
45.8 (-CH2-Cl), 31.7, 26.6, 24.5, 23.0 (CH3 in NHAc); LC-MS (ESI+)  calcd for C21H27N4O5NaCl 
[M + Na]+ 473.2 found 473.1. 
 
Synthesis of compound 25: 
1-Octyne (0.040 mL, 0.269 mmol, 1.2 equiv) was used as the starting material. The crude product 
was purified by column chromatography to afford white solid (84 mg, 84%) as the desired product 
(Rf = 0.5 in 10% MeOH/DCM); mp 246-248 °C; 
1H NMR (400 MHz, d6-DMSO) δ 7.96-7.89 (m, 
2H, -NH-, -HC=C-), 7.51-7.44 (m, 2H, Ar-H), 7.43-7.35 (m, 3H, Ar-H), 5.84 (d, J = 10.0 Hz, 1H, 
H-1), 5.65 (s, 1H, Ph-CH-), 5.58 (d, J = 5.4 Hz, 1H, 3-OH), 4.28-4.16 (m, 2H, H-6a, H-2), 3.90-
3.82 (m, 1H, H-3), 3.77-3.61 (m, 3H, H-6b, H-5, H-4), 2.58 (t, J = 7.4 Hz, 2H, -HC=C-CH2-), 1.63 
(s, 3H, CH3 in NHAc), 1.61-1.51 (m, 2H, -HC=C-CH2-CH2-), 1.31-1.23 (m, 6H, -HC=C-CH2-
CH2-(CH2)3-CH3), 0.86 (t, J = 6.7 Hz, 3H, -HC=C-CH2-CH2-(CH2)3-CH3); 
13C NMR (100 MHz, 





100.8 (Ph-CH-), 85.9 (C-1), 80.7 (C-4), 70.4 (C-3), 68.7 (C-5), 67.4 (C-6), 55.0 (C-2), 31.0, 28.7, 
28.0, 24.8, 22.6 (CH3 in NHAc), 22.0, 13.9; LC-MS (ESI+) calcd for C23H32N4O5Na [M+Na]
+ 
467.2 found 467.3. 
 
Synthesis of compound 26: 
1-Decyne (0.050 mL, 0.269 mmol, 1.2 equiv) was used as the starting material. The crude product 
was purified by column chromatography to afford white solid (87 mg, 82%) as the desired product 
(Rf = 0.6 in 10% MeOH/DCM); mp 243-245 °C; 
1H NMR (400 MHz, d6-DMSO) δ 7.95-7.87 (m, 
2H, -NH-, -HC=C-), 7.52-7.44 (m, 2H, Ar-H), 7.43-7.36 (m, 3H, Ar-H), 5.85 (d, J = 10.0 Hz, 1H, 
H-1), 5.65 (s, 1H, Ph-CH-), 5.57 (d, J = 5.4 Hz, 1H, 3-OH), 4.27-4.16 (m, 2H, H-6a, H-2), 3.90-
3.82 (m, 1H, H-3), 3.77-3.58 (m, 3H, H-6b, H-5, H-4), 2.58 (t, J = 7.5 Hz, 2H, -HC=C-CH2-), 1.63 
(s, 3H, CH3 in NHAc), 1.60-1.51 (m, 2H, -HC=C-CH2-CH2-(CH2)5-CH3), 1.31-1.20 (m, 10H, -
HC=C-CH2-CH2-(CH2)5-CH3), 0.86 (t, J = 6.8 Hz, 3H, -HC=C-CH2-CH2-(CH2)5-CH3); 
13C NMR 
(100 MHz, d6-DMSO) δ 169.1 (C=O in NHAc), 146.7 (-HC=C-), 137.5, 128.9, 128.0, 126.3, 120.4 
(-HC=C-), 100.7 (Ph-CH-), 85.9 (C-1), 80.7 (C-4), 70.4 (C-3), 68.7 (C-5), 67.4 (C-6), 55.0 (C-2), 
31.2, 28.73, 28.68, 28.6, 28.3, 24.8, 22.6 (CH3 in NHAc), 22.0, 13.9; LC-MS (ESI+) calcd for 
C25H36N4O5Na [M + Na]
+ 495.3 found 495.2. 
 
Synthesis of compound 27: 
1-Dodecyne (0.058 mL, 0.269 mmol, 1.2 equiv) was used as the starting material. The crude 
product was purified by column chromatography to afford white solid (96 mg, 85%) as the desired 
product (Rf = 0.6 in 10% MeOH/DCM); mp 241-243 °C; 
1H NMR (400 MHz, d6-DMSO) δ 7.95-





Hz, 1H, H-1), 5.65 (s, 1H, Ph-CH-), 5.57 (d, J = 5.4 Hz, 1H, 3-OH), 4.27-4.16 (m, 2H, H-6a, H-
2), 3.90-3.82 (m, 1H, H-3), 3.77-3.58 (m, 3H, H-6b, H-5, H-4), 2.58 (t, J = 7.5 Hz, 2H, -HC=C-
CH2-), 1.63 (s, 3H, CH3 in NHAc), 1.61-1.52 (m, 2H, -HC=C-CH2-CH2-(CH2)7-CH3), 1.25 (br s, 
14H, -HC=C-CH2-CH2-(CH2)7-CH3), 0.86 (t, J = 6.8 Hz, 3H, -HC=C-CH2-CH2-(CH2)7-CH3); 
13C 
NMR (100 MHz, d6-DMSO) δ 169.1 (C=O in NHAc), 146.7 (-HC=C-), 137.5, 128.9, 128.0, 126.3, 
120.4 (-HC=C-), 100.7 (Ph-CH-), 85.9 (C-1), 80.7 (C-4), 70.4 (C-3), 68.7 (C-5), 67.4 (C-6), 55.0 
(C-2), 31.2, 28.92, 28.91, 28.7, 28.6, 28.3, 24.8, 22.6 (CH3 in NHAc), 22.0, 13.9; LC-MS (ESI+) 
calcd for C27H40N4O5Na [M + Na]
+ 523.3 found 523.3. 
 
Synthesis of compound 28: 
1-Hexdecyne (66 mg, 0.269 mmol, 1.2 equiv) was used as the starting material. The crude product 
was purified by column chromatography to afford white solid (100 mg, 80%) as the desired product 
(Rf = 0.6 in 10% MeOH/DCM); mp 226-228 °C; 
1H NMR (400 MHz, d6-DMSO) δ 7.95-7.89 (m, 
2H, -NH-, -HC=C-), 7.51-7.45 (m, 2H, Ar-H), 7.43-7.36 (m, 3H, Ar-H), 5.85 (d, J = 10.0 Hz, 1H, 
H-1), 5.65 (s, 1H, Ph-CH-), 5.57 (d, J = 5.4 Hz, 1H, 3-OH), 4.27-4.15 (m, 2H, H-6a, H-2), 3.90-
3.80 (m, 1H, H-3), 3.76-3.60 (m, 3H, H-6b, H-5, H-4), 2.50 (t, J = 7.5 Hz, 2H, -HC=C-CH2-), 1.63 
(s, 3H, CH3 in NHAc), 1.60-1.51 (m, 2H, -HC=C-CH2-CH2-), 1.24 (br s, 22H, -HC=C-CH2-CH2-
(CH2)11-CH3), 0.85 (t, J = 6.8 Hz, 3H, -HC=C-CH2-CH2-(CH2)11-CH3); 
13C NMR (100 MHz, d6-
DMSO) δ 169.1 (C=O in NHAc), 146.7 (-HC=C-), 137.5, 128.9, 128.0, 126.3, 120.4 (-HC=C-), 
100.8 (Ph-CH-), 85.9 (C-1), 80.7 (C-4), 70.4 (C-3), 68.7 (C-5), 67.4 (C-6), 55.0 (C-2), 31.2, 29.0, 
28.94, 28.90, 28.7, 28.6, 28.3, 24.8, 22.6 (CH3 in NHAc), 22.0, 13.9; LC-MS (ESI+) calcd for 
C31H49N4O5 [M + H]






Synthesis of compound 29: 
Phenylacetylene (0.030 mL, 0.269 mmol, 1.2 equiv) was used as the starting material. The crude 
product was purified by column chromatography to afford white solid (81 mg, 83%) as the desired 
product (Rf = 0.4 in 10% MeOH/DCM); mp 275-277 °C; 
1H NMR (400 MHz, d6-DMSO) δ 8.74 
(s, 1H, -HC=C-), 8.03 (d, J = 9.1 Hz, 1H, -NH-), 7.88-7.83 (m, 2H, Ar-H), 7.85-7.42 (m, 4H, Ar-
H), 7.41-7.32 (m, 4H, Ar-H), 5.94 (d, J = 10.0 Hz, 1H, H-1), 5.71-5.64 (m, 2H, Ph-CH-, 3-OH), 
4.34-4.22 (m, 2H, H-6a, H-2), 3.96-3.88 (m, 1H, H-3), 3.82-3.66 (m, 3H, H-6b, H-5, H-4), 1.64 (s, 
3H, CH3 in NHAc); 
13C NMR (100 MHz, d6-DMSO) δ 170.1 (C=O in NHAc), 146.7 (-HC=C-), 
137.8, 130.5, 129.3, 128.5, 128.4, 126.7, 125.6, 120.5 (-HC=C-), 101.2 (Ph-CH-), 86.6 (C-1), 80.8 
(C-4), 70.7 (C-3), 69.1 (C-5), 67.7 (C-6), 55.6 (C-2), 22.9 (CH3 in NHAc); LC-MS (ESI+) calcd 
for C23H24N4O5Na [M + Na]
+ 459.2 found 459.2. 
 
Synthesis of compound 30: 
3-Dimethylamino-1-propyne (0.030 mL, 0.269 mmol, 1.2 equiv) was used as the starting material. 
The crude product was purified by column chromatography to afford white solid (73 mg, 78%) as 
the desired product (Rf = 0.3 in 20% MeOH/DCM); mp 223-225 °C; 
1H NMR (400 MHz, d6-
DMSO) δ 8.04 (s, 1H, -HC=C-), 7.94 (d, J = 9.4 Hz, 1H, -NH-), 7.51-7.45 (m, 2H, Ar-H), 7.42-
7.37 (m, 3H, Ar-H), 5.86 (d, J = 10.0 Hz, 1H, H-1), 5.66 (s, 1H, Ph-CH-), 5.57 (d, J = 5.4 Hz, 1H, 
3-OH), 4.30-4.18 (m, 2H, H-6a, H-2), 3.85 (m, 1H, H-3), 3.79-3.63 (m, 3H, H-6b, H-5, H-4), 3.53-
3.43 (m, 2H, -CH2-N-), 2.12 (s, 6H, -N(CH3)2), 1.63 (s, 3H, CH3 in NHAc); 
13C NMR (100 MHz, 
d6-DMSO) δ 169.2 (C=O in NHAc), 143.1 (-HC=C-), 137.5, 128.9, 128.0, 126.4, 122.6 (-HC=C-), 





N-), 44.2 (-N(CH3)2), 22.6 (CH3 in NHAc);




Synthesis of compound 31: 
 4-Pentyn-1-ol (0.026 mL, 0.269 mmol, 1.2 equiv) was used as the starting material. The crude 
product was purified by column chromatography to afford white solid (75 mg, 80%) as the desired 
product (Rf = 0.3 in 10% MeOH/DCM); mp 217-219 °C; 
1H NMR (400 MHz, d6-DMSO) δ 7.97-
7.90 (m, 2H, -NH-, -HC=C-), 7.51-7.45 (m, 2H, Ar-H), 7.42-7.36 (m, 3H, Ar-H), 5.85 (d, J = 10.0 
Hz, 1H, H-1), 5.65 (s, 1H, Ph-CH-), 5.58 (d, J = 5.4 Hz, 1H, 3-OH), 4.45 (t, J = 5.2 Hz, 1H, -CH2-
OH), 4.27-4.16 (m, 2H, H-6a, H-2), 3.86 (m, 1H, H-3), 3.77-3.61 (m, 3H, H-6b, H-5, H-4), 3.44-
3.38 (m, 2H, -CH2-OH), 2.63 (t, J = 7.6 Hz, 2H, -HC=C-CH2-CH2-CH2-OH), 1.76-1.67 (m, 2H, -
HC=C-CH2-CH2-CH2-OH), 1.64 (s, 3H, CH3 in NHAc); 
13C NMR (100 MHz, d6-DMSO) δ 169.3 
(C=O in NHAc), 146.7 (-HC=C-), 137.6, 129.0, 128.1, 126.4, 120.5 (-HC=C-), 100.8 (Ph-CH-), 
86.0 (C-1), 80.7 (C-4), 70.4 (C-3), 68.7 (C-5), 67.5 (C-6), 59.9 (-CH2-OH), 55.1 (C-2), 32.1, 22.7 
(CH3 in NHAc), 21.6; LC-MS (ESI+) calcd for C20H27N4O6 [M+H]
+ 419.2 found 419.2. 
 
Synthesis of compound 32: 
1-Ethynyl-1-cyclohexanol (33 mg, 0.269 mmol, 1.2 equiv) was used as the starting material. The 
crude product was purified by column chromatography to afford white solid (76 mg, 74%) as the 
desired product (Rf = 0.55 in 10% MeOH/DCM); mp 257-259 °C; 
1H NMR (400 MHz, d6-DMSO) 
δ 7.96-7.90 (m, 2H, -NH-, -HC=C-), 7.50-7.45 (m, 2H, Ar-H), 7.43-7.37 (m, 3H, Ar-H), 5.88 (d, 
J = 10.0 Hz, 1H, H-1), 5.65 (s, 1H, Ph-CH-), 5.56 (d, J = 5.5 Hz, 1H, 3-OH), 4.84 (s, 1H, -C-OH), 





(m, 1H), 1.85-1.75 (m, 1H), 1.70-1.64 (m, 6H), 1.54-1.22 (m, 5H); 13C NMR (100 MHz, d6-
DMSO) δ 169.1 (C=O in NHAc), 155.2 (-HC=C-), 137.5, 128.9, 128.0, 126.3, 119.7 (-HC=C-), 
100.8 (Ph-CH-), 85.9 (C-1), 80.7 (C-4), 70.4 (C-3), 68.7 (C-5), 67.8 (-C-OH), 67.4 (C-6), 54.9 (C-
2), 38.0, 37.4, 25.2, 22.6 (CH3 in NHAc), 21.6; LC-MS (ESI+) calcd for C23H30N4O6Na [M + Na]
+ 
481.2 found 481.2. 
 
General procedure for the synthesis of triazoles 33-34: 
Compound with hydroxyl groups free at 2 and 3 position (40 mg, 1 equiv) was dissolved in 2 mL 
of the THF in a scintillation vial. The mixture which was not completely dissolved in THF was 
stirred in ice for 15 minutes. Pyridine (20 equiv) was added. Then acetic anhydride (4 equiv) was 
also added into the mixture. After the addition of the acetic anhydride and pyridine, the reaction 
mixture became a clear solution. The reaction was allowed to warm to room temperature for 18 
hours. TLC and NMR showed that the starting material had been consumed. The mixture became 
opaque again after the completion of the reaction. The solvent was removed under reduced 
pressure. The crude was diluted with 10 mL DCM and washed with 5 mL water. The organic phase 
was dried over sodium sulfate, filtered and concentrated. The crude product was then purified 
using column chromatography with a gradient solvent system from pure DCM to 1% MeOH/DCM 
to afford the desired product. 
 
Synthesis of compound 33:  
White solid (39.8 mg, 81%), mp 253-254 °C; Rf = 0.6 in 3% MeOH/DCM. 
1H NMR (400 MHz, 
CDCl3) δ 7.49-7.42 (m, 3H, -HC=C-, Ar-H), 7.41-7.35 (m, 3H, Ar-H), 5.90 (d, J = 8.9 Hz, 1H, H-





H-4, H-6b, H-5), 2.72 (t, J = 7.5 Hz, 2H, -HC=C-CH2-), 2.07 (s, 3H, CH3 in OAc), 1.88 (s, 3H, 
CH3 in OAc), 1.70-1.61 (m, 2H, -HC=C-CH2-CH2-), 1.43-1.32 (m, 2H, -HC=C-CH2-CH2-CH2-
CH3), 0.93 (t, J = 7.3 Hz, 3H, -HC=C-CH2-CH2-CH2-CH3);
 13C NMR (100 MHz, CDCl3) δ 169.8 
(C=O in OAc), 169.1 (C=O in OAc), 149.1 (-HC=C-), 136.4, 129.3, 128.3, 126.1, 118.8 (-HC=C-), 
101.8 (Ph-CH-), 86.1 (C-1), 78.1 (C-4), 71.7 (C-3), 71.1 (C-2), 69.6 (C-5), 68.1 (C-6), 31.2, 25.3, 
22.1, 20.7 (CH3 in OAc), 20.2 (CH3 in OAc), 13.8; LC-MS (ESI+) calcd for C23H30N3O7 [M + H]
+ 
460.2 found 460.2. 
 
Synthesis of compound 34: 
White solid (39.4 mg, 85%), mp 241-243 °C. Rf = 0.5 in 3% MeOH/DCM; 
1H NMR (400 MHz, 
CDCl3) δ 7.49-7.42 (m, 3H, -HC=C-, Ar-H), 7.40-7.34 (m, 3H, Ar-H), 5.90 (d, J = 8.9 Hz, 1H, H-
1), 5.55 (s, 1H, Ph-CH-), 5.54-5.44 (m, 2H, H-3, H-2), 4.45-4.36 (m, 1H, H-6a), 3.92-3.78 (m, 3H, 
H-4, H-6b, H-5), 2.71 (t, J = 7.5 Hz, 2H, -HC=C-CH2-), 2.07 (s, 3H, CH3 in OAc), 1.88 (s, 3H, 
CH3 in OAc), 1.72-1.61 (m, 2H, -HC=C-CH2-CH2-), 1.39-1.26 (m, 6H, -HC=C-CH2-CH2-(CH2)3-
CH3), 0.88 (t, J = 6.7 Hz, 3H, -HC=C-CH2-CH2-(CH2)3-CH3); 
13C NMR (100 MHz, CDCl3) δ 
169.8, (C=O in OAc), 169.1 (C=O in OAc), 149.2 (-HC=C-), 136.4, 129.3, 128.3, 126.1, 118.8 (-
HC=C-), 101.8 (Ph-CH-), 86.1 (C-1), 78.1 (C-4), 71.7 (C-3), 71.1 (C-2), 69.5 (C-5), 68.1 (C-6), 
31.5, 29.1, 28.7, 25.6, 22.5, 20.7 (CH3 in OAc), 20.2 (CH3 in OAc), 14.0. LC-MS (ESI+) calcd for 
C25H33N3O7 [M + H]
+ 488.2 found 488.2. 
 
Synthesis of the triazole headgroup 35: 
To a 50 mL of round bottomed flask, compound 22 (600 mg, 1.800 mmol, 1 equiv), and 3 mL 





3.600 mmol, 2.0 equiv) dropwise to the mixture at 0 °C (ice-water bath). The resulting mixture 
was stirred initially at 0 °C and then allowed it to wart to rt for overnight stirring. The reaction 
mixture was diluted with EtOAc (30 mL), and then washed with water (5 mL). The combined 
organic layer was dried over Na2SO4 (anhydrous), filtered and concentrated to afford white solid 
(602 mg, 89%) as the desired product. mp 210-212 °C; 1H NMR (400 MHz, CDCl3) δ 7.45-7.40 
(m, 2H), 7.39-7.34 (m, 3H), 5.94 (d, J = 9.4 Hz, 1H), 5.52 (s, 1H), 5.27 (t, J = 9.9 Hz, 1H, H-3), 
4.55 (d, J = 9.3 Hz, 1H, H-1), 4.35 (dd, J = 10.5, 4.9 Hz, 1H, H-6a), 4.16-4.06 (m, 1H, H-2), 3.80 
(t, J = 10.2 Hz, 1H, H-6b), 3.71 (t, J = 9.4 Hz, 1H, H-4), 3.65-3.56 (m, 1H, H-5), 2.09 (s, 3H), 1.97 
(s, 3H); 13C NMR (100 MHz, CDCl3) δ 171.5, 170.4, 136.7, 129.3, 128.3, 126.0, 101.4, 89.5 (C-
1), 78.3 (C-4), 71.7 (C-3), 68.6 (C-5), 68.3 (C-6), 54.0 (C-2), 23.2, 20.9. 
 
General procedure for the synthesis of triazoles 36-38: 
To a 50 mL round bottomed flask, compound 35 (75 mg, 0.200 mmol, 1 equiv), alkyne (0.260 
mmol, 1.3 equiv), CH3CN (4 mL, anhydrous), CuI (7.6 mg, 0.040 mmol, 0.2 equiv) and DIEA 
(0.17 mL, 1.00 mmol, 5 equiv) were added in the given order. The reaction mixture was stirred at 
rt for 24 hrs. Then the solvent was removed to afford the crude product, which was purified by 
column chromatography using eluent from pure DCM to 5% MeOH/DCM to give the desired 
product. 
 
Synthesis of compound 36:  
1-Hexyne (0.030 mL, 0.260 mmol, 1.3 equiv) was used as the starting material. The crude product 
was purified by column chromatography to afford white solid (75 mg, 82%) as the desired product 
(Rf = 0.4 in 5% MeOH/DCM). compound decomposed at 275 °C; 





δ 8.05 (d, J = 9.3 Hz, 1H, -NH-), 8.00 (s, 1H, -HC=C-), 7.43-7.36 (m, 5H, Ar-H), 6.05 (d, J = 9.9 
Hz, 1H, H-1), 5.68 (s, 1H, Ph-CH-), 5.39 (t, J = 9.7 Hz, 1H, H-3), 4.61-4.51 (m ,1H, H-2), 4.27 
(dd, J = 9.9, 4.7 Hz, 1H, H-6a), 3.97 (t, J = 9.4 Hz, 1H, H-4), 3.91-3.83 (m, 1H, H-5), 3.77 (t, J = 
9.9 Hz, 1H, H-6b), 2.60 (t, J = 7.5 Hz, 2H, -HC=C-CH2-), 1.99 (s, 3H, CH3 in OAc), 1.62-1.50 (m, 
5H, CH3 in NHAc, -HC=C-CH2-CH2-), 1.33-1.22 (m, 2H, -HC=C-CH2-CH2-CH2-CH3), 0.88 (t, J 
=7.4 Hz, 3H, -HC=C-CH2-CH2-CH2-CH3); 
13C NMR (100 MHz, d6-DMSO) δ 169.7 (C=O), 169.3 
(C=O), 147.0 (-HC=C-), 137.2, 129.0, 128.1, 126.1, 120.6 (-HC=C-), 100.4 (Ph-CH-), 85.3 (C-1), 
77.6 (C-4), 71.7 (C-3), 68.4 (C-5), 67.3 (C-6), 52.7 (C-2), 30.9, 24.5, 22.3 (CH3 in NHAc), 21.4, 
20.5 (CH3 in OAc), 13.6. LC-MS (ESI+) cacld C23H30N4O6Na [M + Na]
+ 481.2 found 481.2. 
 
Synthesis of compound 37: 
1-Octyne (0.036 mL, 0.260 mmol, 1.3 equiv) was used as the starting material. The crude product 
was purified by column chromatography to afford white solid (70 mg, 80%) as the desired product 
(Rf = 0.4 in 5% MeOH/DCM). compound decomposed at 270 °C; 
1H NMR (d6-DMSO, 400 MHz) 
δ 8.04 (d, J = 9.3 Hz, 1H, -NH-), 8.00 (s, 1H, -HC=C-), 7.42-7.37 (m, 5H, Ar-H), 6.05 (d, J = 9.9 
Hz, 1H, H-1), 5.68 (s, 1H, Ph-CH-), 5.39 (t, J = 9.7 Hz, 1H, H-3), 4.63-4.52 (m, 1H, H-2), 4.27 
(dd, J = 9.9, 4.7 Hz, 1H, H-6a), 3.97 (t, J = 9.4 Hz, 1H, H-4), 3.91-3.83 (m, 1H, H-5), 3.77 (t, J = 
9.9 Hz, 1H, H-6b), 2.60 (t, J = 7.4 Hz, 2H, -HC=C-CH2-), 2.00 (s, 3H, CH3 in OAc), 1.62-1.50 (m, 
5H, CH3 in NHAc, -HC=C-CH2-CH2-), 1.33-1.21 (m, 6H, -HC=C-CH2-CH2-(CH2)3-CH3), 0.86 (t, 
J =6.7 Hz, 3H, -HC=C-CH2-CH2-(CH2)3-CH3); 
13C NMR (d6-DMSO, 100 MHz) δ 169.6 (C=O), 
169.2 (C=O), 147.0 (-HC=C-), 137.2, 128.9, 128.1, 126.1, 120.6 (-HC=C-), 100.4 (Ph-CH-), 85.3 









Synthesis of compound 38:  
1-Decyne (0.038 mL, 0.260 mmol, 1.3 equiv) was used as the starting material. The crude product 
was purified by column chromatography to afford white solid (87 mg, 85%) as the desired product 
(Rf = 0.4 in 5% MeOH/DCM). compound decomposed at 275 °C; 
1H NMR (0.4 mL CDCl3 + 0.1 
mL d4-MeOH) δ 7.57 (s, 1H, -HC=C-), 7.44-7.38 (m, 2H, Ar-H), 7.36-7.30 (m, 3H, Ar-H), 5.87 
(d, J = 10.0 Hz, 1H, H-1), 5.52 (s, 1H, Ph-CH-), 5.37 (t, J = 9.9 Hz, 1H, H-3), 4.54 (t, J = 10.1 Hz, 
1H, H-2), 4.38-4.20 (m, 1H, H-6a), 3.87-3.73 (m, 3H, H-4, H-5, H-6b), 2.63 (t, J =7.6 Hz, 2H, -
HC=C-CH2-), 2.04 (s, 3H, CH3 in NHAc), 1.70 (s, 3H, CH3 in OAc), 1.65-1.57 (m, 2H, -HC=C-
CH2-CH2-), 1.34-1.16 (m, 10H, -HC=C-CH2-CH2-(CH2)5-CH3), 0.83 (t, J = 6.8 Hz, 3H, -HC=C-
CH2-CH2-(CH2)5-CH3); 
13C NMR (0.4 mL CDCl3 + 0.1 mL d4-MeOH) δ 171.2 (C=O), 170.7 
(C=O), 136.4, 129.1, 128.1, 125.9, 101.5 (Ph-CH-), 86.4 (C-1), 78.3 (C-4), 71.5 (C-3), 69.2 (C-5), 
68.0 (C-6), 53.1 (C-2), 31.6, 29.0, 28.94, 28.89, 25.2, 22.4 (CH3 in NHAc), 22.0, 20.3 (CH3 in 
OAc), 13.7. LC-MS (ESI+) cacld C27H38N4O6Na [M + Na]











CHAPTER 3. SYNTHESIS AND CHARACTERIZATION OF BRANCHED 
GLYCOMIMETICS AND THEIR SELF-ASSEMBLING PROPERTIES 
This chapter is adapted from the manuscript submitted to Chemistry: A European Journal titled as 
“Design, synthesis, and study of triazole linked glycoclusters as supramolecular gelators". 
 
3.1 ABSTRACT 
Carbohydrate based branched and dendritic gelators can form useful soft biomaterials with 
interesting properties due to the self-assembled supramolecular network. We have found that 
various monosaccharide based triazole containing glycolipids were effective molecular gelators 
for organic solvents and aqueous solutions. In order to explore the structure and gelation properties 
of sugar triazole derivatives to obtain effective supramolecular materials, we designed, synthesized 
and studied several series of branched glycoclusters with unique structures and accurate molecule 
weight systematically. We expect to observe the multivalence effect of sugar based gelators and 
obtain useful self-assembled materials. In this chapter, several triazole linked dimeric, trimeric, or 
tetrameric form of the momomeric molecular gelators were obtained. The self-assembling 
properties of these compounds were screened in several organic solvents, aqueous solutions, and 
water. We found that the trimeric and tetrameric derivatives are much more effective 
supramolecular gelator in several tested solvent systems, some of the gels were selected to be 
further characterized using rheology and optical microscopy.  
  
Keywords: carbohydrate, self-assembly, glycocluster, dendritic gelators, multivalency, 







Carbohydrates play important roles in biological processes including cellular recognition, 
communication, differentiation and adhesion. Glycoconjugates displayed on cell surfaces are 
typically multivalent and have many branched sugars.129-131 These glycoconjugates can 
specifically bind to lectins that are responsible for many biological responses which are commonly 
seen in infectious disease, cancers, etc.62-63, 129, 131-135 In recent years, many synthetic 
glycomimetics and glycoconjugates that mimic the complex carbohydrates with biological 
functions have been reported. The multivalent effects have been utilized in designing lectin 
inhibitors with better efficacies, glycosidase inhibitors, and new medicals for influenza, cholera 
toxin inhibitors.136-137 There also exists examples of utilizing the same principle for creating 
advanced materials with enhanced properties, which have been shown useful applications 
medicinal chemistry, bioorganic chemistry, and materials chemistry.64, 138-139 The copper catalyzed 
azide alkyne cycloaddition (CuAAC), the “Click” reaction, can afford regioselective 1,4-
disubstituted 1,2,3-triazole product, has shown great application and facilitated the field of 
glycobiology, especially in the synthesis and study of glycoclusters and glycoconjugates.140-143 
Many different glycoconjugates using triazole as the linkage have been synthesized and studied 
for their lectin binding properties, as glycosidase inhibitors or other applications.31, 144-145 
 
Among new materials generated through molecular self-assembling systems, low molecular 
weight gelators (LMWGs), also known as molecular gelators or supramolecular gelators, are small 
molecules that can immobilize organic solvents or water to form reversible gel. These formed gel 
are unique soft materials can function as advanced biomedical materials for drug delivery, enzyme 





and geometry in between small molecule and polymer gels, the unique structure arrangement can 
lead to interesting molecular properties. 61, 146-147 Over the last few decades, dendritic molecules 
and dendrons have been explored for their material applications in the formation of organogels 
and hydrogels.57, 59, 147-149 A number of different systems containing multiple building blocks such 
as amino acids or aryl ethers have been developed and stimuli-responsive materials from these 
dendritic molecules have been prepared.57, 59, 149-150 In dendritic and branched systems, the 
multivalent interactions between the dendrons could enhance the intermolecular interaction and 
stabilize the gel networks. For glycoclusters at lower generation, they are relatively smaller 
branched systems, they have uniform molecular weight and shape, but at the meantime, there 
should be a multivalent effect from the repeating monomeric functional groups. Recently, we have 
shown that introducing a triazole moiety to sugar molecule has led to the formation of functional 
molecular assemblies. The general structures of several sugar triazole derivatives 1-3 are shown 
in Figure 59. These compounds are effective organogelators to gelate alcohols, DMSO and water 
mixtures, ethanol and water mixtures, and water. Interestingly, we have found that dimeric 
glucosyl triazole derivatives 3 are more effective gelators than the corresponding monomeric 
triazoles. Since the supramolecular gel networks are held together solely by weak intermolecular 
forces, we hypothesize that by further formation of branched glycosyl triazole clusters, effective 
supramolecular gels could be obtained. The multivalency effect can contribute to molecular self-
assembling to be more effective and these could result in useful soft gel materials. As a design 
principle of utilizing the multivalent effect and dendronized supramolecular gelators, we would 
like to synthesize and characterize multimeric sugar triazole containing derivatives by covalently 







Figure 59. Sugar triazole monomeric gelators 1-2 and dimeric gelator 3. 
 
3.3 RESULTS AND DISSCUSSIONS 
We systematically synthesized and studied tetrameric branched systems with similar building 
blocks as shown in Figure 60. Using the pentaerythritol 7 as the starting material, esterification 
with 5-pentynoyl chloride afforded the tetrameric alkynyl ester 8. As shown in scheme 4, partial 
click reaction using two equivalents of azide were carried out to obtain a mixture of monomeric, 
dimeric, trimeric and tetrameric triazole adducts in a one pot reaction. They were isolated by flash 
chromatography with a gradient of solvent system carefully. The gelation results of four adducts 
are summarized and listed in Table 6.  
 





It is interesting to notice that increasing the number of sugar unit in the molecules leads to the 
enhancement of gelation properties. The monomer and dimer 10 and 11 failed to form any gels in 
the tested solvents, but the trimeric compound 12 formed gels in ethanol and isopropanol at 20 
mg/mL, the tetrameric compound 13 was the most effective among these four derivatives. It 
formed effective gels in all tested alcohols included glycerol and the best performing gel was in 
isopropanol at 4.0 mg/mL. These results clearly indicated the effect of multivalence with 
tetrameric conjugate being the most effective molecular gelator forming gels in the five tested 
alcohols. Since the tetrameric click reaction product 13 was the most effective gelator, we also 
synthesized the tetrameric click adducts 14 and 15 in excellent yields using glucosyl tetraacetate 
beta azide 5 and galactosyl tetraacetate beta azide 6 with tetrameic alkynyl ester 8. These two 
tetrameric triazole derivatives with different sugars were screened in the same solvents and the 
results included in Table 6. We found that these two compounds were not effective gelator for all 
tested solvents except glycerol. The two compounds were forming gels in glycerol at 20 mg/mL.  
This indicated that the sugar structures play an important role in the molecular self-assembly and 








Scheme 4. Synthesis of glycoclusters with different degree of triazole 10-15.  
 
In order to prove the generality of the rationale, we also synthesized four other glycoconjugates 
using the tetra propargyl ether 9 as the starting material, which was prepared through alkylation 
with propargyl chloride and tetra alcohol 7 in the presence of sodium hydride. Four adducts shown 
in Scheme 5 were obtained in the same fashion as preparing ester triazole adducts. However, the 
molecules of the ether series are more rigid than the tetraester alkyne series with the structural 





similar trend with the ester series, that is, the monomer didn’t form gel in any tested solvent. 
However, interestingly, the dimer 17 formed a hydrogel only, but not in any other organic solvents 
and it is soluble in the all tested alcoholic solvents. The trimer 18 formed gels in most of the 
alcohols and ethanol water mixture. The most effective gelator molecule is the tetramer 19, which 
formed gels in nine of the test solvents, with concentrations ranging from 4 mg/mL to 20 mg/mL. 
The tetrameric compound 19 formed gels in all alcohols similarly to tetramer 15, but compound 
19 also formed gels in ethanol water mixtures, DMSO and water mixtures. A clear trend of 
multivalence effect of gelation by these glycoclusters was revealed as well as the interesting 
gelation property of the dimer 17 in water, but not other solvents.  
 





We also synthesized analogous dimer 20 without the propargyl substituents and studied their self-
assembling properties. These were synthesized by selective protecting the tetra alcohol 7 and 
followed by click reaction as shown in Scheme 6. Starting from phenyl protected compound 21, 
after propargylation, de-protecting benzylidene and click reaction, dimeric conjugate 20 was 
afforded. The two compounds were screened for their gelation properties and the results are 
presented in the Table 6. It is interesting to notice that the dimeric conjugate 18 with two free 
hydroxyl group didn’t form any gels in the tested solvent systems, in fact, it is soluble in all tested 
solvents.  
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G, gel at room temperature, the numbers are the corresponding minimum gelation concentrations 
(MGCs) in mg/mL; C for clear or transparent; T, translucent; O, opaque; UG, unstable gel; I, 
insoluble; P, crystallize or precipitate; S, soluble at ~20 mg/mL. All tested samples are insoluble 





Based on the gelation results of the pentaerythritol derivatives, the tetrameric derivatives are more 
effective gelators than the mono, di, or trimeric derivatives in general. Therefore, for the trimeric 
systems, only trimeric derivatives were obtained from the building blocks shown in Figure 61.  
Tripropargylamine 24 is commercially available and tri-alkynes 26-27 were prepared using 
trimesic acid 25 as the starting material through esterification and amide formation reaction 
respectively.  
 
Figure 61. Structures of trimeric building blocks and alkyne intermediates for the click reaction. 
 
With the three tri-alkyne building blocks in hand, click reaction using slightly excess azide (3.3 
equivalents) reacting with alkyne (1 equivalent) were carried out to afford trimeric compound 28-
31 with the structures shown in Figure 62. After synthesizing the trimeric glycoclusters, their 
gelation performance in several solvents were screened and the results are shown in Table 6. The 
trimeric compound 28 is the only compound that can form gel in toluene among all the 
glycoclusters synthesized. It can also self-assemble in ethanol water mixture and all of the alcohols 
except glycerol. While compound 29 containing protected glucosamine moiety which has the same 
core as compound 28 can form gel in four (n-PrOH, n-BuOH and ethanol water mixture) of the 
tested solvents. Ester linked trimer 30 can only form gel in two tested solvents with relatively high 





efficient gelator which can immobilized a few alcohols and aqueous organic mixture. Several gel 
pictures made from trimeric or tetrameric glycoclusters are shown in Figure 63.  
 
 







a               b               c              d                e                f 
Figure 63. a) A translucent gel formed by compound 13 in i-PrOH at 4 mg/mL; b) A translucent 
gel formed by compound 19 in EtOH:H2O (v1:2) at 4.0 mg/mL; c) A clear gel formed in toluene 
by compound 28 in at 4.0 mg/mL; d) A translucent gel formed by compound 28 in EtOH at 4.0 
mg/mL; e) A clear gel formed by compound 29 in n-PrOH at 3.3 mg/mL; f) A translucent gel 
formed by compound 31 in DMSO:H2O (v1:2) at 2.8 mg/mL. 
 
The gels formed by compounds 28, 29, and 31 were characterized using an optical microscope to 
observe the self-assembled networks of gel matrix. Several optical micrographic images are shown 
in Figure 64-69. In EtOH, compound 28 showed the morphology of long thin entangled fibers 
(Figure 64). From the gel made by compound 28 in i-PrOH, long fibers in diameter (~1 µm) and 
up to 200 µm in length were observed (Figure 65). However, in toluene, the same compound 
formed narrower and shorter fibrous structures (Figure 66) with the diameter measured as 0.5 µm 
and the length measured up to 100 µm. The gel formed by compound 29 in EtOH:H2O (v/v 1:2) 
exhibited uniform fibrous network (Figure 67). Compound 31 show different morphologies in two 
different solvents (Figure 68-69). In DMSO aqueous mixture, short and narrow fiber entangled 






Figure 64. OM image of the gel formed by compound 28 in EtOH at 4.0 mg/mL. 
 






Figure 66. OM image of the gel formed by compound 28 in toluene at 4.0 mg/mL. 
 






Figure 68. OM image of the gel formed by compound 31 in DMSO:H2O (v1:2) at 2.8 mg/mL. 
 





Next we analyzed the rheological properties of the gels formed by several compounds in different 
solvent systems using a rheometer. The storage modulus G and loss modulus G″ at different 
angular frequencies of the gels formed by compounds 13, 19, 28, and 31 are shown in Figure 70. 
The storage moduli for all five gels are always greater than their loss moduli in all frequency 
ranges, which indicates that the gels are stable and have elastic properties.  
 
 
Figure 70. Rheological properties of the gels formed by compound 13 (i-PrOH, 4.0 mg/mL), 19 
(EtOH/H2O, v/v 1:2, 4.0 mg/mL), 28 (n-PrOH, 3.3 mg/mL) and 31 (n-BuOH, 3.3 mg/mL), the 






For all these compounds, the purity was confirmed by 1D (1H, 13C), 2D (HSQC, COSY) NMR 
spectroscopic method and LC-MS/HRMS. Spectra of the ether tetramer series (tetramer, trimer, 
dimer and monomer) and two trimers are shown in Figure 71-80. Detailed procedure and data of 














































Figure 75. HSQC and COSY spectra of compound 19 in d6-DMSO. 
In this HSQC spectrum, 
 Red cross peak 
stands for proton 
correlating with 
carbon attached 
to CH or CH3. 










HRMS (ESI+) ([M + 2H]2+) m/z calcd for C73H102N16O36, 889.331583 found 889.329786 
 
Figure 76. Chemical structure, exact mass and HRMS trace of compound 19. 
This peak is possibly due to 




























Figure 80. HSQC and COSY spectra of compound 31 in d6-DMSO. 
In this HSQC spectrum, 
 Red cross peak 
stands for proton 
correlating with 
carbon attached to 
CH or CH3. 
 Black cross peak 
represents proton 
correlating with 







Several branched compounds functionalized with protected glucose or glucosamine moieties have 
been synthesized and their gelation properties have been studied. In general we found that 
increasing the number of sugar unit in the molecules leads to enhancement of gelation properties. 
Several effective organogelators and hydrogelators have been obtained, the symmetrical trimer 31 
and tetramer 19 are the most efficient gelators forming gel in versatile solvents in the same series. 
Several selected gels were characterized using optical microscopy to observe the fibrous network. 
Rheological properties were studied to reveal the successful preparation of the gels. Future study 
will be concentrated on their potential applications as matrices for cell growth and enzyme 
immobilization and stimuli-responsive smart materials. Furthermore, after proper structural 
modifications, the glycoclusters will also be explored for their lectin binding properties.    
 
3.4 EXPERIMENTAL SECTION 
Please refer to the Experimental Procedure in Chapter 2 for the general method of gel testing, 
optical image, rheological measurement. Carbon and proton signals were assigned only if 2D NMR 
spectra were obtained for that compound. 
 
General procedure for the synthesis of glycoclusters with different degree of triazoles  
To a 50 mL round bottomed flask, 4 (2 equiv), tetra-alkyne (1 equiv), CuSO4 (0.4 equiv), L-
ascorbate sodium salt (0.8 equiv) were added in the given order. Then to the mixture, 9 mL of t-
BuOH: H2O: THF (v/v/v=1:1:1) was added and the reaction mixture was stirred at room 





to give the crude, which was purified by column chromatography using eluent from pure DCM to 
5% MeOH/DCM to afford four products, which are monomer, dimer, trimer and tetramer. Tetra-
alkynes 8-9 were synthesized following literature method with slight modifications using 
pentaerythritol 7 as the starting material. 151-152  
 
Synthesis of ester linker glycoclusters 10-13 
4 (200 mg, 0.540 mmol, 2 equiv), 8 (137 mg, 0.270 mmol, 1 equiv), CuSO4 (13 mg, 0.108 mmol, 
0.4 equiv), L-ascorbic acid sodium salt (43 mg, 0.216 mmol, 0.8 equiv) were used. Four products 
were isolated through column chromatography.  
 
Characterization data of ester linker monomer 10 
Off-white solid, 26 mg (11%); Rf = 0.5 in 5% MeOH/DCM; m.p. 60.0-62.0 °C; 1H NMR (400 
MHz, CDCl3) δ 7.70 (br s, 1H), 5.95 (m, 2H), 5.23 (t, J = 9.7 Hz, 1H), 5.23 (t, J = 9.7 Hz, 1H), 
4.61-4.51 (m, 1H), 4.29 (dd, J = 12.5, 4.9 Hz, 1H), 4.19-4.09 (m, 9H), 4.01-3.96 (m, 1H), 2.76 (m, 
2H), 2.47 (t, J = 7.4 Hz, 6H), 2.38 (m, 2H), 2.26 (dt, J = 6.8, 2.6 Hz, 6H), 2.08-2.05 (m, 11H), 1.99 
(t, J = 2.6 Hz, 3H), 1.88-1.78 (m, 6H), 1.75 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 172.2, 172.0, 
170.0, 169.5, 169.29, 169.25, 146.2, 120.7, 84.7, 83.5, 73.3, 72.3, 71.6, 68.1, 62.1, 61.8, 52.0, 41.7, 
32.4, 32.2, 24.1, 23.9, 23.3, 22.2, 20.5, 20.4, 20.2, 17.0; LC-MS (ESI+) m/z calcd for C43H57N4O16 
[M + H]+ 885.4, found 885.3. 
 
Characterization data of ester linker dimer 11 
White solid, 30 mg (9%); Rf  = 0.4 in 5% MeOH/DCM; m.p. 90.2-91.7 °C; 
1H NMR (400 MHz, 





Hz, 2H), 4.62-4.50 (m, 2H), 4.26-4.19 (m, 2H), 4.17-4.02 (m, 12H), 2.76 (t, J = 2.6 Hz, 2H), 2.63 
(t, J = 7.4 Hz, 4H), 2.40 (t, J = 7.4 Hz, 4H), 2.34 (t, J = 7.4 Hz, 4H), 2.18 (dt, J = 7.0, 2.6 Hz, 4H), 
2.01 (s, 6H), 1.99 (s, 6H), 1.94 (s, 6H), 1.86-1.78 (m, 4H), 1.73-1.64 (m, 4H), 1.57 (s, 6H); 13C 
NMR (100 MHz, d6-DMSO) δ 172.2, 172.0, 170.0, 169.5, 169.29, 169.26, 146.2, 120.7, 84.7, 83.5, 
73.3, 72.3, 71.6, 68.1, 62.1, 62.0, 61.8, 52.0, 41.7, 32.4, 32.2, 24.1, 23.9, 23.3, 22.2, 20.44, 20.36, 
20.2, 17.0; LC-MS (ESI+) m/z calcd for C57H77N8O24 [M + H]
+ 1257.5, found 1257.4.  
 
Characterization data of ester linker trimer 12 
Off-white solid, 63 mg (14%); Rf = 0.22 in 5% MeOH/DCM; m.p. 168.0-170.0 °C; 
1H NMR (400 
MHz, d6-DMSO) δ 8.05-8.00 (m, 6H), 6.03 (d, J = 9.9 Hz, 3H), 5.33 (t, J = 9.8 Hz, 3H), 5.08 (t, J 
= 9.8 Hz, 3H), 4.56 (m, 3H), 4.25-4.19 (m, 3H), 4.18-4.02 (m, 14H), 2.74 (t, J = 2.6 Hz, 1H), 2.63 
(t, J = 7.4 Hz, 6H), 2.40 (t, J = 7.4 Hz, 2H), 2.34 (t, J = 7.4 Hz, 6H), 2.18 (dt, J = 7.0, 2.6 Hz, 2H), 
2.01 (s, 9H), 1.99 (s, 9H), 1.94 (s, 9H), 1.87-1.77 (m, 6H), 1.73-1.63 (m, 2H), 1.57 (s, 9H); 13C 
NMR (100 MHz, d6-DMSO) δ 172.2, 172.0, 170.0, 169.5, 169.28, 169.26, 146.2, 120.7, 84.7, 83.5, 
73.3, 72.3, 71.6, 68.1, 62.0, 61.8, 52.0, 41.8, 32.4, 32.2, 24.1, 23.9, 23.3, 22.2, 20.43, 20.35, 20.2, 
17.0; LC-MS (ESI+) m/z calcd for C71H97N12O32 [M + H]
+ 1629.6, found 1629.5. 
 
Characterization data of ester linker tetramer 13 
Off-white solid, 130 mg (24%); Rf  = 0.08 in 5% MeOH/DCM; m.p. 219.0-221.0 °C; 
1H 
NMR (400 MHz, d6-DMSO) δ 8.04-7.99 (m, 8H), 6.03 (d, J = 9.9 Hz, 4H), 5.33 (t, J = 9.6 Hz, 
4H), 5.08 (t, J = 9.6 Hz, 4H), 4.57 (m, 4H), 4.25-4.18 (m, 4H), 4.18-4.02 (m, 16H), 2.63 (t, J = 7.4 
Hz, 8H), 2.34 (t, J = 7.4 Hz, 8H), 2.01 (s, 12H), 1.99 (s, 12H), 1.94 (s, 12H), 1.82 (m, 8H), 1.57 





72.3, 68.1, 61.9, 61.8, 52.1, 41.8, 32.4, 24.1, 23.9, 22.2, 20.42, 20.35, 20.2. HR-MS (ESI+) ([M + 
2Na]2+) m/z calcd for [C85H116N16O40Na2]/2: 1023.365957, found 1023.364505. 
 
General procedure for the synthesis of tetrameric compounds 13, 14, 15, 19 
To a 50 mL round bottomed flask, azide (4.4 equiv) and tetra-alkyne (1 equiv) were dissolved in 
the 9 mL of solvent mixture of t-BuOH: H2O: THF (v/v/v = 1:1:1). CuSO4 (0.8 equiv) and L-
ascorbic acid sodium salt (1.6 equiv) were added to the reaction mixture. Reaction was stirred for 
24 hours at room temperature. Solvent was removed under reduced pressure to give the crude, 
which was purified by column chromatography using pure DCM to 5% MeOH/DCM as the eluent 
to afford the desired tetrameric compounds 13, 14, 19. Synthesis of tetramer 13 and 19 were carried 
out through above mentioned procedure using 200 mg of azide as the starting material. Yields for 
synthesizing tetramer 13 and 19 are 81% and 83% respectively. Compound 15 was synthesized 
from CuI method and detained procedure of synthesis is shown below. 
 
Synthesis of tetrameric compound 14 
5 (200 mg, 0.536 mmol, 4.4 equiv), 8 (62 mg, 0.122 mmol, 1 equiv), CuSO4 (15.6 mg, 0.098 mmol, 
0.8 equiv), L-ascorbate sodium salt (38.6 mg, 0.195 mmol, 1.6 equiv) were used. White solid (98 
mg, 80%) was obtained as the desired product (Rf  = 0.2 in 5% MeOH/DCM). m.p. 113.0-115.0 
°C; 1H NMR (400 MHz, d6-DMSO) δ 8.16 (s, 4H, -N-CH=C-), 6.28 (d, J = 8.7 Hz, 4H, H-1), 5.66-
5.50 (m, 8H, H-2, H-3), 5.16 (t, J = 9.6 Hz, 4H, H-4), 4.39-4.32 (m, 4H, H-5), 4.17-4.00 (m, 16H, 
Ha-6, Hb-6, -O-CH2-C-), 2.64 (t, J = 7.3 Hz, 8H, -CH2-C=CH-N-), 2.36-2.30 (m, 8H, -CH2-C=O), 
2.03 (s, 12H, -CH3), 1.99 (s, 12H, -CH3), 1.96 (s, 12H, -CH3), 1.86-1.75 (m, 20H, 4x -CH2-CH2-
CH2-, 4x -CH3); 





169.3 (C=O), 168.4 (C=O), 146.8 (-N-CH=C-), 120.9 (-N-CH=C-), 83.7 (C-1), 73.2 (C-5), 72.1 
(C-3), 70.2 (C-2), 67.6 (C-4), 62.3 (-O-CH2-C-), 61.7 (C-6), 42.8 (-O-CH2-C-), 32.5 (-CH2-C=O), 
24.1 (-CH2-C=CH-N-), 23.9 (-CH2-CH2-CH2-), 20.4 (CH3 in OAc), 20.3 (CH3 in OAc), 20.2 (CH3 
in OAc), 19.7 (CH3 in OAc); LC-MS (ESI+) ([M + 2H]
2+) m/z calcd for [C85H114N12O44]/2, 1003.4, 
found 1003.4. 
 
Synthesis of tetrameric compound 15 
To a 50 mL round bottomed flask, 6 (160 mg, 0.431 mmol, 4.4 equiv) and 8 (50 mg, 0.098 mmol, 
1 equiv) were dissolved in the 6 mL of solvent mixture of THF : toluene (1:1). CuI (7.6 mg, 0.040 
mmol, 0.4 equiv) and DIEA (0.068 mL, 0.392 mmol, 4 equiv) were added to the reaction mixture. 
Reaction was stirred at 80 °C for 36 hours. Solvent was removed under reduced pressure to give 
the crude, which was then purified by column chromatography using eluent from 1% MeOH/DCM 
to 5% MeOH/DCM to afford off-white solid (147 mg, 75%) as the desired product (Rf  = 0.5 in 
5% MeOH/DCM). m.p. 125.0-127.0 °C; 1H NMR (400 MHz, d6-DMSO) δ 8.06 (s, 4H, -N-CH=C-
), 6.19 (d, J = 9.0 Hz, 4H, H-1), 5.53 (t, J = 9.2 Hz, 4H, H-2), 5.47-5.39 (m, 8H, H-3, H-4), 4.60-
4.54 (m, 4H, H-5), 4.16-4.06 (m, 12H, -O-CH2-C-, Ha-6), 4.01 (dd, J = 11.5, 7.2 Hz, 4H, Hb-6), 
2.64 (t, J = 7.4 Hz, 8H, -CH2-C=CH-N-), 2.33 (t, J = 7.4 Hz, 8H, -CH2-C=O), 2.17 (s, 12H, -CH3), 
1.98 (s, 12H, -CH3), 1.93 (s, 12H, -CH3), 1.88-1.81 (m, 8H, -CH2-CH2-CH2-), 1.79 (s, 12H, -CH3); 
13C NMR (100 MHz, d6-DMSO) δ 172.2 (C=O), 170.0 (C=O), 169.9 (C=O), 169.5 (C=O), 168.5 
(C=O), 146.8 (-N-CH=C-), 121.2 (-N-CH=C-), 84.2 (C-1), 72.9 (C-5), 70.4 (C-3), 67.9 (C-2), 67.3 
(C-4), 61.9 (-O-CH2-C-), 61.5 (C-6), 41.8 (-O-CH2-C-), 32.5 (-CH2-C=O), 24.02 (-CH2-C=CH-N-





(CH3 in OAc); HR-MS (ESI+) ([M + 2H]
2+) m/z calcd for [C85H114N12O44]/2, 1003.352044, found 
1003.349721. 
 
Synthesis of ester linker glycoclusters 16-19 
4 (200 mg, 0.538 mmol, 2 equiv), 9 (77 mg, 0.269 mmol, 1 equiv), CuSO4 (13 mg, 0.108 mmol, 
0.4 equiv), L-ascorbate sodium salt (43 mg, 0.216 mmol, 0.8 equiv) were used. Four products were 
isolated through column chromatography.  
 
Characterization data of ether linker monomer 16 
Off-white solid, 19 mg (11%); Rf  = 0.35 in 5% MeOH /DCM; m.p. 63.0-65.0 °C; 
1H NMR (400 
MHz, CDCl3) δ 7.88 (s, 1H, -N-CH=C-), 6.46 (d, J = 9.1 Hz, 1H, -NH-), 6.10 (d, J = 10.0 Hz, 1H, 
H-1), 5.53 (t, J = 9.9 Hz, 1H, H-3), 5.22 (t, J = 9.9 Hz, 1H, H-4), 4.67-4.51 (m, 3H, -N-CH=C-
CH2-O-, H-2), 4.30 (dd, J = 12.6, 4.9 Hz, 1H, H-6a), 4.16-4.08 (m, 7H, 3x -CH2-C≡CH, H-6b), 
4.06-4.00 (m, 1H, H-5), 3.51 (s, 6H, 3x -CH2-O-CH2-C≡CH), 3.49 (s, 2H, -N-CH=C-CH2-O-CH2-
), 2.43 (t, J = 2.4 Hz, 3H, 3x -C≡CH), 2.06 (s, 3H, CH3 in OAc), 2.05 (s, 6H, CH3 in OAc), 1.76 
(s, 3H, CH3 in NHAc); 
13C NMR (100 MHz, CDCl3) δ 170.6 (C=O), 170.54 (C=O), 170.5 (C=O), 
169.3 (C=O), 146.1 (-N-CH=C-), 121.8 (-N-CH=C-), 85.6 (C-1), 80.1 (-C≡CH), 74.9 (C-5), 74.3 
(-C≡CH), 72.3 (C-3), 69.2 (-N-CH=C-CH2-O-CH2-), 68.8 (-CH2-O-CH2-C≡CH), 68.1 (C-4), 64.9 
(-N-CH=C-CH2-O-), 61.7 (C-6), 58.6 (-CH2-C≡CH), 53.6 (C-2), 44.9 (-C-CH2-O-CH2-C≡CH), 
22.8 (CH3 in NHAc), 20.7 (CH3 in OAc), 20.59 (CH3 in OAc), 20.55 (CH3 in OAc). LC-MS (ESI+) 
calcd for C31H41N4O12 [M+H]







Characterization data of ether linker dimer 17 
White solid, 28 mg (10%); Rf  = 0.25 in 5% MeOH/DCM; m.p. 171.0-173.0 °C; 
1H NMR (400 
MHz, CDCl3) δ 7.94 (s, 2H, -N-CH=C-), 6.79 (d, J = 9.2 Hz, 2H, -NH-), 6.15 (d, J = 9.9 Hz, 2H, 
H-1), 5.50 (t, J = 9.2 Hz, 2H, H-3), 5.36 (t, J = 9.2 Hz, 2H, H-4), 4.76-4.64 (m, 2H, H-2), 4.61-
4.49 (m, 4H, 2x -N-CH=C-CH2-O-), 4.35 (dd, J = 12.5, 4.8 Hz, 2H, H-6a), 4.21 (dd, J = 12.5, 2.0 
Hz, 2H, H-6b), 4.13-4.06 (m, 6H, 2x -CH2-C≡CH, 2x H-5), 3.50-3.38 (m, 8H, 2x -CH2-O-CH2-
C≡CH, 2x -N-CH=C-CH2-O-CH2-), 2.41 (t, J = 2.3 Hz, 2H, 2x -C≡CH), 2.07 (s, 6H, CH3 in OAc), 
2.06 (s, 6H, CH3 in OAc), 2.04 (s, 6H, CH3 in OAc), 1.74 (s, 6H, CH3 in NHAc); 
13C NMR (100 
MHz, CDCl3) δ 170.9 (C=O), 170.7 (C=O), 170.6 (C=O), 169.4 (C=O), 145.5 (-N-CH=C-), 122.1 
(-N-CH=C-), 85.7 (C-1), 80.1 (-C≡CH), 75.1 (C-5), 74.2 (-C≡CH), 72.7 (C-3), 68.7 (-N-CH=C-
CH2-O-CH2- and -CH2-O-CH2-C≡CH), 68.1 (C-4), 64.4 (-N-CH=C-CH2-O-), 61.8 (C-6), 58.7 (-
CH2-C≡CH), 53.4 (C-2), 44.9 (-C-CH2-O-CH2-C≡CH), 22.7 (CH3 in NHAc), 20.7 (CH3 in OAc), 




Characterization data of ether linker trimer 18 
White solid, 30 mg (8%); Rf  = 0.17 in 5% MeOH/DCM; m.p. 244.0-246.0 °C; 
1H NMR (400 MHz, 
CDCl3) δ 7.93 (s, 3H, -N-CH=C-), 6.95 (d, J = 9.0 Hz, 3H, -NH-), 6.19 (d, J = 9.9 Hz, 2H, H-1), 
5.54 (t, J = 10.2 Hz, 3H, H-3), 5.33 (t, J = 10.2 Hz, 3H, H-4), 4.71-4.49 (m, 9H, 3x H-2, 3x -N-
CH=C-CH2-O-), 4.34 (dd, J = 12.7, 4.8 Hz, 3H, H-6a), 4.21 (dd, J = 12.7, 1.9 Hz, 3H, H-6b), 4.14-
4.07 (m, 5H, -CH2-C≡CH, 3x H-5), 3.50-3.34 (m, 8H, -CH2-O-CH2-C≡CH, 3x -N-CH=C-CH2-O-
CH2-), 2.46 (t, J = 2.3 Hz, 1H, -C≡CH), 2.07 (s, 9H, CH3 in OAc), 2.06 (s, 9H, CH3 in OAc), 2.04 
(s, 9H, CH3 in OAc), 1.73 (s, 9H, CH3 in NHAc); 





170.7 (C=O), 170.5 (C=O), 169.4 (C=O), 145.4 (-N-CH=C-), 122.3 (-N-CH=C-), 85.6 (C-1), 80.1 
(-C≡CH), 75.0 (C-5), 74.5 (-C≡CH), 72.5 (C-3), 68.7 (-N-CH=C-CH2-O-CH2-), 68.6 (-CH2-O-
CH2-C≡CH), 68.2 (C-4), 64.3 (-N-CH=C-CH2-O-), 61.8 (C-6), 58.6 (-CH2-C≡CH), 53.6 (C-2), 
45.0 (-C-CH2-O-CH2-C≡CH), 22.7 (CH3 in NHAc), 20.68 (CH3 in OAc), 20.65 (CH3 in OAc), 
20.61 (CH3 in OAc). LC-MS calcd for C31H40N4O12Na [M+Na]
+ 1427.5 found 1427.4. 
 
Characterization data of ether linker tetramer 19 
White solid, 156 mg (33%); Rf  = 0.06 in 5% MeOH /DCM; m.p. 250.0-252.0 °C;
 1H NMR (400 
MHz, d6-DMSO) δ 8.24 (s, 4H, -N-CH=C-), 8.05 (d, J = 9.1 Hz, 4H, -NH-), 6.12 (d, J = 10.0 Hz, 
4H, H-1), 5.36 (t, J = 9.8 Hz, 4H, H-3), 5.09 (t, J = 9.8 Hz, 4H, H-4), 4.66-4.54 (m, 4H, H-2), 4.45 
(s, 8H, -N-CH=C-CH2-O-), 4.15 (dd, J = 12.5, 5.1 Hz, 4H, H-6a), 4.06 (dd, J = 12.2, 1.8 Hz, 4H, 
H-6b), 3.38 (s, 8H, -O-CH2-C-), 2.01 (s, 12H, CH3 in OAc), 1.97 (s, 12H, CH3 in OAc), 1.95 (s, 
12H, CH3 in OAc), 1.79 (s, 12H, CH3 in NHAc); 
13C NMR (100 MHz, d6-DMSO) δ 170.0, 169.5, 
169.4, 169.3, 144.3 (-N-CH=C-), 122.6 (-N-CH=C-), 84.6 (C-1), 73.4 (C-5), 72.4 (C-3), 69.0 (-O-
CH2-C-), 68.0 (C-4), 64.1 (-N-CH=C-CH2-O-), 61.7 (C-6), 52.0 (C-2), 45.0 (-O-CH2-C-), 22.2 
(CH3 in NHAc), 20.4 (CH3 in OAc), 20.35 (CH3 in OAc), 20.2 (CH3 in OAc). HR-MS (ESI+) ([M 
+ 2H]2+) m/z calcd for [C73H102N16O36]/2, 889.331583 found 889.329786. 
 
Synthesis of dimeric compound 20 
Synthesis of phenyl protected di-alkyne 22 
To a 50 mL round bottomed flask, 21 (1.50 g, 6.69 mmol, 1 equiv) was mixed with anhydrous 
DMF (5 mL) and then the mixture was cooled to 0 °C in an ice bath. To the mixture, NaH (60% 





was stirred at 0 °C for 30 minutes. Propargyl chloride (1.85 mL, 16.73 mmol, 2.5 equiv) was added 
and then the mixture was allowed to warm to room temperature and stirred overnight. The reaction 
mixture was poured into a mixture of water (5 mL) and EtOAc (30 mL). Then the mixture was 
transferred to a separatory funnel. The aqueous phase was washed twice with EtOAc (30 mL x 2). 
The combined organic phase was dried (over anhydrous Na2SO4), filtered, and concentrated to 
give the crude, which was purified by column chromatography using eluent from pure hexanes to 
10% EtOAc/hexanes to afford the colorless oil (1.81 g, 90%) as the product (Rf = 0.55 in 20% 
EtOAc/hexanes). 1H NMR (400 MHz, CDCl3) δ 7.53-7.46 (m, 2H), 7.41-7.33 (m, 3H), 5.44 (s, 
1H), 4.21 (d, J = 2.4 Hz, 2H), 4.15-4.09 (m, 4H), 3.93-3.86 (m, 4H), 3.38 (s, 2H), 2.44, 2.43 (2 
overlapping triplets, J = 2.4 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 138.3, 128.9, 128.3, 126.1, 
101.8, 79.9, 79.5, 74.5, 74.2, 69.9, 69.8, 68.7, 58.77, 58.75, 38.5; LC-MS (ESI+) [M+H]+ calcd 
for C18H21O4 301.1, found 301.1. 
 
Synthesis of free hydroxyl di-alkyne 23 
To a 50 mL round bottomed flask, 22 (150 mg, 0.500 mmol, 1 equiv) was added with 2 mL of 
acetic acid and water mixture (v/v = 4:1). The mixture was heated at 50 °C for 3 hours. Solvent 
was removed under reduced pressure to give the crude product, which was purified by column 
chromatography using eluent from pure hexanes to 40% EtOAc/hexanes to yellowish oil (81 mg, 
76%) as the desired product. (Rf = 0.2 in 40% EtOAc/Hexanes). 
1H NMR (400 MHz, CDCl3) δ 
4.15 (d, J = 2.4 Hz, 4H), 3.69 (s, 4H), 3.60 (s, 4H), 2.45 (t, J = 2.4 Hz, 2H), 2.29 (br s, 2H); 13C 
NMR (100 MHz, CDCl3) δ 79.4, 74.8, 71.0, 64.4, 58.8, 44.9; LC-MS (ESI+) [M+H]
+ calcd for 
C11H17O4







Synthesis of dimeric compound 20 
To a 50 mL round bottomed flask, 4 (232 mg, 0.623 mmol, 2.2 equiv), 23 (60 mg, 0.283 mmol, 1 
equiv) were dissolved in a solvent mixture of t-BuOH: H2O: THF (6 mL, v/v/v=1:1:1). Then 
CuSO4 (18 mg, 0.113 mmol, 0.4 equiv) and L-ascorbate sodium salt (45 mg, 0.226 mmol, 0.4 
equiv) were added to the mixture. The resulting mixture was heated at 50 °C and stirred for 2 
hours. Solvent was removed under the reduced pressure to give the crude product, which was 
purified by column chromatography using eluent from pure DCM to 5% MeOH/DCM to give 
white solid (227 mg, 84%) as the desired product (Rf = 0.5 in 10% MeOH/DCM). m.p. 167.0-
169.0 °C; 1H NMR (400 MHz, CDCl3) δ 7.96 (s, 2H), 7.14 (d, J = 9.2 Hz, 2H), 6.13 (d, J = 9.9 
Hz, 2H), 5.49 (t, J = 9.7 Hz, 2H), 5.29 (t, J = 9.7 Hz, 2H), 4.68-4.54 (m, 6H), 4.36-4.28 (m, 2H), 
4.22-4.15 (m, 2H), 4.14-4.08 (m, 2H), 3.58 (s, 4H), 3.51-3.42 (m, 4H), 2.09-2.02 (m, 18H), 1.72 
(s, 6H); 13C NMR (100 MHz, CDCl3) δ 171.3, 170.7, 170.6, 169.4, 145.2, 122.0, 85.9, 74.9, 72.5, 
70.0, 68.1, 64.2, 63.8, 61.8, 53.6, 45.2, 22.6, 20.7, 20.61, 20.57; LC-MS (ESI+) [M+H]+ calcd for 
C39H57N8O20
 957.4, found 957.4. 
 
General procedure for the synthesis of trimeric compounds 28-31   
 
To a 50 mL round bottomed flask, azide (3.3 equiv) and tri-alkyne (1 equiv) were dissolved in the 
6 mL of solvent mixture of t-BuOH: H2O: THF (v/v/v = 1:1:1). CuSO4 (0.6 equiv) and L-ascorbic 
acid sodium salt (1.2 equiv) were added to the reaction mixture. Reaction was stirred for 24 hours 
at room temperature. Solvent was removed under reduced pressure to give the crude, which was 
purified by column chromatography using pure DCM to 5% MeOH/DCM as the eluent to afford 
the desired trimeric compound 28-31. Tri-alkynes 26-27 were synthesized following literature 





Synthesis of trimeric compound 28  
5 (170 mg, 0.457 mmol, 3.3 equiv), 24 (0.02 mL, 0.139 mmol, 1 equiv), CuSO4 (13.2 mg, 0.083 
mmol, 0.6 equiv) and L-ascorbic acid sodium salt (32.8 mg, 0.167 mmol, 1.2 equiv) were used. 
White solid (130 mg, 75%) was obtained as the product. m.p. 137.0-139.0 °C; 1H NMR (400 MHz, 
CDCl3) δ 7.95 (s, 3H, -N-CH=C-), 5.87 (d, J = 9.3 Hz, 3H, H-1), 5.54 (t, J = 9.4 Hz, 3H, H-2), 
5.42 (t, J = 9.4 Hz, 3H, H-3), 5.24 (t, J = 9.4 Hz, 3H, H-4), 4.28 (dd, J = 12.8, 5.2 Hz, 3H, Ha-6), 
4.16 (dd, J = 12.8, 2.0 Hz, 3H, Hb-6), 4.03-3.97 (m, 3H, H-5), 3.82-3.70 (m, 6H, -N-CH2-), 2.09-
2.02 (m, 27H, CH3 in OAc), 1.86 (s, 9H, CH3 in OAc); 
13C NMR (100 MHz, CDCl3) δ 170.5 
(C=O), 169.9 (C=O), 169.3 (C=O), 169.0 (C=O), 145.2 (-N-CH=C-), 122.0 (-N-CH=C-), 85.8 (C-
1), 75.1 (C-5), 72.7 (C-3), 70.4 (C-2), 67.8 (C-4), 61.7 (C-6), 47.2 (-N-CH2-), 20.7 (CH3 in OAc), 
20.51 (CH3 in OAc), 20.47 (CH3 in OAc), 20.1 (CH3 in OAc); LC-MS (ESI+) m/z calcd for 
C51H67N10O27 [M + H]
+ 1251.4, found 1251.3. 
Synthesis of trimeric compound 29 
4 (170 mg, 0.457 mmol, 3.3 equiv), 24 (0.02 mL, 0.139 mmol, 1 equiv), CuSO4 (13.2 mg, 0.083 
mmol, 0.6 equiv) and L-ascorbic acid sodium salt (32.8 mg, 0.167 mmol, 1.2 equiv) were used. 
white solid (145 mg, 84%) as the product (Rf = 0.6 in 10% MeOH/DCM). m.p. decomposed at 
270.0 °C;  1H NMR (400 MHz, CDCl3 + 5 drops of d4-MeOH) δ 8.06
 (s, 3H), 7.64 (d, J = 9.1 Hz, 
3H), 5.97 (d, J = 9.9 Hz, 3H), 5.40 (t, J = 9.7 Hz, 3H), 5.18 (t, J = 9.7 Hz, 3H), 4.59-4.47 (m, 3H), 
4.23 (dd, J = 12.6, 5.0 Hz, 3H), 4.13-4.06 (m, 3H), 4.03-3.96 (m, 3H), 3.73-3.59 (m, 6H), 2.04-
1.94 (m, 27H), 1.65 (s, 9H); 13C NMR (100 MHz, CDCl3 + 5 drops of d4-MeOH) δ 171.4, 170.9, 
170.7, 169.6, 144.1, 123.0, 85.7, 74.7, 72.3, 68.1, 61.9, 53.2, 46.9, 22.1, 20.44, 20.37, 20.3; LC-
MS (ESI+) m/z calcd for C51H70N13O24 [M + H]





Synthesis of trimeric compound 30 
5 (191 mg, 0.513 mmol, 3.3 equiv), 26 (50 mg, 0.157 mmol, 1 equiv), CuSO4 (14 mg, 0.094 mmol, 
0.6 equiv) and L-ascorbic acid sodium salt (36 mg, 0.188 mmol, 1.2 equiv) were used. Off-white 
solid (178 mg, 79 %) was obtained as the desired product (Rf  = 0.4 in 5% MeOH/DCM). m.p. 
165.0-167.0 °C; 1H NMR (400 MHz, CDCl3) δ 8.34 (t, J = 5.4 Hz, 3H, -NH-), 8.12 (s, 3H, -N-
CH=C-), 8.09 (s, 3H, Ar-H), 5.94 (d, J = 9.4 Hz, 3H, H-1), 5.75 (t, J = 9.4 Hz, 3H, H-2), 5.43 (t, 
J = 9.4 Hz, 3H, H-3), 5.31 (t, J = 9.4 Hz, 3H, H-4), 4.84-4.70 (m, 6H, -CH2-NH-), 4.31 (dd, J = 
12.7, 5.1 Hz, 3H, H-6a) 4.13 (dd, J = 12.7, 1.9 Hz, 3H, H-6b), 4.10-4.04 (m, 3H, H-5), 2.05 (s, 9H, 
CH3 in OAc), 2.01 (s, 9H, CH3 in OAc), 1.98 (s, 9H, CH3 in OAc), 1.76 (s, 9H, CH3 in OAc); 
13C 
NMR (100 MHz, CDCl3) δ 170.5 (C=O), 170.0 (C=O), 169.44 (C=O), 169.36 (C=O), 166.1 (-NH-
C=O), 146.0 (-N-CH=C-), 134.5 (Ar-C), 128.5 (Ar-C), 121.5 (-N-CH=C-), 85.8 (C-1), 75.0 (C-5), 
72.9 (C-3), 70.5 (C-2), 67.8 (C-4), 61.8 (C-6), 35.8 (-CH2-NH-), 20.60 (CH3 in OAc), 20.55 (CH3 
in OAc), 20.1 (CH3 in OAc). LC-MS (ESI+) m/z C60H73N12O30 [M + H]
+ calcd for 1441.4, found 
1441.4. 
Synthesis of trimeric compound 31 
4 (189 mg, 0.495 mmol, 3.3 equiv) and 27 (50 mg, 0.150 mmol, 1 equiv), CuSO4 (14 mg, 0.090 
mmol, 0.6 equiv) and L-ascorbic acid sodium salt (36 mg, 0.180 mmol, 1.2 equiv) were used. Off-
white solid (184 mg, 83 %) was obtained as the desired product (Rf  = 0.5 in 7% MeOH/DCM). 
m.p. 246.0-248.0 °C; 1H NMR (400 MHz, d6-DMSO) δ 8.65 (s, 3H, Ar-H), 8.43 (s, 3H, -N-CH=C-
), 8.03 (d, J = 9.1 Hz, 3H, -NH-), 6.14 (d, J = 9.9 Hz, 3H, H-1), 5.48 (s, 6H, -CH2-O-), 5.35 (t, J = 
9.7 Hz, 3H, H-3), 5.09 (t, J = 9.7 Hz, 3H, H-4), 4.64-4.53 (m, 3H, H-2), 4.27-4.20 (m, 3H, H-5), 
4.18-4.11 (m, 3H, H-6a), 4.09-4.02 (m, 3H, H-6b), 2.01 (s, 9H, CH3 in OAc), 1.99 (s, 9H, CH3 in 
OAc), 1.94 (s, 9H, CH3 in OAc), 1.55 (s, 9H, CH3 in NHAc); 





170.0 (C=O), 169.5 (C=O), 169.4 (C=O), 169.2 (C=O), 163.7 (-CH2-O-C=O), 141.7 (-N-CH=C-
), 133.8 (Ar-C), 130.8 (Ar-C), 124.0 (-N-CH=C-), 84.7 (C-1), 73.4 (C-5), 72.2 (C-3), 68.0 (C-4), 
61.7 (C-6), 58.4 (-CH2-O-), 52.1 (C-2), 22.2 (CH3 in NHAc), 20.4 (CH3 in OAc), 20.3 (CH3 in 
OAc), 20.2 (CH3 in OAc). LC-MS (ESI+) m/z C60H73N12O30 [M + H]




















CHAPTER 4. SYNTHESIS AND CHARACTERIZATION OF NOVEL 
CARBOHYDRATE BASED MACROCYCLES  
This chapter is adapted from the paper submitted to European Journal of Organic Chemistry titled 
as “Syntheses of bis-triazole linked carbohydrate based macrocycles and their applications for 
accelerating copper sulfate mediated click reaction”. 
 
4.1 ABSTRACT 
Macrocyclic compounds play an important role in many research fields including drug discovery 
and development, bioorganic chemistry, and materials sciences. Sugar containing macrocycles are 
especially interesting compounds and they have found applications as catalysts in asymmetric 
synthesis, as ligands or sensors for cation or anion recognitions, and in preparation of functional 
supramolecular assemblies. In this chapter, development of efficient methods to synthesize sugar 
containing macrocycles linked with 1,2,3-triazole functional group will be discussed using N-
acetyl glucosamine as the starting material. Eight unsymmetrical glucosamine based and triazole 
linked macrocycles have been synthesized. Copper catalyzed cycloaddition reaction was utilized 
as the ring-closing step to construct novel sugar based macrocyclic scaffold. These macrocycles 
are expected to exhibit interesting property for catalysis due to formation of chiral cavities from 
the sugar ring and metal binding properties from the triazole ring. 
 









Macrocyclic skeletons are important features in many natural products and pharmaceutics. Nature 
existing macrocycles often exhibit useful biological activities that allow them to function as drugs 
or lead compounds for drug discovery.80-81, 155 Synthetic macrocycles also play an important role 
in many fields due to the structure diversity and the easy access of pure compounds. Because of 
their importance in drug discovery, molecular recognition, and materials sciences; many synthetic 
strategies have been developed towards the synthesis of macrocyclic compounds.74, 79, 155-156 
Among the natural and synthetic macrocycles, carbohydrate containing macrocycles are especially 
interesting. Carbohydrates are naturally abundant and renewable resources with rich chirality and 
structure diversity, using carbohydrate as templates is highly desirable for the design and synthesis 
of different macrocycles.94, 157-159 The structures of these compounds contain the chiral sugar 
skeleton and are often exhibiting natural product like properties and they may also find 
applications in medicinal chemistry and supramolecular chemistry.78, 157, 160-161 Many chiral centers 
in carbohydrate make it possible to expand the structural diversity through functionalization at 
different positions of the sugar ring. In addition, the conformational restricted nature of sugar ring 
allows the formation of chiral cavities, which are useful for metal complexation,162 guest 
encapsulation163 and chiral recognition.164 Synthetic sugar containing macrocycles are important 
for drug discovery as anti-leukemia agents.165-167 Many of synthetic sugar based macrocycles are 
also glycosidase inhibitors, important intermediates for drugs, chiral scaffolds for bio-active 
targets, and chiral auxiliaries or building blocks for asymmetric synthesis.168-169  
 
Because of their unique structures and functions, many synthetic strategies have been developed 





functionalized sugar derived macrocycles are especially intriguing due to their unique structures 
and functions.171, 176 The heterocycles not only functions as linkers they also have properties that 
leads to biological activities or as ligands or sensors for guest recognitions, and in preparation of 
functional supramolecular assemblies.31, 159, 176-177 In recent years, the copper catalyzed azide 
alkyne cyclization reaction (CuAAC), or “click chemistry” strategies have greatly shaped the 
synthesis and study of glycoconjugates thus significantly advancing carbohydrate field.31, 60, 131-132, 
178 The click chemistry has shown remarkable utility for the construction of sugar based 
macrocycles either as the last step of cyclization or for synthesizing precursors before the 
cyclization.83, 93, 175-177, 179-185 A few examples of sugar based macrocycles obtained by click 
chemistry as the cyclization strategy are shown in Figure 81. Galacturonic acid based macrocycle 
1 possesses copper-complexation ability.162 Cyclodextrin mimics 2 have been synthesized for 
guest encapsulations.163 C2-symmetrical sugar based macrocycle 3 exhibits chiral discrimination 
between L- and D-phenylalanine methyl ester hydrochlorides.164 And the galactose derived 
macrocycle 4 was synthesized and identified as an inducer of apoptosis in leukemic cells.165 
 
 






Due to the importance of heterocycle functionalized macrocyclic compounds in organic synthesis, 
materials chemistry, and medicinal chemistry, we are interested in developing strategy that will 
create novel macromolecular scaffolds effectively. In this research, we designed and synthesized 
several novel macrocycles with the general structure 8 in five steps, which contain a pyranose ring 
derived from N-acetyl glucosamine in the backbones and linked through 1,4-disubstituted 1,2,3 
triazoles from easily accessible building blocks 5-7. The heterocycles in the molecules together 
with the sugar ring fused to the macrocycles form unique cavity and binding sites for metals or 
ligands and can be explored for chiral recognition and catalysis.  
 
 
Scheme 7. General structure of designed novel sugar triazole macrocycles 8. 
 
4.3 RESULTS AND DISSCUSSIONS 
We carried out the synthesis of a series of glycomacrocycles using the click chemistry as the 
cyclization key step for the synthesis of macrocycles with general structure of 8 as shown in 
Scheme 7. The detailed synthesis of acetate macrocycles with two carbon spacer at anomeric 
position is presented in Scheme 8. Glycosylation of N-acetyl-D-Glucosamine 5 with 2-





gave compound 9. Selective mono-tosylation on 6-hydoxyl group of 9 and subsequently protecting 
free hydroxyl group with acetate furnished tosylate azido compounds 10 in one-pot reaction. 
Reaction of 10 with 1,8-nonadiyne or 1,9-decadiyne under copper (I) cycloaddition condition 
afforded the mono-click products 11 which were further converted to the 6-azido compounds 12. 
These compound have both alkyne and azido functional groups in the same molecule, an 
intramolecular click reaction was carried out to afford the desired macrocycles AM25, AM26 in 
moderate yields.  
 
 







As shown in Scheme 9, benzoate macrocycles BM25, BM26 were prepared in moderate yields 
starting from N-acetyl-D-Glucosamine 5 through glycosylation, azide formation, tosylation, 
benzoyl protection 13, mono-click reaction 14, azide displacement to give acyclic intermediate 15 
followed by cyclization. 
 
 










Acetate and benzoate protected macrocycles AM35, AM36, BM35 and BM36 with three carbon 
spacer were obtained in the same manner compared to the two carbon spacer series with identical 
scaffold and ring size as shown in Scheme 10-11. 
 
 







Scheme 11. Macrocycle synthesis of BM35, BM36 via click chemistry as ring-closing step. 
 
We also attempted to introduce 4-brompphenyl group to the macrocycle as shown in Scheme 12. 
When protecting 3, 4-dihydroxyl groups, we found that 3-postion protected compound 23 is the 
major product possibly due to the steric hindrance of extra bromo group on phenyl ring. Mono 
click reaction of the intermediate 23 with a 1,8-nonadiyne afforded compound 24, then the tosyl 
group was displaced with an azido group to afford the intermediate azido alkyne 25, which failed 
to cyclize to form the desired macrocycle 26. This implies that protecting group on 3 or 4 hydroxyl 








Scheme 12. Attempted procedure to synthesize 4-bromophenyl protected macrocycle 26. 
 
The calculated conformations of AM25 and AM36 are shown in Figure 82. The two triazoles 
adopted very different conformations in the two models. In AM25, the two triazole rings are 
paralleled stacked, while in AM36 they are perpendicular. The distance between the two triazole 
rings are within the range of 5-6 Å, the cavity should be flexible that we expect them to be able to 
bind guest molecules of small size, such as metal ions and amino acid derivatives. It is interesting 
to see that two triazole rings are facing different directions depending on the size of the 







                              
Figure 82. The energy minimized stable conformations of the acetate protected macrocycles 
AM25 (a) and AM36 (b). 
 
The successful synthesis of all the intermediates was confirmed with the help of 1D (1H, 13C), 2D 
(HSQC, COSY) NMR spectroscopic method and LC-MS/HRMS. Spectra of the intermediates 
related to the synthesis of AM25 are shown in Figure 83-89. Detailed procedure and data of all the 













































Figure 88. HSQC and COSY spectra of compound AM25 in CDCl3. 
In this HSQC spectrum, 
 Red cross peak 
stands for proton 
correlating with 
carbon attached 
to CH or CH3. 






















In summary, we have synthesized a series of eight sugar based triazole linked 18-20 membered 
macrocycles using copper (I) catalyzed azide-alkyne cycloaddition reaction as the key step. The 
resulting macromolecules with unique architecture may lead to interesting biological properties as 
enzyme inhibitors or may have recognitions with suitable guest. The heterocycles in the molecules 
together with the sugar ring fused to the macrocycles form unique cavity and binding sites for 
metals or ligands and can be explored for chiral recognition and catalysis. With a method that 
allows the synthesis of complex pyranose containing macrocycles, we can understand the 
conformation of macrocycles that leading to their potential biological applications and molecular 
recognitions. These in turn will have importance in the design and synthesis of drug molecules and 
catalysis. UV-vis absorption, FTIR spectroscopic study and LC-MS could potentially be utilized 
to prove the utility of the macrocycle, which is a part of the ongoing research in our lab.  
 
4.5 EXPERIMENTAL SECTION 
Proton signals below 2 ppm of mono-click products and azide alkyne containing compounds as 
well as the protons signals below 3 ppm of macrocyclic products were not assigned because of 
protons on different carbons overlapping with each other. Carbon signals of phenyl ring (120 to 
145 ppm) and aliphatic chain (below 30 ppm) were not assigned accurately due to clusters of 
proton signals present in the aromatic and aliphatic regions. 
Procedure A: synthesis of mono-click reaction products 11a-b, 14a-b, 18a-b, 21a-b 
To a 50 mL round bottom flask, azide (1 equiv), CuI (0.2 equiv) and di-alkyne (2 equiv) were 





stirred at room temperature for 12 hours. After the complete disappearance of azide starting 
material indicated by both proton NMR spectrum and TLC, stirring was stopped and the solvent 
was removed under reduced pressure to afford the crude, which was purified by column 
chromatography using eluent from pure DCM to 5% MeOH/DCM to afford the desired mono-
triazole products. Amount of all chemicals, yield, Rf value and characterization of the product are 
listed respectively. 
 
Procedure B: synthesis of azide alkyne containing compounds 12a-h, 15a-b, 19a-b, 22a-b 
To a 50 mL round bottom flask, mono-triazole compound (1 equiv) and NaN3 (3 equiv) were 
dissolved in DMF (anhydrous). The resulting mixture was stirred at 70 °C for 10 hours. Solvent 
was removed under reduced pressure and then work up was performed using DCM (10 mL x 3) 
and water (5 mL). The combined organic layers were dried over (anhydrous Na2SO4), filtered and 
concentrated to afford the crude, which was purified by column chromatography using eluent from 
pure DCM to 5% MeOH/DCM to afford yellow slurry as the desired azide alkyne containing 
products. Amount of all chemicals, yield, Rf value and characterization of the product are listed 
respectively. 
 
Procedure C: synthesis of macrocycles  
To a 50 mL round bottom flask, macrocycle precursor (1 equiv), CuI (0.2 equiv) and DIEA (5 
equiv) were mixed with CH3CN as solvent (starting material/solvent = ~0.015 mmol/mL). The 
reaction was stirred at 10 hours under 0 °C. Solvent was removed by the rotavap to afford the 





to afford desired macrocycles. Amount of all chemicals, yield, Rf value and characterization of the 
macrocycle are listed respectively. 
 
Synthesis of anomeric two carbon spacer macrocycle AM25, AM26, BM25, BM26 
 
Synthesis of compound 9 
To a 50 mL rounded bottom flask, N-acetyl-D-glucosamine 5 (5.00 g, 22.60 mmol, 1 equiv) was 
suspended in 2-chloroethanol (7.6 mL, 113.0 mmol, 5 equiv) followed by adding BF3•Et2O (0.70 
mL, 5.65 mmol, 0.25 equiv). The resulting mixture was then heated at 85 °C for 6 hours. The 
reaction mixture was concentrated under reduced pressure to afford the crude. To the crude was 
added EtOAc (20 mL) and the organic layer was washed with H2O (20 mL x 3). The water layer 
was combined and water was removed by rotavap under reduced pressure. The residue was treated 
with toluene (10 mL x 2) followed by vacuum pump drying the crude for 5 hours to afford brown 
solid (6.07 g, 95%, α: β = 91:9), which was used for the next reaction without further purification. 
To the toluene-treated crude, NaN3 (4.19 g, 64.41 mmol, 3 equiv) and DMF (anhydrous, 10 mL) 
were added in the given order. The resulting mixture was stirred at 70 °C for 10 hours under the 
N2 atmosphere. Then DMF was removed under reduced pressure to afford the slurry, which was 
purified by column chromatography using eluent from pure DCM to 10% MeOH/DCM to give 
white solid (4.85 g, 74% over two steps) as the desired alpha anomer product (Rf = 0.25 in 10% 
MeOH/DCM). m.p. 120.0-122.0 °C. 1H NMR (400 MHz, D2O) δ 4.91 (d, J = 3.6 Hz, 1H), 3.95-
3.81 (m, 3H), 3.80-3.61 (m, 4H), 3.55-3.42 (m, 3H), 2.02 (s, 3H); 13C NMR (100 MHz, D2O) δ 
175.2, 97.6, 72.7, 71.5, 70.6, 67.2, 61.2, 54.2, 50.9, 22.5; LC-MS (ESI+) calcd for C10H19N4O6 





Synthesis of compound 10 
To a solution of 9 (500 mg, 1.72 mmol, 1 equiv) in pyridine (4 mL) was added TsCl (656 mg, 3.44 
mmol, 2 equiv) and the mixture was stirred at 0 °C for 3 hours and then continue stirring for 8 
hours at room temperature. Both 1H NMR spectrum of the reaction and TLC indicated the complete 
conversion of 9 to 6-monotosylate derivative. Then reaction mixture was cooled to 0 °C and acetic 
anhydride (0.49 mL, 5.16 mmol, 3 equiv) was added dropwise followed by adding a small pinch 
of DMAP. The mixture was allowed to warm up to room temperature and the stirring was 
continued for 3 more hours. 1H NMR spectrum indicated the completion of the reaction. Work up 
was performed with H2O (10 mL) and DCM (20 mL x 3). The combined organic layer was dried 
over Na2SO4 (anhydrous), filtered and concentrated to afford the crude, which was purified by 
column chromatography using eluent from pure DCM to 3% MeOH/DCM to give white solid (645 
mg, 71% over two steps) as the desired product (Rf = 0.5 in 5% MeOH/DCM). m.p. 143.0-145.0 
C. 1H NMR (400 MHz, CDCl3) δ 7.77 (d, J = 8.4 Hz, 2H, Ar-H), 7.35 (d, J = 8.0 Hz, 2H, Ar-H), 
5.73 (d, J = 9.4 Hz, 1H, -NH), 5.20 (dd, J = 10.8, 9.4 Hz, 1H, H-3), 4.93 (t, J = 9.4 Hz, 1H, H-4), 
4.82 (d, J = 3.6 Hz, 1H, H-1), 4.36 (ddd, J = 10.8, 9.4, 3.7 Hz, 1H, H-2), 4.13-3.98 (m, 3H, H-6a, 
H-6b, H-5), 3.91-3.85 (m, 1H, -O-CHa-CH2-N3), 3.64-3.47 (m, 2H, -O-CHb-CH2-N3, -O-CH2-CHa-
N3), 3.36-3.29 (m, 1H, -O-CH2-CHb-N3), 2.45 (s, 3H, CH3 in OTs), 2.00 (s, 6H, 2 x CH3), 1.93 (s, 
3H, CH3); 
13C NMR (100 MHz, CDCl3) δ 171.2 (C=O), 170.1 (C=O), 169.4 (C=O), 145.1 (Ar-C), 
132.6 (Ar-C), 129.9 (Ar-C), 128.0 (Ar-C), 97.3 (C-1), 70.7 (C-3), 68.4 (C-4), 68.1 (C-5), 68.0 (C-
6), 67.6 (-O-CH2-CH2-N3), 51.6 (C-2), 50.3 (-O-CH2-CH2-N3), 23.1 (CH3 in NHAc), 21.6 (CH3 in 
OTs), 20.6 (CH3 in OAc), 20.5 (CH3 in OAc); LC-MS (ESI+) m/z calcd for C21H29N4O10S [M + 






Synthesis of compound 11a 
Follow procedure A, 10 (225 mg, 0.426 mmol, 1 equiv), CuI (16 mg, 0.085 mmol, 0.2 equiv), 1,8-
nonadiyne (0.13 mL, 0.852 mmol, 2 equiv), CH3CN (7 mL), DIEA (0.15 mL, 0.852 mmol, 2 
equiv). Yellow slurry (220 mg, 80%) was as the desired product (Rf = 0.4 in 5% MeOH/DCM). 
1H NMR (400 MHz, CDCl3) δ 7.75 (d, J = 8.2 Hz, 2H, Ar-H), 7.40 (s, 1H, -HC=C-), 7.34 (d, J = 
8.2 Hz, 2H, Ar-H), 5.93 (d, J = 9.3 Hz, 1H, -NH), 5.07 (t, J = 9.8 Hz, 1H, H-3), 4.88 (t, J = 9.8 
Hz, 1H, H-4), 4.70 (d, J = 3.6 Hz, 1H, H-1), 4.53 (t, J = 4.9 Hz, 2H, -O-CH2-CH2-N), 4.26-4.17 
(m, 1H, H-2), 4.12-3.96 (m, 3H, -O-CHa-CH2-N, H-6a, H-6b), 3.86-3.77 (m, 2H, -O-CHb-CH2-N, 
H-5), 2.72 (t, J = 7.4 Hz, 2H, -HC=C-CH2-), 2.45 (s, 3H, CH3 in OTs), 2.19 (dt, J = 6.9, 2.6 Hz, 
2H, -CH2-C≡CH), 1.97 (s, 3H, CH3), 1.965 (s, 3H, CH3), 1.95-1.91 (m, 4H, CH3, -C≡CH), 1.75-
1.63 (m, 2H), 1.60-1.44 (m, 4H); 13C NMR (100 MHz, CDCl3) δ 171.0 (C=O), 170.3 (C=O), 169.3 
(C=O), 145.2 (Ar-C), 132.5 (Ar-C), 129.9 (Ar-C), 128.0 (Ar-C), 121.6 (-HC=C-), 97.4 (C-1), 84.4 
(-C≡CH), 70.9 (C-3), 68.3 (C-4), 68.2 (C-5), 67.9 (C-6), 66.6 (-O-CH2-CH2-N), 51.4 (C-2), 49.4 
(-O-CH2-CH2-N), 28.8, 28.3, 28.1, 25.5, 23.0, 21.6, 20.6, 20.5, 18.2; LC-MS (ESI+) m/z calcd for 
C30H41N4O10S  [M + H]
+ 649.3, found 649.3. 
 
Synthesis of compound 11b 
Follow procedure A, 10 (225 mg, 0.426 mmol, 1 equiv), CuI (16 mg, 0.085 mmol, 0.2 equiv), 1,9-
decadiyne (0.14 mL, 0.852 mmol, 2 equiv), CH3CN (7 mL), DIEA (0.15 mL, 0.852 mmol, 2 
equiv). Colorless slurry (220 mg, 78%) was obtained as the desired product (Rf = 0.3 in 5% 
MeOH/DCM). 1H NMR (400 MHz, CDCl3) δ 7.35 (d, J = 8.0 Hz, 2H, Ar-H), 7.39 (s, 1H, HC=C-
), 7.35 (d, J = 8.0 Hz, 2H, Ar-H), 5.85 (d, J = 9.2 Hz, 1H, -NH), 5.10 (t, J = 9.8 Hz, 1H, H-3), 4.89 





4.26-4.18 (m, 1H, H-2), 4.13-3.98 (m, 3H, -O-CHa-CH2-N, H-6a, H-6b), 3.88-3.79 (m, 2H, H-5, -
O-CHb-CH2-N), 2.72 (t, J = 7.4 Hz, 2H, -HC=C-CH2-), 2.45 (s, 3H, CH3 in OTs), 2.18 (dt, J = 6.9, 
2.6 Hz, 2H, -CH2-C≡CH), 1.983 (s, 3H, CH3), 1.978 (s, 3H, CH3), 1.95 (s, 3H, CH3), 1.93 (t, J = 
2.6 Hz, 1H, -C≡CH), 1.75-1.63 (m, 2H), 1.58-1.34 (m, 6H); 13C NMR (100 MHz, CDCl3) δ 171.1 
(C=O), 170.3 (C=O), 169.3 (C=O), 145.2 (Ar-C), 132.6 (Ar-C), 129.9 (Ar-C), 128.0 (Ar-C), 97.4 
(C-1), 84.6 (-C≡CH), 70.9 (C-3), 68.3 (-C≡CH), 68.22 (C-5), 68.19 (C-4), 67.9 (C-6), 66.6 (-O-
CH2-CH2-N), 51.4 (C-2), 49.4 (-O-CH2-CH2-N), 29.2, 28.7, 28.4, 28.3, 25.6, 23.1, 21.7, 20.6, 20.5, 
18.3; LC-MS (ESI+) m/z calcd for C31H43N4O10S  [M + H]
+ 663.3, found 663.2. 
 
Synthesis of compound 12a 
Follow procedure B, 11a (220 mg, 0.339 mmol, 1 equiv), NaN3 (66 mg, 1.018 mmol, 3 equiv), 
DMF (anhydrous, 3 mL). Yellow slurry (155 mg, 88%) was obtained as the desired product (Rf = 
0.3 in 5% MeOH/DCM). 1H NMR (400 MHz, CDCl3) δ 7.36 (s, 1H, HC=C-), 5.93 (d, J = 9.3 Hz, 
1H, -NH), 5.12 (dd, J = 10.5, 9.5 Hz, 1H, H-3), 4.89 (t, J = 9.5 Hz, 1H, H-4), 4.80 (d, J = 3.6 Hz, 
1H, H-1), 4.61-4.49 (m, 2H, -O-CH2-CH2-N), 4.34-4.26 (m, 1H, H-2), 4.18-4.10 (m, 1H, -O-CHa-
CH2-N), 3.92-3.82 (m, 1H, -O-CHb-CH2-N), 3.71-3.64 (m, 1H, H-5), 3.29 (dd, J = 13.3, 6.7 Hz, 
1H, H-6a), 3.21 (dd, J = 13.3, 2.7 Hz, 1H, H-6b), 2.72 (t, J = 7.8 Hz, 2H, -HC=C-CH2-), 2.19 (dt, 
J = 6.9, 2.6 Hz, 2H, -CH2-C≡CH), 2.01 (s, 3H, CH3), 1.99 (s, 3H, CH3), 1.96 (s, 3H, CH3), 1.93 (t, 
J = 2.6 Hz, 1H, -C≡CH), 1.74-1.64 (m, 2H), 1.61-1.43 (m, 4H); 13C NMR (100 MHz, CDCl3) δ 
171.1 (C=O), 170.3 (C=O), 169.3 (C=O), 148.5 (HC=C-), 121.2 (HC=C-), 97.5 (C-1), 84.4 (-
C≡CH), 70.9 (C-3), 69.6 (C-5), 69.2 (C-4), 68.3 (-C≡CH), 66.7 (-O-CH2-CH2-N), 51.5 (C-2), 51.0 
(C-6), 49.4 (-O-CH2-CH2-N), 28.8, 28.3, 28.1, 25.5, 23.1, 20.63, 20.55, 18.2; LC-MS (ESI+) m/z 
calcd for C23H34N7O7 [M + H]





Synthesis of compound 12b 
Follow procedure B, 11b (220 mg, 0.332 mmol, 1 equiv), NaN3 (65 mg, 0.996 mmol, 3 equiv), 
DMF (anhydrous, 3 mL). Yellow slurry (154 mg, 87%) was obtained as the desired product (Rf = 
0.2 in 5% MeOH/DCM). 1H NMR (400 MHz, CDCl3) δ 7.35 (s, 1H, HC=C-), 5.88 (d, J = 9.3 Hz, 
1H, -NH), 5.12 (dd, J = 10.7, 9.8 Hz, 1H, H-3), 4.89 (t, J = 9.8 Hz, 1H, H-4), 4.81 (d, J = 3.6 Hz, 
1H, H-1), 4.62-4.50 (m, 2H, -O-CH2-CH2-N), 4.35-4.27 (m, 1H, H-2), 4.19-4.11 (m, 1H, -O-CHa-
CH2-N), 3.93-3.85 (m, 1H, -O-CHb-CH2-N), 3.74-3.66 (m, 1H, H-5), 3.30 (dd, J = 13.4, 6.7 Hz, 
1H, H-6a), 3.22 (dd, J = 13.4, 2.7 Hz, 1H, H-6b), 2.72 (t, J = 7.8 Hz, 2H, -HC=C-CH2-), 2.18 (dt, 
J = 6.9, 2.6 Hz, 2H, -CH2-C≡CH), 2.02 (s, 3H, CH3), 2.00 (s, 3H, CH3), 1.97 (s, 3H, CH3), 1.93 (t, 
J = 2.6 Hz, 1H, -C≡CH), 1.74-1.65 (m, 2H), 1.58-1.34 (m, 6H); 13C NMR (100 MHz, CDCl3) δ 
171.2 (C=O), 170.3 (C=O), 169.3 (C=O), 148.7 (HC=C-), 121.1 (HC=C-), 97.5 (C-1), 84.6 (-
C≡CH), 70.9 (C-3), 69.6 (C-5), 69.2 (C-4), 68.2 (-C≡CH), 66.7 (-O-CH2-CH2-N), 51.6 (C-2), 51.0 
(C-6), 49.4 (-O-CH2-CH2-N), 29.3, 28.7, 28.4, 28.3, 25.6, 23.1, 20.7, 20.6, 18.3; LC-MS (ESI+) 
m/z calcd for C24H36N7O7 [M + H]
+ 534.3, found 534.2. 
 
Synthesis of compound AM25 
Follow procedure C, 12a (54 mg, 0.104 mmol, 1 equiv), CuI (3.8 mg, 0.021 mmol, 0.2 equiv), 
DIEA (0.09 mL, 0.520 mmol, 5 equiv), CH3CN (7 mL). Off-white solid (22 mg, 41%) was 
obtained as the desired product (Rf = 0.2 in 5% MeOH/DCM). 
1H NMR (400 MHz, CDCl3) δ 7.42 
(s, 1H, HC=C-), 7.31 (s, 1H, HC=C-), 5.77 (d, J = 9.4 Hz, 1H, -NH), 5.25 (dd, J = 10.7, 9.4 Hz, 
1H, H-3), 5.06 (t, J = 9.4 Hz, 1H, H-4), 4.81 (d, J = 3.7 Hz, 1H, H-1), 4.72-4.63 (m, 1H, -O-CH2-
CHa-N), 4.52-4.22 (m, 5H, H-6a, H-2, -O-CH2-CHb-N, H-6b, H-5), 3.53-3.44 (m, 1H, -O-CHa-





CH3), 2.07 (s, 3H, CH3), 2.00 (s, 3H, CH3), 1.86-1.65 (m, 3H), 1.65-1.51 (m, 1H), 1.32-1.19 (m, 
1H), 1.15-1.01 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 171.2 (C=O), 170.0 (C=O), 169.8 (C=O), 
96.5 (C-1), 70.8 (C-3), 70.0 (C-4), 68.9 (C-5), 65.9 (-O-CH2-CH2-N), 51.7 (C-2), 51.3 (C-6), 48.5 
(-O-CH2-CH2-N), 27.1, 26.7, 25.6, 24.6, 24.0, 23.1, 20.6. HRMS (ESI+) ([M + Na]
+) m/z calcd 
for C23H33N7O7Na, 542.233368, found 542.233021. 
 
Synthesis of compound AM26 
Follow procedure C, 12b (50 mg, 0.090 mmol, 1 equiv), CuI (3.4 mg, 0.018 mmol, 0.2 equiv), 
DIEA (0.08 mL, 0.450 mmol, 5 equiv), CH3CN (6 mL). Off-white solid (23.5 mg, 47%) was 
obtained as the desired product (Rf = 0.3 in 5% MeOH/DCM). 
1H NMR (400 MHz, CDCl3) δ 7.40 
(s, 1H, HC=C-), 7.32 (s, 1H, HC=C-), 5.70 (d, J = 9.4 Hz, 1H, -NH), 5.21 (dd, J = 10.7, 9.6 Hz, 
1H, H-3), 5.04 (t, J = 9.6 Hz, 1H, H-4), 4.79 (d, J = 3.7 Hz, 1H, H-1), 4.72-4.63 (m, 1H, -O-CH2-
CHa-N), 4.59-4.54 (m, 1H, H-6a), 4.42-4.34 (m, 1H, H-2), 4.31-4.12 (m, 3H, -O-CH2-CHb-N, H-
6b, H-5), 3.57-3.48 (m, 1H, -O-CHa-CH2-N), 3.28-3.18 (m, 1H, -O-CHb-CH2-N), 2.78 (t, J = 5.8 
Hz, 2H), 2.69-2.53 (m, 2H), 2.09 (s, 3H, CH3), 2.05 (s, 3H, CH3), 1.98 (s, 3H, CH3), 1.91-1.79 (m, 
1H), 1.73-1.59 (m, 2H), 1.56-1.34 (m, 3H), 1.33-1.07 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 
171.3 (C=O), 170.0 (C=O), 169.8 (C=O), 148.4 (HC=C-), 122.9 (HC=C-), 122.1 (HC=C-), 96.8 
(C-1), 70.6 (C-3), 70.0 (C-4), 69.0 (C-5), 65.6 (-O-CH2-CH2-N), 51.8 (C-2), 51.0 (C-6), 48.1 (-O-
CH2-CH2-N), 28.7, 27.2, 26.9, 26.6, 24.1, 23.1, 20.7. HRMS (ESI+) ([M + H]
+) m/z calcd for 












Synthesis of compound 13 
To a solution of 9 (500 mg, 1.72 mmol, 1 equiv) in pyridine (4 mL) was added TsCl (656 mg, 3.44 
mmol, 2 equiv) and the mixture was stirred at 0 °C for 3 hours and then continue stirring for 8 
hours at room temperature. Both 1H NMR spectrum of the reaction and TLC indicated the complete 
conversion of 9 to 6-monotosylate derivative. Then reaction mixture was cooled to 0 °C and 
benzoyl chloride (0.60 mL, 5.16 mmol, 3 equiv) was added dropwise followed by adding a small 
pinch of DMAP. The mixture was allowed to warm up to room temperature and the stirring was 
continued for 3 more hours. 1H NMR spectrum indicated the completion of the reaction. Work up 
was performed with H2O (10 mL) and DCM (20 mL x 3). The combined organic layer was dried 
over Na2SO4 (anhydrous), filtered and concentrated to afford the crude, which was purified by 
column chromatography using eluent from pure DCM to 3% MeOH/DCM to give colorless oil 
(898 mg, 80%) as the desired product (Rf = 0.6 in 5% MeOH/DCM). 
1H NMR (400 MHz, CDCl3) 
δ 7.91-7.83 (m, 4H, Ar-H), 7.71 (d, J = 8.3 Hz, 2H, Ar-H), 7.55-7.45 (m, 2H, Ar-H), 7.39-7.31 (m, 
4H, Ar-H), 7.22 (d, J = 8.1 Hz, 2H, Ar-H), 5.91 (d, J = 9.5 Hz, 1H, -NH), 5.62 (dd, J = 10.9, 9.5 
Hz, 1H, H-3), 5.36 (t, J = 9.5 Hz, 1H, H-4), 4.96 (d, J = 3.6 Hz, 1H, H-1), 4.56-4.48 (m, 1H, H-2), 
4.29-4.10 (m, 3H, H-5, H-6a, H-6b), 4.03-3.97 (m, 1H, -O-CHa-CH2-N3), 3.71-3.64 (m, 1H, -O-
CHb-CH2-N3), 3.63-3.55 (m, 1H, -O-CH2-CHa-N3), 3.44-3.36 (m, 1H, -O-CH2-CHb-N3), 2.37 (s, 
3H, CH3 in OTs), 1.85 (s, 3H, CH3 in NHAc); 
13C NMR (100 MHz, CDCl3) δ 170.1 (C=O), 166.9 
(C=O), 165.1 (C=O), 145.0, 133.6, 133.5, 132.4, 130.0, 129.84, 129.78, 128.7, 128.6, 128.4, 128.3, 
128.0, 97.5 (C-1), 71.1 (C-3), 68.9 (C-4), 68.6 (C-5), 68.3 (C-6), 67.8 (-O-CH2-CH2-N3), 52.0 (C-
2), 50.4 (-O-CH2-CH2-N3), 23.0 (CH3 in NHAc), 21.6 (CH3 in OTs); LC-MS (ESI+) m/z calcd for 
C31H33N4O10S [M + H]






Synthesis of compound 14a 
Follow procedure A, 13 (300 mg, 0.460 mmol, 1 equiv), CuI (17 mg, 0.092 mmol, 0.2 equiv), 1,8-
nonadiyne (0.14 mL, 0.920 mmol, 2 equiv), CH3CN (8 mL), DIEA (0.16 mL, 0.920 mmol, 2 
equiv). Yellow slurry (270 mg, 76%) was obtained as the desired product (Rf = 0.4 in 5% 
MeOH/DCM). 1H NMR (400 MHz, CDCl3) δ 7.89-7.82 (m, 4H, Ar-H), 7.70 (d, J = 8.3 Hz, 2H, 
Ar-H), 7.56-7.44 (m, 3H, Ar-H), 7.40-7.30 (m, 4H, Ar-H), 7.22 (d, J = 8.0 Hz, 2H, Ar-H), 5.99 (d, 
J = 9.2 Hz, 1H, -NH), 5.52 (t, J = 9.5 Hz, 1H, H-3), 5.29 (t, J = 9.5 Hz, 1H, H-4), 4.86 (d, J = 3.5 
Hz, 1H, H-1), 4.66-4.58 (m, 2H, -O-CH2-CH2-N), 4.51-4.43 (m, 1H, H-2), 4.23-4.03 (m, 4H, -O-
CHa-CH2-N, H-6a, H-6b, H-5), 3.95-3.87 (m, 1H, -O-CHb-CH2-N), 2.74 (s, 2H, -HC=C-CH2-), 2.36 
(s, 3H, CH3 in OTs), 2.17 (dt, J = 6.9, 2.6 Hz, 2H, -CH2-C≡CH), 1.93 (t, J = 2.6 Hz, 1H, -C≡CH), 
1.86 (s, 3H, CH3 in NHAc), 1.77-1.66 (m, 2H), 1.60-1.42 (m, 4H); 
13C NMR (100 MHz, CDCl3) 
δ 170.3 (C=O), 166.8 (C=O), 165.1 (C=O), 145.0, 133.6, 133.4, 132.3, 129.84, 129.81, 128.8, 
128.6, 128.42, 128.4, 128.0, 97.6 (C-1), 84.5 (-C≡CH), 71.2 (C-3), 68.9 (C-4), 68.7 (C-5), 68.3 
(C-6), 66.6 (-O-CH2-CH2-N), 51.8 (C-2), 49.6 (-O-CH2-CH2-N), 28.9, 28.4, 28.1, 25.6, 23.1, 21.6, 
18.3; LC-MS (ESI+) m/z calcd for C40H45N4O10S [M + H]
+ 773.3, found 773.3.  
 
Synthesis of compound 14b 
Follow procedure A, 13 (300 mg, 0.460 mmol, 1 equiv), CuI (17 mg, 0.092 mmol, 0.2 equiv), 1,9-
decadiyne (0.15 mL, 0.920 mmol, 2 equiv), CH3CN (8 mL), DIEA (0.16 mL, 0.920 mmol, 2 
equiv). Yellow slurry (265 mg, 79%) was obtained as the desired product (Rf = 0.4 in 5% 
MeOH/DCM). 1H NMR (400 MHz, CDCl3) δ 7.90-7.81 (m, 4H, Ar-H), 7.70 (d, J = 8.2 Hz, 2H, 
Ar-H), 7.56-7.44 (m, 3H, Ar-H), 7.40-7.30 (m, 4H, Ar-H), 7.22 (d, J = 8.0 Hz, 2H, Ar-H), 5.99 (d, 





Hz, 1H, H-1), 4.74-4.59 (br s, 2H, -O-CH2-CH2-N), 4.52-4.41 (m, 1H, H-2), 4.30-4.00 (m, 4H, -
O-CHa-CH2-N, H-6a, H-6b, H-5), 3.99-3.86 (m, 1H, -O-CHb-CH2-N), 2.74 (br s, 2H, -HC=C-CH2-
), 2.36 (s, 3H, CH3 in OTs), 2.15 (dt, J = 6.9, 2.6 Hz, 2H, -CH2-C≡CH), 1.91 (t, J = 2.6 Hz, 1H, -
C≡CH), 1.87 (s, 3H, CH3 in NHAc), 1.79-1.67 (m, 2H), 1.56-1.33 (m, 6H); 
13C NMR (100 MHz, 
CDCl3) δ 170.3 (C=O), 166.8 (C=O), 165.1 (C=O), 145.0, 133.5, 133.4, 132.3, 129.9, 129.84, 
129.81, 128.8, 128.6, 128.43, 128.4, 128.0, 97.5 (C-1), 84.6 (-C≡CH), 71.2 (C-3), 68.9 (C-4), 68.7 
(C-5), 68.3 (C-6), 68.2 (-C≡CH), 66.5 (-O-CH2-CH2-N), 51.8 (C-2), 29.1, 28.8, 28.4, 28.3, 28.2, 
25.6, 23.2, 21.6, 18.3; LC-MS (ESI+) m/z calcd for C41H47N4O10S [M + H]
+ 787.3, found 787.3. 
 
Synthesis of compound 15a 
Follow procedure B, 14a (200 mg, 0.259 mmol, 1 equiv), NaN3 (51 mg, 0.777 mmol, 3 equiv), 
DMF (anhydrous, 3 mL). Yellow slurry (147 mg, 88%) was obtained as the desired product (Rf = 
0.3 in 5% MeOH/DCM). 1H NMR (400 MHz, CDCl3) δ 7.93-7.86 (m, 4H, Ar-H), 7.54-7.45 (m, 
2H, Ar-H), 7.43 (s, 1H, HC=C-), 7.40-7.31 (m, 4H, Ar-H), 6.04 (d, J = 9.2 Hz, 1H, -NH), 5.56 
(dd, J = 10.7, 9.5 Hz, 1H, H-3), 5.40 (t, J = 9.5 Hz, 1H, H-4), 4.94 (d, J = 3.6 Hz, 1H, H-1), 4.68-
4.50 (m, 3H, -O-CH2-CH2-N, H-2), 4.28-4.20 (m, 1H, -O-CHa-CH2-N), 3.99-3.88 (m, 2H, -O-
CHb-CH2-N, H-5), 3.42 (dd, J = 13.3, 6.8 Hz, 1H, H-6a), 3.32 (dd, J = 13.3, 2.6 Hz, 1H, H-6b), 
2.74 (t, J = 7.7 Hz, 2H, -HC=C-CH2-), 2.17 (dt, J = 6.8, 2.6 Hz, 2H, -CH2-C≡CH), 1.92 (t, J = 2.6 
Hz, 1H, -C≡CH), 1.88 (s, 3H, CH3 in NHAc), 1.75-1.66 (m, 2H), 1.58-1.43 (m, 4H);
 13C NMR 
(100 MHz, CDCl3) δ 170.3 (C=O), 166.9 (C=O), 165.2 (C=O), 148.6 (HC=C-), 133.6, 133.4, 
129.83, 129.77, 128.8, 128.7, 128.5, 128.4, 121.2 (HC=C-), 97.7 (C-1), 84.4 (-C≡CH), 71.2 (C-3), 





CH2-CH2-N), 28.9, 28.3, 28.1, 25.6, 23.0, 18.3; LC-MS (ESI+) m/z calcd for C33H38N7O7 [M + 
H]+ 644.3, found 644.3. 
 
 
Synthesis of compound 15b 
Follow procedure B, 14b (200 mg, 0.254 mmol, 1 equiv), NaN3 (50 mg, 0.762 mmol, 3 equiv), 
DMF (anhydrous, 3 mL). Yellow slurry (142 mg, 85%) was obtained as the desired product (Rf = 
0.3 in 5% MeOH/DCM). 1H NMR (400 MHz, CDCl3) δ 7.93-7.86 (m, 4H), 7.54-7.46 (m, 2H), 
7.42 (s, 1H, HC=C-), 7.40-7.31 (m, 4H), 6.03 (d, J = 9.1 Hz, 1H, -NH), 5.57 (dd, J = 10.7, 9.7 Hz, 
1H, H-3), 5.41 (t, J = 9.7 Hz, 1H, H-4), 4.95 (d, J = 3.5 Hz, 1H, H-1), 4.68-4.51 (m, 3H, -O-CH2-
CH2-N, H-2), 4.28-4.20 (m, 1H, -O-CHa-CH2-N), 4.00-3.88 (m, 2H, -O-CHb-CH2-N, H-5), 3.42 
(dd, J = 13.3, 6.8 Hz, 1H, H-6a), 3.32 (dd, J = 13.3, 2.5 Hz, 1H, H-6b), 2.74 (t, J = 7.7 Hz, 2H, -
HC=C-CH2-), 2.15 (dt, J = 7.0, 2.6 Hz, 2H, -CH2-C≡CH), 1.92 (t, J = 2.6 Hz, 1H, -C≡CH), 1.88 
(s, 3H, CH3 in NHAc), 1.75-1.65 (m, 2H), 1.55-1.46 (m, 2H), 1.45-1.34 (m, 4H);
 13C NMR (100 
MHz, CDCl3) δ 170.3 (C=O), 166.9 (C=O), 165.2 (C=O), 133.6, 133.4, 129.9, 129.84, 128.79, 
128.7, 128.5, 128.4, 97.6 (C-1), 84.5 (-C≡CH), 71.2 (C-3), 70.1 (C-5), 69.8 (C-4), 68.2 (-C≡CH), 
66.6 (-O-CH2-CH2-N), 51.9 (C-2), 51.2 (C-6), 29.1, 28.8, 28.4, 28.3, 28.2, 25.6, 23.2, 18.3; LC-
MS (ESI+) m/z calcd for C34H40N7O7 [M + H]
+ 658.3, found 658.3. 
 
Synthesis of compound BM25 
Follow procedure C, 15a (50 mg, 0.078 mmol, 1 equiv), CuI (2.8 mg, 0.016 mmol, 0.2 equiv), 
DIEA (0.07 mL, 0.390 mmol, 5 equiv), CH3CN (5 mL). Off-white solid (20 mg, 40%) was 
obtained as the desired product (Rf = 0.2 in 5% MeOH/DCM). 
1H NMR (400 MHz, CDCl3) δ 8.00-





NH), 5.68 (t, J = 9.7 Hz, 1H, H-3), 5.46 (t, J = 9.7 Hz, 1H, H-4), 4.90 (d, J = 3.5 Hz, 1H, H-1), 
4.80-4.31 (m, 6H, H-2, H-5, H-6a, -O-CH2-CHa-N, -O-CH2-CHb-N, H-6b), 3.56-3.46 (m, 1H, -O-
CHa-CH2-N), 3.39-3.27 (m, 1H, -O-CHb-CH2-N), 2.92-2.66 (m, 3H), 2.65-2.50 (m, 1H), 1.89 (s, 
3H, CH3), 1.86-1.74 (m, 2H), 1.70-1.47 (m, 2H), 1.31-1.00 (m, 2H); 
13C NMR (100 MHz, CDCl3) 
δ 170.1 (C=O), 166.9 (C=O), 165.7 (C=O), 133.9, 133.6, 129.9, 129.8, 128.60, 128.57, 128.5, 
128.3, 96.8 (C-1), 71.2 (C-3), 70.6 (C-4), 69.5 (C-5), 66.0 (-O-CH2-CH2-N), 52.0 (C-2), 51.4 (C-
6), 48.6 (-O-CH2-CH2-N), 27.1, 26.6, 25.6, 24.7, 23.9, 23.1. HRMS (ESI+) ([M + Na]
+) m/z calcd 
for C33H37N7O7Na, 666.264668, found 666.264092. 
 
Synthesis of compound BM26 
Follow procedure C, 15b (50 mg, 0.078 mmol, 1 equiv), CuI (2.8 mg, 0.016 mmol, 0.2 equiv), 
DIEA (0.07 mL, 0.390 mmol, 5 equiv), CH3CN (5 mL). Off-white solid (24 mg, 48%) was 
obtained as the desired product (Rf = 0.2 in 5% MeOH/DCM). 
1H NMR (400 MHz, CDCl3) δ 8.00-
7.85 (m, 4H, Ar-H), 7.59-7.45 (m, 3H, Ar-H), 7.43-7.31 (m, 5H, Ar-H), 5.96 (d, J = 7.8 Hz, 1H, -
NH), 5.67 (t, J = 9.7 Hz, 1H, H-3), 5.45 (t, J = 9.7 Hz, 1H, H-4), 4.90 (d, J = 3.5 Hz, 1H, H-1), 
4.77-4.57 (m, 3H, H-6a, -O-CH2-CHa-N, H-2), 4.51-4.43 (m, 1H, H-5), 4.42-4.29 (m, 2H, -O-CH2-
CHb-N, H-6b), 3.63-3.52 (br s, 1H, -O-CHa-CH2-N), 3.31-3.22 (br s, 1H, -O-CHb-CH2-N), 2.88-
2.72 (br s, 2H), 2.66-2.51 (br s, 2H), 1.89 (s, 3H, CH3), 1.87-1.76 (m, 2H), 1.73-1.56 (m, 2H), 
1.49-1.22 (m, 3H), 1.16-1.04 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 170.1 (C=O), 170.0 (C=O), 
165.7 (C=O), 133.9, 133.6, 129.9, 129.8, 128.6, 128.5, 128.3, 97.1 (C-1), 71.0 (C-3), 70.6 (C-4), 
69.4 (C-5), 65.7 (-O-CH2-CH2-N), 52.0 (C-2), 51.2 (C-6), 48.3 (-O-CH2-CH2-N), 28.7, 27.1, 26.9, 






Synthesis of anomeric three carbon spacer macrocycle AM35, AM36, BM35, BM36 
 
Synthesis of compound 16 
To a 50 mL rounded bottom flask, N-acetyl-D-glucosamine 5 (3.00 g, 13.56 mmol, 1 equiv) was 
suspended in 3-chloro-propan-1-ol (4.5 mL, 54.24 mmol, 4 equiv) followed by adding BF3•Et2O 
(0.42 mL, 3.39 mmol, 0.25 equiv). The resulting mixture was then heated at 85 °C for 5 hours. 
The reaction mixture was concentrated under reduced pressure to afford the crude. To the crude 
was added EtOAc (20 mL) and the organic layer was washed with H2O (20 mL x 3). The water 
layer was combined and water was removed by rotavap under reduced pressure. The residue was 
treated with toluene (10 mL x 2) followed by vacuum pump drying the crude for 5 hours to afford 
brown solid (3.91 g, 97%, α: β = 89:11) which was used for the next reaction without further 
purification. To the toluene-treated crude, NaN3 (2.56 g, 39.45 mmol, 3 eq.) and DMF (anhydrous, 
8 mL) were added in the given order. The resulting mixture was stirred at 70 °C for 10 hours under 
the N2 atmosphere. Then DMF was removed under reduced pressure to afford the slurry, which 
was purified by column chromatography using eluent from pure DCM to 10% MeOH/DCM to 
give white solid (3.13 g, 76% over two steps) as the desired alpha anomer product (Rf = 0.25 in 
10% MeOH/DCM). m.p. 125.0-127.0 °C. 1H NMR (400 MHz, D2O) δ 4.84 (d, J = 3.6 Hz, 1H), 
3.91-3.63 (m, 6H), 3.54-3.40 (m, 4H), 2.01 (s, 3H) 1.91-1.83 (m, 2H); 13C NMR (100 MHz, D2O) 
δ 175.0, 97.5, 72.5, 71.6, 70.6, 65.6, 61.2, 54.4, 48.8, 28.6, 22.5; LC-MS (ESI+) calcd for 
C11H21N4O6 [M+H]








Synthesis of compound 17 
To a solution of 16 (500 mg, 1.64 mmol, 1 equiv) in pyridine (4 mL) was added TsCl (627 mg, 
3.29 mmol, 2 equiv) and the mixture was stirred at 0 °C for 3 hours and then continue stirring for 
8 hours at room temperature. Both 1H NMR spectrum of the reaction and TLC indicated the 
complete conversion of 16 to 6-monotosylate derivative. Then reaction mixture was cooled to 0 
°C and acetic anhydride (0.47 mL, 4.92 mmol, 3 equiv) was added dropwise followed by adding 
a small pinch of DMAP. The mixture was allowed to warm up to room temperature and the stirring 
was continued for 3 more hours. 1H NMR spectrum indicated the completion of the reaction. Work 
up was performed with H2O (10 mL) and DCM (20 mL x 3). The combined organic layer was 
dried over Na2SO4 (anhydrous), filtered and concentrated to afford the crude, which was purified 
by column chromatography using eluent from 30% to 50% EtOAc/hexanes to give colorless oil 
(604 mg, 68% over two steps) as the desired product (Rf = 0.42 in 80% EtOAc/hexanes). 
1H NMR 
(CDCl3, 400 MHz) δ 7.78 (d, J = 8.3 Hz, 2H, Ar-H), 7.35 (d, J = 8.1 Hz, 2H, Ar-H), 5.69 (d, J = 
9.3 Hz, 1H, -NH), 5.16 (dd, J = 10.6, 9.4 Hz, 1H, H-3), 4.93 (t, J = 9.4 Hz, 1H, H-4), 4.76 (d, J = 
3.7 Hz, 1H, H-1), 4.24 (ddd, J = 10.6, 9.3, 3.7 Hz, 1H, H-2), 4.13-4.03 (m, 2H, H-6a, H-6b), 4.01-
3.95 (m, 1H, H-5), 3.79 (dt, J = 10.1, 6.0 Hz, 1H, -O-CHa-CH2-CH2-N3), 3.51-3.34 (m, 3H, -O-
CHb-CH2-CH2-N3, -O-CH2-CH2-CH2-N3), 2.46 (s, 3H, CH3 in OTs), 2.00 (s, 6H, 2 x CH3), 1.93 
(s, 3H, CH3), 1.92-1.85 (m, 2H, -O-CH2-CH2-CH2-N3); 
13C NMR (CDCl3, 100 MHz) δ 171.3 
(C=O), 169.8 (C=O), 169.4 (C=O), 145.1 (Ar-C), 132.7 (Ar-C), 129.9 (Ar-C), 128.0 (Ar-C), 97.1 
(C-1), 71.0 (C-3), 68.5 (C-4), 68.0 (C-6), 67.9 (C-5), 65.5 (-O-CH2-CH2-CH2-N3), 51.8 (C-2), 48.5 
(-O-CH2-CH2-CH2-N3), 28.5 (-O-CH2-CH2-CH2-N3), 23.1 (CH3 in NHAc), 21.6 (CH3 in OTs), 
20.7 (CH3 in OAc), 20.5 (CH3 in OAc). LC-MS (ESI+) C22H31N4O10S [M + H]







Synthesis of compound 18a 
Follow procedure A, 17 (270 mg, 0.498 mmol, 1 equiv), CuI (19 mg, 0.099 mmol, 0.2 equiv), 1,8-
nonadiyne (0.17 mL, 0.996 mmol, 2 equiv), CH3CN (8 mL), DIEA (0.18 mL, 0.996 mmol, 2 
equiv). Yellow slurry (267 mg, 81%) was obtained as the desired product (Rf = 0.35 in 5% 
MeOH/DCM). 1H NMR (CDCl3, 400 MHz) δ 7.75 (d, J = 8.3 Hz, 2H, Ar-H), 7.34 (br s, 1H, 
HC=C-), 7.33 (d, J = 8.1 Hz, 2H, Ar-H), 6.18 (d, J = 9.3 Hz, 1H, -NH), 5.14 (dd, J = 10.5, 9.4 Hz, 
1H, H-3), 4.89 (t, J = 9.4 Hz, 1H, H-4), 4.66 (d, J = 3.5 Hz, 1H, H-1), 4.62-4.53 (m, 1H, -O-CH2-
CH2-CHa-N), 4.45-4.36 (m, 1H, -O-CH2-CH2-CHb-N), 4.28-4.20 (m, 1H, H-2), 4.10-3.99 (m, 3H, 
H-5, H-6a, H-6b), 3.79-3.71 (m, 1H, -O-CHa-CH2-CH2-N), 3.27-3.19 (m, 1H, -O-CHb-CH2-CH2-
N), 2.72 (t, J = 7.3 Hz, 2H, -HC=C-CH2-), 2.44 (s, 3H, CH3 in OTs), 2.25-2.12 (m, 4H, -O-CH2-
CH2-CH2-N, -CH2-C≡CH), 2.04 (s, 3H, CH3), 1.99 (s, 3H, CH3), 1.98 (s, 3H, CH3), 1.92 (t, J = 2.6 
Hz, 1H, -C≡CH), 1.74-1.64 (m, 2H), 1.61-1.43 (m, 4H); 13C NMR (CDCl3, 100 MHz) δ 171.1 
(C=O), 170.5 (C=O), 169.4 (C=O), 145.1 (Ar-C), 132.5 (Ar-C), 129.8 (Ar-C), 128.0 (Ar-C), 97.3 
(C-1), 84.5 (-C≡CH), 71.0 (C-3), 68.6 (C-4), 68.2 (C-5), 68.1 (C-6), 68.0 (-C≡CH), 64.7 (-O-CH2-
CH2-CH2-N), 51.5 (C-2), 46.7 (-O-CH2-CH2-CH2-N), 29.8, 28.8, 28.3, 28.1, 25.5, 23.1, 21.6, 20.7, 
20.5, 18.3. LC-MS (ESI+) m/z calcd for C31H43N4O10S [M + H]
+ 663.3, found 663.3.  
 
Synthesis of compound 18b 
Follow procedure A, 17 (130 mg, 0.240 mmol, 1 equiv), CuI (9 mg, 0.048 mmol, 0.2 equiv), 1,9-
decadiyne (0.08 mL, 0.48 mmol, 2 equiv), CH3CN (6 mL), DIEA (0.08 mL, 0.480 mmol, 2 equiv). 
Colorless oil (125 mg, 77%) was obtained as the desired product (Rf = 0.35 in 5% MeOH/DCM) 
1H NMR (CDCl3, 400 MHz) δ 7.76 (d, J = 8.3 Hz, 2H, Ar-H), 7.38 (br s, 1H, HC=C-), 7.34 (d, J 





J = 9.4 Hz, 1H, H-4), 4.68 (d, J = 3.3 Hz, 1H, H-1), 4.64-4.55 (m, 1H, -O-CH2-CH2-CHa-N), 4.47-
4.36 (m, 1H, -O-CH2-CH2-CHb-N), 4.30-4.20 (m, 1H, H-2), 4.13-3.99 (m, 3H, H-5, H-6a, H-6b), 
3.80-3.72 (m, 1H, -O-CHa-CH2-CH2-N), 3.28-3.20 (m, 1H, -O-CHb-CH2-CH2-N), 2.72 (br s, 2H, 
-HC=C-CH2-), 2.45 (s, 3H, CH3 in OTs), 2.23-2.13 (m, 4H, -O-CH2-CH2-CH2-N, -CH2-C≡CH), 
2.05 (s, 3H, CH3), 2.00 (s, 6H, 2 x CH3), 1.93 (t, J = 2.6 Hz, 1H, -C≡CH), 1.74-1.64 (m, 2H), 1.58-
1.48 (m, 2H), 1.47-1.35 (m, 4H); 13C NMR (CDCl3, 100 MHz) δ 171.1 (C=O), 170.5 (C=O), 169.4 
(C=O), 145.1 (Ar-C), 132.6 (Ar-C), 129.9 (Ar-C), 128.0 (Ar-C), 97.4 (C-1), 84.6 (-C≡CH), 77.2 
(-C≡CH), 71.1 (C-3), 68.7 (C-4), 68.2 (C-5), 68.1 (C-6), 64.7 (-O-CH2-CH2-CH2-N), 51.5 (C-2), 
46.8 (-O-CH2-CH2-CH2-N), 29.8, 29.2, 28.7, 28.4, 28.3, 25.6, 23.2, 21.6, 20.7, 20.5, 18.3. LC-MS 
(ESI+) m/z calcd for C32H45N4O10S [M + H]
+ 677.3, found 677.3. 
 
Synthesis of compound 19a 
Follow procedure B, 18a (250 mg, 0.377 mmol, 1 equiv), NaN3 (74 mg, 1.131 mmol, 3 equiv), 
DMF (anhydrous, 3 mL). Yellow slurry (178 mg, 88%) was obtained as the desired product (Rf = 
0.3 in 5% MeOH/DCM). 1H NMR (400 MHz, CDCl3) δ 7.31 (s, 1H, HC=C-), 6.19 (d, J = 9.2 Hz, 
1H, -NH), 5.18 (dd, J = 10.7, 9.7 Hz, 1H, H-3), 5.00 (t, J = 9.7 Hz, 1H, H-4), 4.78 (d, J = 3.6 Hz, 
1H, H-1), 4.63-4.55 (m, 1H, -O-CH2-CH2-CHa-N), 4.48-4.39 (m, 1H, -O-CH2-CH2-CHb-N), 4.38-
4.30 (m, 1H, H-2), 3.97-3.90 (m, 1H, H-5), 3.85-3.77 (-O-CHa-CH2-CH2-N), 3.37-3.22 (m, 3H, 
H-6a, -O-CHb-CH2-CH2-N, H-6b), 2.73 (t, J = 7.7 Hz, 2H, -HC=C-CH2-), 2.26-2.15 (m ,4H, -O-
CH2-CH2-CH2-N, -CH2-C≡CH), 2.07 (s, 3H, CH3), 2.03 (s, 3H, CH3), 2.01 (s, 3H, CH3), 1.93 (t, J 
= 2.6 Hz, 1H, -C≡CH), 1.75-1.65 (m, 2H), 1.61-1.44 (m, 4H); 13C NMR (100 MHz, CDCl3) δ 
171.2 (C=O), 170.5 (C=O), 169.4 (C=O), 148.8 (HC=C-), 120.4 (HC=C-), 97.4 (C-1), 84.5 (-





2), 51.2 (C-6), 46.6 (-O-CH2-CH2-CH2-N), 29.9, 28.8, 28.3, 28.1, 25.5, 23.2, 20.7, 20.6, 18.3; LC-
MS (ESI+) m/z calcd for C24H36N7O7 [M + H]
+ 534.3, found 534.3. 
 
Synthesis of compound 19b 
Follow procedure B, 18b (110 mg, 0.163 mmol, 1 equiv), NaN3 (32 mg, 0.489 mmol, 3 equiv), 
DMF (anhydrous, 3 mL). Yellow slurry (79 mg, 89%) was obtained as the desired product (Rf = 
0.3 in 5% MeOH/DCM). 1H NMR (400 MHz, CDCl3) δ 7.30 (s, 1H, HC=C-), 6.19 (d, J = 9.3 Hz, 
1H, -NH), 5.18 (dd, J = 10.7, 9.7 Hz, 1H, H-3), 5.01 (t, J = 9.7 Hz, 1H, H-4), 4.78 (d, J = 3.6 Hz, 
1H, H-1), 4.64-4.55 (m, 1H, -O-CH2-CH2-CHa-N), 4.48-4.39 (m, 1H, -O-CH2-CH2-CHb-N), 4.39-
4.31 (m, 1H, H-2), 3.98-3.90 (m, 1H, H-5), 3.85-3.77 (-O-CHa-CH2-CH2-N), 3.39-3.22 (m, 3H, -
O-CHb-CH2-CH2-N, H-6a, H-6b), 2.72 (t, J = 7.7 Hz, 2H, -HC=C-CH2-), 2.24-2.15 (m ,4H, -O-
CH2-CH2-CH2-N, -CH2-C≡CH), 2.07 (s, 3H, CH3), 2.04 (s, 3H, CH3), 2.02 (s, 3H, CH3), 1.93 (t, J 
= 2.6 Hz, 1H, -C≡CH), 1.74-1.63 (m, 2H), 1.58-1.48 (m, 2H), 1.47-1.35 (m, 4H); 13C NMR (100 
MHz, CDCl3) δ 171.2 (C=O), 170.5 (C=O), 169.4 (C=O), 148.9 (HC=C-), 120.4 (HC=C-), 97.4 
(C-1), 84.6 (-C≡CH), 71.1 (C-3), 69.6 (C-4), 69.5 (C-5), 68.2 (-C≡CH), 64.5 (-O-CH2-CH2-CH2-
N), 51.7 (C-2), 51.2 (C-6), 46.6 (-O-CH2-CH2-CH2-N), 29.9, 29.2, 28.7, 28.4, 28.3, 25.6, 23.2, 
20.7, 20.6, 18.3; LC-MS (ESI+) m/z calcd for C25H38N7O7 [M + H]
+ 548.3, found 548.3. 
 
Synthesis of compound AM35 
Follow procedure C, 19a (50 mg, 0.094 mmol, 1 equiv), CuI (3.3 mg, 0.019 mmol, 0.2 equiv), 
DIEA (0.08 mL, 0.470 mmol, 5 equiv), CH3CN (6 mL). Off-white solid (21 mg, 42%) was 
obtained as the desired product. Rf = 0.2 in 5% MeOH/DCM). 
1H NMR (400 MHz, CDCl3) 7.28 





H-3), 4.98 (t, J = 9.6 Hz, 1H, H-4), 4.70 (d, J = 3.5 Hz, 1H, H-1), 4.48-4.16 (m, 6H, H-6a, -O-CH2-
CH2-CH2-N, H-5, H-2, H-6b), 3.09-2.98 (m, 1H, -O-CHa-CH2-CH2-N), 2.96-2.85 (m, 4H), 2.67-
2.58 (m, 1H), 2.22-1.06 (m, 5H), 2.03 (s, 3H, CH3), 1.95 (s, 3H, CH3), 1.84-1.66 (m, 3H), 1.59-
1.51 (m, 1H), 1.24-0.98 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 171.3 (C=O), 169.9 (C=O), 169.8 
(C=O), 148.0 (HC=C-), 147.2 (HC=C-), 123.1 (HC=C-), 121.2 (HC=C-), 97.2 (C-1), 70.8 (C-3), 
70.5 (C-4), 68.3 (C-5), 64.1 (-O-CH2-CH2-CH2-N), 52.0 (C-2), 51.3 (-O-CH2-CH2-CH2-N), 46.6 
(C-6), 29.8, 27.8, 27.7, 26.1, 24.8, 24.6, 23.2, 20.7. LC-MS (ESI+) ([M + H]+) m/z calcd for 
C24H36N7O7, 534.3, found 534.3. 
 
Synthesis of compound AM36 
Follow procedure C, 19b (90 mg, 0.164 mmol, 1 equiv), CuI (6.3 mg, 0.033 mmol, 0.2 equiv), 
DIEA (0.14 mL, 0.820 mmol, 5 equiv), CH3CN (11 mL). Off-white solid (38 mg, 42%) was 
obtained as the desired product (Rf = 0.3 in 5% MeOH/DCM). 
1H NMR (400 MHz, CDCl3 + d4-
MeOH, spectrum was taken at 45 °C) δ 7.55 (br s, 2H, HC=C-), 5.21 (t, 9.3 Hz, 1H, H-3), 4.96 (t, 
J = 9.3 Hz, 1H, H-4), 4.71 (d, J = 3.5 Hz, 1H, H-1), 4.56-4.21 (m, 6H, H-6a, -O-CH2-CH2-CH2-N, 
H-6b, H-5, H-2), 3.09-2.98 (br s, 1H, -O-CHa-CH2-CH2-N), 2.96-2.85 (br s, 1H, -O-CHb-CH2-CH2-
N), 2.84-2.44 (m, 4H), 2.08-1.95 (m, 8H), 1.91 (s, 3H, CH3), 1.82-1.70 (br s, 1H), 1.67-1.10 (m, 
7H); 13C NMR (100 MHz, CDCl3 + d4-MeOH) δ 171.4 (C=O), 170.7 (C=O), 170.0 (C=O), 97.5 
(C-1), 70.6 (C-3), 70.5 (C-4), 68.2 (C-5), 64.0 (-O-CH2-CH2-CH2-N), 51.8 (C-2), 46.8 (-O-CH2-
CH2-CH2-N), 30.0, 28.2, 27.4, 26.7, 26.4, 24.2, 24.0, 22.7, 20.5. HRMS (ESI+) ([M + H]
+) m/z 
calcd for C25H38N7O7,







Synthesis of compound 20 
To a solution of 16 (500 mg, 1.64 mmol, 1 equiv) in pyridine (4 mL) was added TsCl (627 mg, 
3.29 mmol, 2 equiv) and the mixture was stirred at 0 °C for 3 hours and then continue stirring for 
8 hours at room temperature. Both 1H NMR spectrum of the reaction and TLC indicated the 
complete conversion of 16 to 6-monotosylate derivative. Then reaction mixture was cooled to 0 
°C and benzoyl chloride (0.57 mL, 4.92 mmol, 3 equiv) was added dropwise followed by adding 
a small pinch of DMAP. The mixture was allowed to warm up to room temperature and the stirring 
was continued for 3 more hours. 1H NMR spectrum indicated the completion of the reaction. Work 
up was performed with H2O (10 mL) and DCM (20 mL x 3). The combined organic layer was 
dried over Na2SO4 (anhydrous), filtered and concentrated to afford the crude, which was purified 
by column chromatography using eluent 30% EtOAc/hexanes to give white solid (650 mg, 64% 
over two steps) as the desired product (Rf = 0.45 in 60% EtOAc/hexanes). m.p. 62.0 C to 64.0 
C; 1H NMR (CDCl3, 400 MHz) δ 7.90-7.83 (m, 4H, Ar-H), 7.71 (d, J = 8.3 Hz, 2H, Ar-H), 7.55-
7.48 (m, 2H, Ar-H), 7.40-7.31 (m, 4H, Ar-H), 7.22 (d, J = 8.1 Hz, 2H, Ar-H), 5.89 (d, J = 9.2 Hz, 
1H, -NH), 5.59 (dd, J = 10.9, 9.5 Hz, 1H, H-3), 5.35 (t, J = 9.5 Hz, 1H, H-4), 4.90 (d, J = 3.6 Hz, 
1H, H-1), 4.48 (ddd, J = 10.9, 9.2, 3.6 Hz, 1H, H-2), 4.25-4.10 (m, 3H, H-5, H-6a, H-6b), 3.87 (dt, 
J = 10.1, 6.0 Hz, 1H, -O-CHa-CH2-CH2-N3), 3.59-3.41 (m, 3H, -O-CHb-CH2-CH2-N3, -O-CH2-
CH2-CH2-N3), 2.37 (s, 3H, CH3 in OTs), 2.00-1.92 (m, 2H, -O-CH2-CH2-CH2-N3), 1.85 (s, 3H, 
CH3 in NHAc); 
13C NMR (CDCl3, 100 MHz) δ 169.9 (C=O), 167.1 (C=O), 165.1 (C=O), 145.0, 
133.53, 133.49, 132.5, 129.84, 129.78, 129.76, 128.7, 128.6, 128.43, 128.42, 128.0, 97.3 (C-1), 
71.4 (C-3), 68.9 (C-4), 68.4 (C-5), 68.2 (C-6), 65.6 (-O-CH2-CH2-CH2-N3), 52.2 (C-2), 48.6 (-O-
CH2-CH2-CH2-N3), 28.6 (-O-CH2-CH2-CH2-N3), 23.1 (CH3 in NHAc), 21.6 (CH3 in OTs). LC-
MS (ESI+) C32H35N4O10S [M + H]





Synthesis of compound 21a 
Follow procedure A, 20 (130 mg, 0.195 mmol, 1 equiv), CuI (7 mg, 0.039 mmol, 0.2 equiv), 1,8-
nonadiyne (0.07 mL, 0.390 mmol, 2 equiv), CH3CN (6 mL), DIEA (0.07 mL, 0.390 mmol, 2 
equiv). Yellow slurry (121 mg, 79%) was obtained as the desired product (Rf = 0.4 in 5% 
MeOH/DCM). 1H NMR (400 MHz, CDCl3) δ 7.92-7.82 (m, 4H), 7.68 (d, J = 8.3 Hz, 2H), 7.55-
7.44 (m, 2H), 7.44-7.30 (m, 5H), 7.20 (d, J = 8.1 Hz, 2H), 6.28 (d, J = 9.2 Hz, 1H, -NH), 5.58 (dd, 
J = 10.6, 9.7 Hz, 1H, H-3), 5.30 (t, J = 9.7 Hz, 1H, H-4), 4.82 (d, J = 3.2 Hz, 1H, H-1), 4.71-4.59 
(m, 1H, -O-CH2-CH2-CHa-N), 4.54-4.42 (m, 2H, H-2, -O-CH2-CH2-CHb-N), 4.31-4.23 (m, 1H, H-
5), 4.19-4.06 (m, 2H, H-6a, H-6b), 3.89-3.81 (m, 1H, -O-CHa-CH2-CH2-N), 3.38-3.27 (m, 1H, -O-
CHb-CH2-CH2-N), 2.74 (br s, 2H, -HC=C-CH2-), 2.35 (s, 3H, CH3 in OTs), 2.30-2.14 (m, 4H, -O-
CH2-CH2-CH2-N, -CH2-C≡CH), 1.96 (s, 3H, CH3 in NHAc), 1.93 (t, J = 2.6 Hz, 1H, -C≡CH), 
1.76-1.66 (m, 2H), 1.61-1.44 (m, 4H); 13C NMR (100 MHz, CDCl3) δ 170.5 (C=O), 166.8 (C=O), 
165.2 (C=O), 145.0, 133.5, 133.3, 132.3, 129.83, 129.78, 129.77, 128.9, 128.7, 128.4, 128.0, 97.6 
(C-1), 84.5 (-C≡CH), 71.4 (C-3), 69.2 (C-4), 68.6 (C-5), 68.4 (C-6), 68.2 (-C≡CH), 64.9 (-O-CH2-
CH2-CH2-N), 51.9 (C-2), 46.9 (-O-CH2-CH2-CH2-N), 29.9, 28.8, 28.3, 28.1, 25.5, 23.1, 21.6, 18.3; 
LC-MS (ESI+) m/z calcd for C41H47N4O10S [M + H]
+ 787.3, found 787.3.  
Synthesis of compound 21b 
Follow procedure A, 20 (300 mg, 0.451 mmol, 1 equiv), CuI (16 mg, 0.090 mmol, 0.2 equiv), 1,9-
nonadiyne (0.15 mL, 0.902 mmol, 2 equiv), CH3CN (8 mL), DIEA (0.16 mL, 0.902 mmol, 2 
equiv). Yellow slurry (278 mg, 77%) was obtained as the desired product (Rf = 0.4 in 5% 
MeOH/DCM). 1H NMR (400 MHz, CDCl3) δ 7.92-7.84 (m, 4H, Ar-H), 7.69 (d, J = 8.3 Hz, 2H, 





J = 9.1 Hz, 1H, -NH), 5.59 (t, J = 10.4 Hz, 1H, H-3), 5.30 (t, J = 10.4 Hz, 1H, H-4), 4.83 (d, J = 
2.4 Hz, 1H, H-1), 4.72-4.60 (m, 1H, -O-CH2-CH2-CHa-N), 4.56-4.43 (m, 2H, H-2, -O-CH2-CH2-
CHb-N), 4.32-4.23 (m, 1H, H-5), 4.20-4.07 (m, 2H, H-6a, H-6b), 3.90-3.81 (m, 1H, -O-CHa-CH2-
CH2-N), 3.38-3.28 (m, 1H, -O-CHb-CH2-CH2-N), 2.73 (br s, 2H, -HC=C-CH2-), 2.36 (s, 3H, CH3 
in OTs), 2.32-2.21 (m, 2H, -O-CH2-CH2-CH2-N), 2.17 (dt, J = 6.9, 2.6 Hz, 2H, -CH2-C≡CH), 1.96 
(s, 3H, CH3 in NHAc), 1.93 (t, J = 2.6 Hz, 1H, -C≡CH), 1.70 (br s, 2H), 1.58-1.33 (m, 6H); 
13C 
NMR (100 MHz, CDCl3) δ 170.5 (C=O), 166.8 (C=O), 165.2 (C=O), 145.0, 133.5, 133.4, 132.3, 
129.84, 129.81, 129.8, 128.9, 128.7, 128.4, 128.0, 97.6 (C-1), 84.6 (-C≡CH), 71.4 (C-3), 69.2 (C-
4), 68.6 (C-5), 68.5 (C-6), 68.2 (-C≡CH), 64.9 (-O-CH2-CH2-CH2-N), 51.9 (C-2), 46.9 (-O-CH2-
CH2-CH2-N), 29.9, 29.2, 28.7, 28.4, 28.3, 25.6, 23.1, 21.6, 18.3; LC-MS (ESI+) m/z calcd for 
C42H49N4O10S [M + H]
+ 801.3, found 801.3.  
Synthesis of compound 22a 
Follow procedure B, 21a (110 mg, 0.140 mmol, 1 equiv), NaN3 (27 mg, 0.420 mmol, 3 equiv), 
DMF (anhydrous, 3 mL). Yellow slurry (81 mg, 88%) was obtained as the desired product (Rf = 
0.35 in 5% MeOH/DCM). 1H NMR (400 MHz, CDCl3) δ 7.99-7.86 (m, 4H, Ar-H), 7.54-7.45 (m, 
2H, Ar-H), 7.41-7.31 (m, 5H, Ar-H), 6.30 (d, J = 9.2 Hz, 1H, -NH), 5.63 (dd, J = 10.6, 9.5 Hz, 
1H, H-3), 5.43 (t, J = 9.5 Hz, 1H, H-4), 4.92 (d, J = 3.5 Hz, 1H, H-1), 4.70-4.45 (m, 3H, -O-CH2-
CH2-CHa-N, H-2, -O-CH2-CH2-CHb-N), 4.19-4.11 (m, 1H, H-5), 3.94-3.84 (m, 1H, -O-CHa-CH2-
CH2-N), 3.50-3.31 (m, 3H, H-6a, -O-CHb-CH2-CH2-N, H-6b), 2.74 (t, J = 7.7 Hz, 2H, -HC=C-
CH2-), 2.36-2.16 (m, 4H, -O-CH2-CH2-CH2-N, -CH2-C≡CH), 1.98 (s, 3H, CH3 in NHAc), 1.93 (t, 
J = 2.6 Hz, 1H, -C≡CH), 1.75-1.66 (m, 2H), 1.61-1.44 (m, 4H); 13C NMR (100 MHz, CDCl3) δ 
170.5 (C=O), 167.0 (C=O), 165.3 (C=O), 148.8 (HC=C-), 133.5, 133.4, 129.9, 129.8, 128.9, 128.8, 





(-C≡CH), 64.7 (-O-CH2-CH2-CH2-N), 52.1 (C-2), 51.3 (C-6), 46.7 (-O-CH2-CH2-CH2-N), 30.0, 
28.9, 28.3, 28.1, 25.6, 23.1, 18.3; LC-MS (ESI+) m/z calcd for C34H40N7O7 [M + H]
+ 658.3, found 
658.3.  
Synthesis of compound 22b 
Follow procedure B, 21b (200 mg, 0.250 mmol, 1 equiv), NaN3 (49 mg, 0.750 mmol, 3 equiv), 
DMF (anhydrous, 3 mL). Colorless slurry (144 mg, 86%) was obtained as the desired product (Rf 
= 0.35 in 5% MeOH/DCM). 1H NMR (400 MHz, CDCl3) δ 7.96-7.88 (m, 4H, Ar-H), 7.55-7.46 
(m, 2H, Ar-H), 7.42-7.32 (m, 5H, Ar-H), 6.31 (d, J = 9.2 Hz, 1H, -NH), 5.63 (dd, J = 10.8, 9.5 Hz, 
1H, H-3), 5.43 (t, J = 9.5 Hz, 1H, H-4), 4.92 (d, J = 3.5 Hz, 1H, H-1), 4.70-4.55 (m, 2H, -O-CH2-
CH2-CHa-N, H-2), 4.54-4.45 (m, 1H, -O-CH2-CH2-CHb-N), 4.20-4.12 (m, 1H, H-5), 3.93-3.86 (m, 
1H, -O-CHa-CH2-CH2-N), 3.50-3.31 (m, 3H, H-6a, -O-CHb-CH2-CH2-N, H-6b), 2.73 (t, J = 7.7 
Hz, 2H, -HC=C-CH2-), 2.36-2.21 (m, 2H, -O-CH2-CH2-CH2-N), 2.17 (dt, J = 6.9, 2.6 Hz, 2H, -
CH2-C≡CH), 1.98 (s, 3H, CH3 in NHAc), 1.93 (t, J = 2.6 Hz, 1H, -C≡CH), 1.75-1.65 (m, 2H), 
1.58-1.33 (m, 6H); 13C NMR (100 MHz, CDCl3) δ 170.5 (C=O), 167.0 (C=O), 165.3 (C=O), 148.9 
(HC=C-), 133.5, 133.4, 129.9, 129.8, 128.9, 128.8, 128.5, 128.4, 120.4 (HC=C-), 97.6 (C-1), 84.6 
(-C≡CH), 71.4 (C-3), 70.1 (C-4), 70.0 (C-5), 68.2 (-C≡CH), 64.7 (-O-CH2-CH2-CH2-N), 52.1 (C-
2), 51.3 (C-6), 46.7 (-O-CH2-CH2-CH2-N), 30.0, 29.3, 28.7, 28.4, 28.3, 25.6, 23.1, 18.3; LC-MS 
(ESI+) m/z calcd for C35H42N7O7 [M + H]
+ 672.3, found 672.3. 
Synthesis of compound BM35 
Follow procedure C, 22a (50 mg, 0.076 mmol, 1 equiv), CuI (2.6 mg, 0.015 mmol, 0.2 equiv), 
DIEA (0.07 mL, 0.380 mmol, 5 equiv), CH3CN (5 mL). Off-white solid (22 mg, 44%) was 
obtained as the desired product (Rf = 0.2 in 5% MeOH/DCM). 





7.82 (m, 4H, Ar-H), 7.55-7.45 (m, 2H, Ar-H), 7.43-7.27 (m, 6H, Ar-H), 5.90 (d, J = 10.0 Hz, 1H, 
-NH), 5.73 (t, J = 10.2 Hz, 1H, H-3), 5.40 (t, J = 10.2 Hz, 1H, H-4), 4.82 (br s, 1H, H-1), 4.66-
4.28 (m, 6H, H-5, H-6a, H-2, -O-CH2-CH2-CH2-N, H-6b), 3.20-3.04 (m, 1H, -O-CHa-CH2-CH2-
N), 2.96-3.71 (m, 4H), 2.69-1.58 (m, 1H), 2.29-2.10 (m, 2H), 1.86 (s, 3H), 1.82-1.64 (m, 3H), 
1.59-1.50 (m, 1H), 1.22-0.96 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 169.9 (C=O), 167.0 (C=O), 
165.7 (C=O), 148.0 (HC=C-), 147.2 (HC=C-), 133.8, 133.5, 129.9, 129.8, 128.7, 128.5, 128.42, 
128.28, 123.4 (HC=C-), 121.4 (HC=C-), 97.4 (C-1), 71.1 (C-3 and C-4), 68.7 (C-5), 64.1 (-O-
CH2-CH2-CH2-N), 52.2 (C-2), 51.5 (C-6), 46.7 (-O-CH2-CH2-CH2-N), 29.8, 27.9, 27.7, 26.2, 24.8, 
24.6, 23.1. LC-MS (ESI+) ([M + H]+) m/z calcd for C34H40N7O7, 658.3, found 658.3. 
 
Synthesis of compound BM36 
Follow procedure C, 22b (50 mg, 0.078 mmol, 1 equiv), CuI (2.8 mg, 0.016 mmol, 0.2 equiv), 
DIEA (0.07 mL, 0.390 mmol, 5 equiv), CH3CN (5 mL). Off-white solid (20 mg, 40%) was 
obtained as the desired product (Rf = 0.2 in 5% MeOH/DCM).
 1H NMR (400 MHz, CDCl3) δ 7.97 
(d, J = 7.4 Hz, 2H, Ar-H), 7.91 (d, J = 7.2 Hz, 2H, Ar-H), 7.56-7.46 (m, 3H, Ar-H), 7.42-7.32 (m, 
5H, Ar-H), 5.93 (d, J = 8.9 Hz, 1H, -NH), 5.72 (t, J = 9.4 Hz, 1H, H-3), 5.44 (t, J = 9.4 Hz, 1H, 
H-4), 4.88 (br s, 1H, H-1), 4.73-4.32 (m, 6H, H-6a, -O-CH2-CH2-CH2-N, H-6b, H-5, H-2), 3.22-
3.06 (br s, 1H, -O-CHa-CH2-CH2-N), 3.50-3.31 (m, 5H), 2.21-1.95 (m, 2H), 1.89 (s, 3H), 1.73-
1.43 (m, 3H), 1.41-1.16 (m, 5H); 13C NMR (100 MHz, CDCl3) δ 169.9 (C=O), 167.1 (C=O), 165.7 
(C=O), 133.8, 133.6, 129.9, 129.8, 128.7, 128.53, 128.47, 128.4, 97.8 (C-1), 71.2 (C-3), 71.0 (C-
4), 68.8 (C-5), 64.3 (-O-CH2-CH2-CH2-N), 52.5 (C-2), 46.8 (-O-CH2-CH2-CH2-N), 30.4, 29.7, 
28.4, 27.7, 26.9, 26.5, 24.4, 24.3, 23.1. HRMS (ESI+) ([M + Na]+) m/z calcd for C35H41N7O7Na, 





CHAPTER 5. CONCLUSION REMARKS AND FUTURE DIRECTIONS 
 
Carbohydrate based molecular self-assemblies have emerged as new tools in the fields of 
environment remediation, drug delivery, metal ion absorption and catalysis. The rich chirality and 
structure diversity of carbohydrates allow various chemical modifications which can help in 
designing functional materials with desired properties. In this study, several classes of sugar based 
new compounds have been designed and synthesized. Figure 90 shows several representatives of 




Figure 90. Representatives of glycolipids, glycoclusters and glycomacrocycles synthesized from 
D-glucose and N-acetyl-D-glucosamine. 
 
From the research results in chapters 2, 3, and 4, we can draw some conclusions regarding the 





performance of synthesized β-triazolyl glycolipids has enabled us to understand the gelation 
weaken effect from 4,6-O-benzylidene acetal functional group as well as the critical role of free 3-
hydroxyl group in forming molecular self-assembly. After synthesizing and screening the gelation 
behavior of triazole linked glycoclusters, the result has provided us the some insight on 
multivalence effect on gelation properties. As expected, increasing the number of sugar unit in the 
branched molecules leads to the enhanced gelation properties. The synthesized glycomacrocycles 
from N-acetyl-D-glucosamine were fully characterized by proton and carbon NMR, 2D NMR 
(HSQC, COSY) and HRMS. The calculated energy minimized conformation of all prepared 
macrocycle show different orientation of triazole ring depending on the ring sizes. The following 
are the detailed summaries for each class of these novel sugar based triazole derivatives. 
 
In chapter 2, we have designed, synthesized and systematically studied a series of β-triazolyl 
glycoside of 4,6-O-benzylidene acetal protected D-glucose and D-glucosamine. These sugar based 
derivatives are brand new class of organogelators that have never been reported before. We found 
that the presence of the 4,6-O-benzylidene acetal functional group seems to weaken the gelation 
properties for some triazolyl glycosides compared to the corresponding tetra-acetyl glycosyl 
triazoles. A few effective organogelators were further fully acetylated and we observed that their 
gelation abilities were lost. We proposed that the hydrogen bonding of the free 3-OH group plays 
an important role in this observed gelation trend. And it was proved by variable temperature 1H 
NMR studies and computational modeling for compound 1 and its acetate 2 as depicted in Figure 
91. Intermolecular hydrogen bonding (bond length 2.0 Å) was observed in compound 1. However, 
in its acetate 2 no intermolecular hydrogen bonding exists. To explore the potential biological 





DMSO water mixtures. We found that naproxen was slowly from the gel matrix to the aqueous 
phase using UV-vis spectroscopy.  
 
 
Figure 91. Computation modeling of gelator 1 and nongelator 2 (acetylated form of gelator 1). 
 
In chapter 3, several branched compounds functionalized with acetate protected glucose, 
glucosamine and galactose moieties have been synthesized through click reaction. These include 
using pentaerythritol as the core structures to obtain monomeric, dimeric, trimeric, and tetrameric 
sugar triazole conjugates and their gelation properties have been analyzed. To the best of my 
knowledge, this is the first time that multivalency effect has been applied and studied in the design 
of supramolecular gelators on glycoclusters. In general, we found that increasing the number of 
sugar unit in the molecules leads to enhancement of gelation properties. Tetrameric derivatives 
with peracetyl glucosamine triazoles are effective gelators. For pentaerythritol ester series, the 
gelation properties of the tetrameric derivatives are affected by the sugar ring structures, glucose 







blocks including tris-propargyl amine and trimesic acid for the synthesis of glycoclusters using 
either glucose or glucosamine peracetate azides. All of the trimeric compounds were effective 
gelators in at least two solvents. The symmetrical trimesic acid derivative 3 and tetrameric 
pentaerythritol ether derivative 4 are the most efficient gelators in corresponding series as shown 
in Figure 92. The gels prepared from the selected glycoclusters were characterized using optical 
microscopy and rheology.  
 
 
Figure 92. Chemical structures of glycoclusters 3 and 4 in trimeric and tetrameric series. 
 
In chapter 4, using copper (I) catalyzed azide alkyne cycloaddition reactions as the ring-closing 
step in macrocycle formation we have synthesized a series of eight glucosamine based triazole 
linked macrocycles. The cyclization step was obtained in moderate yields. The distance and 





These sugar embedded macrocycles are expected to exhibit interesting properties as natural 
product analogs and they may be useful for chiral recognition of small interesting molecules. We 
also expect that these macrocycles are useful as ligands or catalysts for certain reactions. The 
ongoing research on finding applications of these novel macrocycles will be reported in due course. 
 
Future study on these three novel types of sugar based derivatives include the further structure 
modification and the applications of these compounds.  For the glycolipid project, stimuli gelation 
system could be obtained and will be studied by protecting and deprotecting the 3-hydroxyl group. 
The acetate groups on the peripheral sugar moieties in glycoclusters could be deproetected to 
afford free OH followed by testing their binding affinity towards lectin. Another direction is to 
even functionalize the free hydroxyl to obtain hyper-branched molecules potentially as new 
material or therapeutic agents. Regarding the glycomacrocycle project, the cyclization protocol 
can be updated to improve the yield on choosing the copper sources, the amine-based ligands and 
even the reaction solvent systems. After improving the yield of the ring-closing step, the method 
can be applied and extended to other easily available sugars to construct versatile cyclic chiral 
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